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ABSTRACT 
SHALINI MINOCHA: Investigations into the Mechanisms of Cell Death: The Common 
Link between Anticancer Nanotherapeutics and Nanotoxicology 
(Under the direction of Russell J. Mumper, Ph.D.)  
 
Nanotoxicology and anticancer nanotherapeutics are essentially two sides of the same 
coin. The nanotoxicology discipline deals with the nanoparticle (NP)-induced toxicity and 
mechanisms of cell death in healthy cells, whereas anticancer agents delivered via nano-
based approaches aim to induce cell death in abnormally proliferating cancer cells. The 
objectives of the studies presented herein were two-fold; to (a) systematically study the 
physico-chemical properties and cell death mechanisms of model NPs and (b) utilize the 
knowledge gained from cell death-nanotoxicity studies in developing a potentially novel 
anticancer nanotherapeutic agent. For the first objective, the effect of a distinguishing 
characteristic, i.e., surface carbon coating on the matched pairs of carbon-coated and non-
coated copper and nickel NPs (Cu, C-Cu, Ni and C-Ni) on the physico-chemical properties 
and toxicity in A549 alveolar epithelial cells were evaluated. The effect of carbon coating on 
particle size, zeta potential, oxidation state, cellular uptake, release of soluble metal and 
concentration dependent toxicity of Cu and Ni NPs was systematically evaluated. A 
significant effect of carbon coating was observed on the physico-chemical properties, 
interaction with cellular membranes, and overall toxicity of the NPs. C-Cu NPs, compared to 
Cu NPs, showed four-fold lower release of soluble copper, ten-fold higher cellular uptake 
and protection against surface oxidation. In toxicity assays, C-Cu NPs induced higher
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 mitochondrial damage than Cu NPs whereas Cu NPs were associated with a significant 
damage to plasma membrane integrity. Nickel and carbon coated nickel NPs were less toxic 
compared to Cu and C-Cu NPs. Thus, by studying the effect of carbon coating, correlations 
between physico-chemical properties and toxicity of NPs were established. 
The second objective was focused on utilizing nano-based approaches for the 
intracellular delivery of an anticancer agent, Cytochrome c (Cyt c), to breast cancer cells for 
inducing apoptosis. Cytochrome c is an endogenous mitochondrial protein and upon its 
release to cytosol, leads to apoptotic cell death. Although the mechanism by which Cyt c 
induces apoptosis theoretically makes it an attractive anti-cancer therapeutic agent, the lack 
of physicochemical characteristics required for successful cell permeation requires the use of 
delivery systems such as nanocarriers to facilitate its intracellular delivery. Cytochrome c, 
being a protein, is susceptible to changes in structural integrity and aggregation which might 
occur upon exposure to organic solvents and high shear/stress conditions, often used during 
nanoparticle preparation. Furthermore, successful delivery to cell cytosol requires endosomal 
release. Therefore, to deliver Cyt c intracellularly, while maintaining conditions for its 
stability, entrapment was performed using a film hydration method with 1,2-dioleoyl-3-
trimethylammonium-propane and cholesterol (DOTAP-Chol) liposomes. It was shown that 
modulation of hydration buffer pH from 7 to 8.5 increased entrapment of Cyt c in DOTAP-
Chol liposomes from 2% to 30%. The optimized formulation showed apoptotic activity in 
MDA-MB-231 cells. It was also shown that no aggregation, secondary and heme crevice 
structure change and deamidation was observed for Cyt c released from optimized 
formulation and that released Cyt c retained apoptotic activity after storage of formulation for 
twenty eight days at 4 oC.
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 Chapter I 
 
Metal-Based Nanoparticles and their Toxicity  
 
1.1    Summary  
Nanoparticles, due to their small size and unique properties, offer tremendous 
opportunities and applications in many fields. The risk of exposure of nanoparticles to 
humans is yet to be fully known, since only limited data is available on exposure that can 
occur during occupational settings. Metal NPs have gained most popularity in terms of 
applications and according to a recent analysis report by project on emerging 
nanotechnologies, five out of six  materials currently referenced in nanotechnology consumer 
products are metal based. The rapid growth in the number and use of NPs requires rapid and 
reliable methods to test their toxicity potential. In-vitro cell culture based methods can 
provide information on the mechanism of toxicity and differences in toxicity between various 
NPs. However, the dynamic nature of NPs in cell culture media can lead to changes in NP 
composition, agglomeration and release of toxic ions and can complicate the interpretation of 
results from nanotoxicity studies if careful and detailed investigations into the physico-
chemical properties are not undertaken. This chapter provides an introduction to the 
nanotoxicity field and emphasizes the need to rigorously evaluate the physico-chemical 
properties of NPs along with their toxicity. The sections in this chapter will focus on (1) 
introduction to the emergence of the nanotoxicity field, (2) issues in evaluating NP toxicity
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and regulatory status for monitoring NP toxicity (3) increasing applications of metal NPs, (4) 
literature review of studies on metal NP toxicity evaluation in-vitro,  and (5) the need to 
systematically evaluate the physico-chemical properties of NPs and rationale for choosing 
carbon coated and non-coated copper and nickel NPs for toxicity evaluation studies. 
1.2    Emergence of Nanotoxicity Field and Relevance 
Nanoparticles are defined by the National Nanotechnology Initiative and the Food and 
Drug Administration as particles with at least one dimension less than 100 nm. Here after, 
engineered or manufactured nanoparticles will be referred to as NPs. Nanoparticles due to 
their small size offer exciting opportunities for application in various fields as diverse as 
medicine, semiconductor, agriculture and information technology. The unique characteristic 
of NPs is their small size that creates larger surface areas compared to large particles with 
same mass per unit volume (Nel et al., 2006). Unique properties of NPs have opened many 
avenues for a variety of new applications. There are already 1317 nanotechnology based 
products in nanotechnology consumer products inventory (nanotechproject.org, 2012). Along 
with the increase in manufacturing capability and applications of NPs over the past decade, 
there has also been considerable increase in research efforts dedicated to understand the 
adverse effects of NPs. 
Historically, particle based toxicity has been attributed to air-borne particulate matter 
and inorganic materials. Exposure to particulate matter from pollution has been correlated to 
mortalities caused by cardiovascular and respiratory diseases (Pope et al., 2004). 
Furthermore, research has shown that particular size fractions PM10 (particulate matter with 
an average aerodynamic diameter of 10 micron or less) present in the environment correlate 
to health risks. Particle fraction composed of particulate matter with an average diameter of 
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2.5 micron or less (PM 2.5) and ultrafine particles (less than 100 nm) have also been 
investigated as potential concerns to human health (Donaldson et al., 2001). Asbestos related 
toxicity is well documented and has been linked with mesothelioma (Boffetta, 1998). NPs, 
however, are different from ultrafine particles in many ways. Ultrafine particles are highly 
heterogeneous and polydisperse whereas NPs usually are of well defined chemical 
compositions and their size and surface properties can be modified depending on surface 
coatings (Oberdorster et al., 2005). Given the unique properties of NPs, their increasing 
applications and differences from airborne ultrafine particles, the discipline of 
nanotoxicology emerged. Oberdoster et al., referred to nanotoxicology as an emerging 
discipline evolving from studies of ultrafine particles and defined it as “science of engineered 
nanodevices and nanostructures that deals with their effects on living organisms” 
(Oberdorster et al., 2005). Toxicity of NPs has been shown to be more than large particles of 
similar compositions and a clear size dependent increase in toxicity has been demonstrated. 
The higher toxicity of NPs over larger particles has been attributed to increased proportion of 
atoms on the NP surface as the size decreases. Moreover, especially below 100 nm, there is 
an exponential increase in the percent surface atoms on the NP surface (Figure 1.1). It was 
also suggested that not only the extent of toxicity but type of interaction with cellular and sub 
cellular structures can be different for NPs, given their higher reactivity and change in 
surface properties at such small size (Donaldson et al., 2004; Oberdorster et al., 2005). 
Additionally, it has been shown that ultrafine particles and NPs due to their small size could 
evade the defense mechanisms such as macrophages in lungs and can translocate from 
alveolar epithelium to systemic circulation (Simko and Mattsson, 2010). Thus, it is very 
important to systematically evaluate the potential adverse effects of NP exposure and more 
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importantly to determine the physico-chemical characteristics of NPs that may give rise to 
NP toxicity so that the best of nanotechnology could be harnessed while maintaining human 
and environmental safety. 
1.3    Issues in Evaluating NP Toxicity and Regulatory Status for Monitoring NP 
Toxicity 
Some reports pertaining to in-vitro toxicity evaluations are rather perplexing since the 
testing results of the same or very similar material in different labs has given different results. 
The variation in toxicity data of NPs can be attributed to source, method of dispersion, 
interference with absorbance or fluorescence data and most importantly lack of detailed 
physical and chemical characterization. For example, Worl-Knirsch et al. reported that false 
positive results were obtained when carbon nanotube toxicity was tested with the MTT ((3-
(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay because the nanotubes 
interfered with the measured absorbance (Worle-Knirsch et al., 2006). Similar results were 
observed while testing carbon NP toxicity with neutral red dye (Monteiro-Riviere and Inman, 
2006). As carbon NPs have large surface area and adsorptive properties, neutral red was 
adsorbed on the NP surface and showed false negative results. Special precautions, proper 
controls and use of multiple cytotoxicity assays has been suggested to overcome possibly 
conflicting results (Stone et al., 2009). Nanoparticles are usually dispersed in relevant 
biological media before testing their toxicity. Change in particle size, agglomeration, 
composition and release of toxic metal ions are some of the issues that have been reported, 
thus it is very important to measure the physico-chemical characteristics and toxicity of NPs 
in relevant biological media (Maiorano et al., 2010; Murdock et al., 2008; Warheit, 2008). 
The dynamic nature of NPs has given rise to difficulties in assessing the contribution of the 
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nanoparticulate state towards observed toxicity. Therefore, the need to correlate the physico-
chemical properties of NPs with toxicity end points has been much emphasized (Powers et 
al., 2006; Warheit, 2008). Another aspect of NP toxicity evaluation is to understand the 
mechanisms underlying these toxic manifestations. A hierarchical oxidative stress paradigm 
has been suggested by Nel et al. (Nel et al., 2006). They emphasize a tiered approach towards 
evaluation of NP toxicity, starting with antioxidant defense responses followed by 
inflammatory pathway and finally effects on mitochondria. 
Seaton et al. described in their review that “Hazard of a material translates into risk by 
exposure of humans and /or their environment to the agent in question, and risk is reduced by 
control of exposure usually guided by regulation based on understanding of the mechanism 
of action” (Seaton et al., 2009). The widespread application of NPs in various products poses 
a risk of exposure to humans and the environment at various stages of the NP lifecycle. 
Starting from small scale synthesis on the bench to large scale commercial production to 
transfer operations requiring manipulation of NPs into products to consumer end use to final 
disposal, all stages are portals where NP exposure can occur (Oberdorster et al., 2005; Seaton 
et al., 2010). Thus, it is important to regulate the potential levels of exposure and be aware of 
risks associated with exposure. However, establishing the limits for NP exposure has been 
complicated for various reasons. Limited data on real life exposure scenarios (such as 
increase in the levels of NP concentration while transfer and handling operations of NPs) is 
available and shows higher particulate concentration compared to background (Hirano, 2009; 
Seaton et al., 2009). Furthermore, due to varied applications of NPs, the regulatory authority 
which would pass regulations also differs. Thus far, no specific regulatory requirements exist 
for NPs compared to their bulk counterparts. Recently, FDA guidance on the use of 
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nanotechnology by the food and cosmetic industries has been released for public comment 
(FDAfactsheet, 2012).  
1.4    Increasing Applications of Metal NPs 
According to a recent analysis report by project on emerging nanotechnologies, five 
out of six NP materials currently referenced in nanotechnology consumer products are metal 
based (nanotechproject.org, 2012). Metal based NPs have a myriad of applications ranging 
from their use in semiconductors, in imaging and as antimicrobial agents, to name just a few. 
Furthermore, the possibility of modifying their surfaces by coating with various functional 
groups can further enhance their application potential. Table 1.1 provides a compilation of 
applications of various metal based NPs. Considering the tremendous increase in the use and 
production of metal based NPs, toxicity testing requires development of rapid and reliable 
methods. Since, in-vivo testing is time consuming, expensive and requires animal use, in-
vitro testing of NP toxicity has been vastly employed. Although, in-vitro tests are relatively 
rapid and inexpensive as compared to in-vivo tests, many issues relating to changing NP 
physico-chemical characteristics in biological media complicates interpretation of in-vitro 
toxicity results. Thus, there exists a need to systematically evaluate the toxicity of NPs such 
that one characteristic can be studied at a time and some level of correlation can be made 
between the physico-chemical characteristics and observed toxicity end points. Tremendous 
efforts have been dedicated towards assessing toxicity of metal NPs using in-vitro methods. 
Therefore, the next section will present the chronological review of literature for the past ten 
years in metal based in-vitro toxicity analysis. The review pertains to the type of metal NP, 
cell line, mechanism of toxicity and special attention was paid to whether any correlation 
between physico-chemical properties and toxicity was evaluated 
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1.5    Literature Review 
Jaeger et al. studied the in-vitro toxicity of TiO2 NPs (20 nm) in HaCaT keratinocytes 
by evaluating increases in ROS (reactive oxygen species), damage to mitochondrial DNA, 
and micronucleus formation (Jaeger et al., 2012). The authors observed a 2.2-fold and a 1.8-
fold increase in micronucleus formation after treatment with 5 µg/mL (48 h) and 10 µg/mL 
(24 h) doses of TiO2, respectively. They reported damage to mitochondria as a result of 
increased ROS, however, the effect of particle size and distribution on toxicity was not 
examined.  
Murray et al. studied the in-vitro toxicity of dextran coated superparamagnetic iron 
oxide NPs of varied particle sizes (15 nm, 20 nm, and 50 nm) acquired from different sources 
(Murray et al., 2012). The toxicity was evaluated in HEK human epidermal keratinocytes and 
murine epidermal cells. The authors reported differences in internalization of NPs depending 
upon the source. A decrease in HEK cell viability was observed from 20 nm NPs, while 15 
nm and 50 nm NPs did not result in decrease in viability. However, the authors did not 
investigate the underlying reasons for differences in toxicity and internalization from the NPs 
of different sizes and sources.  
Mbeh et al. assessed the toxicity of magnetite (Fe3O4) NPs with different surface 
coatings (Mbeh et al., 2012). Three types of coatings were evaluated: (a) a shell of amine 
containing silane (i.e., Fe3O4-NH2), (b) a shell of silica (i.e., Fe3O4-SiO2), and (c) a shell of 
amine containing silane over a shell of silica (i.e., Fe3O4-SiO2-NH2). The toxicity of these 
NPs was systematically evaluated in A549 cells. Higher cytotoxicity was reported with 
amine coated NPs (i.e., Fe3O4-NH2) compared to other coatings. Interestingly, the authors 
also monitored the effect of time for which the NPs were suspended in cell culture medium 
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prior to their exposure to cells. Higher toxicity was observed for NPs which were suspended 
for 24 h compared to the NPs which were suspended for 2 h. The difference in cytotoxicity 
was attributed to the change in composition of NPs during their suspension in cell culture 
medium.  
The toxicity of 24 nm Ag NPs was studied in THP-1 macrophage cell line by Martinez-
Gutierrez et al. (Martinez-Gutierrez et al., 2012). Ag NPs have been proposed as anti-
bacterial agents and therefore this study also evaluated the anti-bacterial activity of Ag NPs 
in a panel of bacteria isolated from medical devices used in hospital intensive care units. 
Although Ag NPs were highly effective in inhibiting bacterial growth even for resistant 
strains, significant increase in toxicity was associated with 12.5 µg/mL dose in THP-1 cells. 
Therefore, the authors concluded that the beneficial and harmful effects of use of Ag NPs on 
biomedical devices needed to be carefully weighed.   
Saquib et al. evaluated the toxicity of TiO2 NPs (30.6 nm, rutile) in human amnion 
epithelial cells (WISH) (Saquib et al., 2012). A dose range of 0.62-10 µg/mL was evaluated 
and a significant increase in ROS and reduction in glutathione levels were observed at 10 
µg/mL. The dose dependent cytotoxicity observed in WISH cells was attributed to increase 
in ROS. 
Silver NP toxicity was evaluated by Mukherjee et al. in HaCaT keratinocytes and HeLa 
cervix epithelial adenocarcinoma cell lines (Mukherjee et al., 2012). A dose and time 
dependent increase in toxicity and a decrease in glutathione levels was observed in both cell 
lines. A significant difference in the sensitivity of two cell lines towards Ag NPs was 
observed, where HeLa cells were more sensitive and this was attributed to naturally 
occurring low antioxidant level in HeLa cells compared to HaCaT cells. 
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Choi et al. studied the toxicity of gold NPs (30 nm) in A549 human lung alveolar 
epithelial cells and reported an IC50 of 49 µg/mL using the MTT assay after 24 h exposure 
(Choi et al., 2012). The authors demonstrated coating of the negatively-charged gold NPs 
with components of serum in cell culture medium and uptake of the protein coated NPs in 
A549 cells. Intrinsic (increased mRNA expression of pro-apoptotic proteins bax and bak) and 
extrinsic (increased caspase-8 activity) apoptotic pathways were shown to be involved in 
gold NP induced cell damage.   
Hematite (α-Fe2O3) NP and microparticle toxicity was evaluated in lung cancer cell 
lines (BEAS-2B and IMR-90) (Bhattacharya et al., 2012). In this study, the genotoxic effects 
of both microparticles and NPs at 50 µg/mL concentrations were observed. The authors 
reported only slightly higher toxicity from NP exposure as compared to microparticles and 
this was attributed to higher agglomeration of NPs in comparison to microparticles. In 
conclusion, the authors highlighted the importance of characterizing physico-chemical 
properties of NPs and correlating them to the observed cytotoxic effect.  
The cytotoxicity of cadmium (Cd)-based quantum dots (QD), specifically CdTe 
(cadmuium telluride) was studied by Chen et al. using the MTT assay (Chen et al., 2012). 
The cytotoxicity of CdTe QDs was reported to be higher than CdCl2 at equivalent 
intracellular Cd2+ ions concentrations. The abnormally high local concentration of Cd2+ ions 
in the peri-nuclear region after treatment with CdTe QDs was linked to the additional toxicity 
due to nanoscale effects of CdTe QDs.  
The toxicity of TiO2 NPs with UVA co-exposure was evaluated in retinal pigment 
epithelial cells (ARPE-19) (Sanders et al., 2012). Nanoparticles of different sizes (22-214 
nm) and compositions (anatase, rutile, and anatase/rutile) were evaluated.  It was found that 
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UVA co-exposure increased the toxicity of TiO2 NPs. The 25 nm anatase and 31 nm 
anatase/rutile were reported as highly phototoxic with an IC50 of < 5 µg/mL, and 142 nm 
anatase and 214 nm rutile were reported as least phototoxic. The authors reported the 
increased cytotoxicity of TiO2 NPs with UVA co-exposure due to increased reactivity of 
TiO2 NPs. A systematic correlation was drawn between higher reactivity of TiO2 NPs 
(quantified by an acellular thiobarbituric acid reactive substances assay) and IC50 values 
measured in cell-based cytotoxicity assays. 
Sun et al. evaluated a panel of metal oxide NPs (CuO, silica, TiO2 and Fe2O3) for their 
toxicity in-vitro in A549 cells (Sun et al., 2012). They reported that CuO NPs were highly 
toxic and resulted in 30% viability after 24 h treatment with 30 µg/mL dose, whereas other 
NPs except silica (slightly toxic) were not found to be toxic at the same dose. A significant 
increase in LC3-II protein (microtubule associated protein1 light chain 3) and accumulation 
of autophagosomes in A549 cells after treatment with CuO NPs was observed. Therefore, 
autophagy was reported as a possible mechanism by which CuO NPs induced cell-death. 
However, no information was presented on particle size assessment or aggregation potential 
of the panel of NPs that were tested.  
Park et al. studied the effect of particle size on cytotoxicity, inflammation, and 
genotoxicity of Ag NPs in-vitro in L929 fibroblasts and RAW 264.7 macrophages (Park et 
al., 2011). Three different particle sizes: 20 nm, 80 nm, and 113 nm were evaluated. It was 
found that 20 nm particles displayed higher toxicity than 80 nm and 113 nm particles. The 
authors investigated the role of acellular ROS production as a possible reason for higher 
cytotoxicity observed with 20 nm particles, however, this poorly correlated with ROS 
generation potential of different sized NPs in cell-based assays. The authors also reported 
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higher sensitivity of L929 fibroblasts towards NP induced cytotoxicity compared to RAW 
264.7 cells. The possibility of higher release of Ag ions in lysosomes of cells was suggested 
as a possible reason for higher toxicity with 20 nm particles. However, no direct correlation 
or underlying reasons were reported for higher toxicity observed with 20 nm particle 
compared to larger sized 80 nm and 113 nm NPs.  
Zhang et al. compared the toxicities of TiO2, ZnO, SiO2 and Al2O3 NPs (primary size 
20 nm) in human fetal lung fibroblasts cells (HFL-1) (Zhang et al., 2011). They reported that 
ZnO showed most cytotoxicity in HFL-1 cells compared to other NP types. A dose range of 
250-1500 µg/mL was tested for all NPs and a dose dependent increase in cytotoxicity was 
reported. The dose range used by the authors was particularly higher compared to other 
studies. Furthermore, no correlations were drawn between the higher toxicity of ZnO and its 
physico-chemical properties compared to other NPs.  A similar report by Sun et al. also 
compared the toxicities of six different metal oxide NPs (Sun et al., 2011). Toxicity of ZnO, 
CuO, Fe2O3, Fe3O4, MgO and Al2O3 NPs in human cardiac microvascular endothelial cells 
(HCMEC) was evaluated at two time points (12 h and 24 h) and six dose levels with a 
maximum dose of 100 µg/mL. The authors reported ZnO and CuO as most toxic NPs 
followed by MgO, and reported no toxic effects of Fe2O3, Fe3O4 and Al2O3 NPs in 
HCMEC’s. However, similar to previous studies, this study also did not correlate the 
physico-chemical characteristics of the NPs displaying toxicity versus the “non-toxic” NPs in 
order to understand the origin of toxicity and concluded that compositional differences exist 
in toxicity of NPs. Although, the particles size and zeta potential analysis indicated higher 
agglomeration and close to zero zeta potential of Fe2O3 and Fe3O4 NPs compared to other NP 
types, this observation was not discussed. 
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Afeseh Ngwa et al. evaluated the neurotoxicity potential of Mn NPs in N27 
dopaminergic neuronal cells (Afeseh Ngwa et al., 2011). They characterized particle size of 
Mn NPs upon suspension in cell culture media and reported agglomeration of NPs ranging 
from 100 nm to 900 nm in size. The neurotoxic effects of Mn NPs in dopaminergic N27 cells 
were characterized by an elevation of ROS and induction of apoptosis (caspase 3 activation). 
However, the authors reported that ROS was not the only mechanism leading to cell death as 
co-incubation of antioxidants did not rescue cells. Autophagic cell death (overexpression of 
LC 3 protein) was reported to be another pathway induced by Mn NPs as cause of 
neurotoxicity. 
A systematic study of Ag NP and Ag microparticles to induce hemolysis was studied 
by Choi et al. (Choi et al., 2011).The authors studied the effect of surface citrate coating and 
size on hemolysis. They tested citrate coated Ag NPs (< 100 nm), non coated Ag NPs (35 
nm), citrate coated Ag microparticles and heat treated Ag microparticles (to remove surface 
citrate coating). They evaluated the effect of varying suspension conditions (DI water, PBS 
and PBS/Plasma mixtures) on agglomeration of NPs in order to compare the physico-
chemical properties of particles in media conditions relevant to hemolysis analysis. The 
authors reported that agglomeration varied with changing the media conditions and higher 
agglomeration was observed in PBS and PBS/plasma mixtures compared to DI water. 
Furthermore, higher hemolytic activity due to NPs compared to microparticles was observed. 
The higher hemolytic activity due to NPs compared to microparticles was correlated to 
higher Ag ion release and higher surface area of NPs compared to microparticles. 
Horev-Azaria et al. described a modeling approach to understand and rank the 
parameters that were critical to toxicity of Co NPs and Co ions in-vitro (Horev-Azaria et al., 
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2011). The effects of Co NPs and Co ions were evaluated in six cell lines using different 
concentrations (0.05-1 mM), two time points (48 h and 72 h) and various cytotoxicity assays 
(such as MTT, neutral red membrane integrity and alamar blue assays). As per their 
modeling analysis, the critical parameters influencing toxicity were ranked as follows:  
concentration > compound type (Co NP versus Co ions) > cell model > duration. They also 
correlated the toxicity effects of Co NPs to the release of Co ions from aggregated Co NPs. 
Teodoro et al. reported on the mechanism of mitochondrial toxicity of Ag NPs in rat 
liver mitochondria (Teodoro et al., 2011). The authors reported that Ag NPs affected the 
mitochondrial membrane potential and altered the permeability of mitochondrial membranes. 
They further reported that mitochondrial injury due to Ag NPs affected oxidative 
phophorylation and respiratory functions.  
Hackenberg et al. evaluated the toxicity of ZnO NPs (< 100 nm primary size) in 
primary human nasal mucosa cells in-vitro in the air-liquid interface (Hackenberg et al., 
2011). The effect of ZnO was evaluated on mitochondrial damage, plasma membrane 
integrity, DNA fragmentation and pro-inflammatory potential. A significant genotoxicity 
(DNA fragmentation) at 10µg/mL and cytotoxicity at 50 µg/mL was reported. Additionally 
potent pro-inflammatory potential was observed at 5 µg/mL ZnO NP dose. The authors also 
tested the toxicity of ZnO powder for comparison but did not observe any genotoxicity or 
cytotoxicity at equivalent doses. The authors suggested role of both Zn2+ ions and NPs 
themselves in mediating the genotoxic and cytotoxic effects. 
Naqvi et al evaluated the dose- and time-dependent toxicity of tween 80-coated 
superparamagnetic iron oxide NPs of mean diameter 30 nm on murine macrophage (J774) 
cells (Naqvi et al., 2010). The study also aimed at investigating the role of oxidative stress in 
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this toxicity. Higher concentrations (300-500 µg/mL) of NP and prolonged exposure of ~ 6 h 
resulted in reduced viability of 55-65%, while lower concentrations (25-200 µg/mL) and a 3 
h exposure resulted in 95% viability. The cell membrane injury induced by NPs showed both 
concentration and time dependent killing as well as enhanced production of ROS at higher 
concentrations. The authors concluded that the NP concentration was critical to avoid 
oxidative stress-induced cell injury and death.   
Horie et al. studied the toxicity of TiO2 NP (< 100 nm) in HaCaT keratinocytes (Horie 
et al., 2010). The authors observed and reported formation of secondary TiO2 particles 
(aggregates) upon dispersion in DMEM media supplemented with FBS. No significant 
toxicity was observed except a weak apoptotic response (6-7% apoptotic cells after 24 h 
exposure) which was attributed to increase in ROS.  
Li et al. reported toxicity of Au NPs (35 nm) in human lung fibroblast cells (MRC-5) 
(Li et al., 2010).They showed increased oxidative stress, lipid hydroperoxides generation and 
autophagy as a mechanism of cell death and toxicity. A comprehensive analysis of 
mechanism of toxicity was carried out by the authors. However, little information was 
presented on physico-chemical properties of Au NPs and their possible correlation to toxicity 
mechanisms.  
Samberg et al. studied the toxicity of Ag NPs (unwashed, washed and carbon coated) 
on HEK human keratinocyte cells using a variety of cell viability assays and measurement of 
pro-inflammatory cytokines (Samberg et al., 2010). They reported that Ag NPs (unwashed 
which contained formaldehyde and methanol as by product contaminants of the synthesis 
process) were highly toxic and pro-inflammatory whereas the washed NPs (serial washing by 
PBS) and carbon coated Ag NPs did not display significant toxicity. Thus, the authors 
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concluded that the residual contaminants in the unwashed NPs were responsible for inducing 
cytotoxic effects.  
Liu et al. reported on the toxicity of TiO2 NPs in PC12 neuronal cell line as result of 
increased ROS that lead to apoptosis (Liu et al., 2010). Increased ROS was concluded as a 
mechanism of apoptosis as pretreatment with N-(mercaptopropionyl)-glycine (N-MPG), an 
ROS scavenger inhibited apoptosis. 
Choi et al. compared the toxicity of PEG modified MnO and Fe3O4 NPs with 
commercially available medical contrast agent Feridex in breast cancer, lung 
adenocarcinoma and glioblastoma cells (Choi et al., 2009). They reported that no toxicity 
was observed after 18 h incubation with PEG modified MnO, Fe3O4 NPs or Feridex at a 
concentration of 500 µg/mL. It was found that  only after 2 days and 4 days, did PEG coated 
MnO NPs display toxicity.  
Kim et al. studied the toxicity of Ag NPs in comparison to AgNO3 in human hepatoma 
cells to assess the role of Ag+ ions in toxicity of Ag NPs (Kim et al., 2009). The Ag NPs 
were de-ionized using an ion exchange resin before exposing the NP suspension to cell 
culture. They report equivalent toxicity and ROS induction by AgNO3 and Ag NPs; however 
the expression of metallothionein 1b (a protein presumably reported to be increased by Ag+ 
ions) was elevated only in AgNO3 treated cells. The authors concluded that the toxicity of Ag 
NPs was due to NPs themselves rather than Ag+ ions, however they discussed the possibility 
of release of Ag+ ions from Ag NPs in cell culture media during their incubation with cells.  
Ponti et al. studied the toxicity of Co NPs and Co2+ ions in BALB/3T3 mouse 
fibroblast cells (Ponti et al., 2009). They found that Co NPs were more toxic than Co2+ ions 
at shorter incubation times (2 h and 24 h). However, 72 h after incubation, the toxicity 
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profiles was similar for Co2+ ions and Co NPs when only 35% of Co2+ ions were released 
from Co NPs after 72 h under cell culture conditions. Thus, they attributed the toxicity of CO 
NPs due to both Co2+ ions and the NPs themselves. 
Ghio et al., studied the effect of secondary organic aerosols and inorganic acids 
(constituents of particulate matter in ambient air) on the toxicity of Fe3O4 NPs in BEAS 2B 
human bronchial epithelial cells (Ghio et al., 2009). The authors showed that cell associated 
Fe concentrations were significantly higher than controls only after co-exposure of Fe3O4 
NPs with secondary organic aerosols and inorganic acids. Concomitantly, an increase in 
oxidative stress and IL-8 levels were also observed in cells exposed to Fe3O4 NPs with 
secondary organic aerosols and inorganic acids. Therefore, the authors concluded that 
secondary organic aerosols and inorganic acids interacted with Fe3O4 NPs to change their 
cellular uptake and consequently their toxicity. 
Horie et al. studied the effect of protein adsorption by various metal NPs (ZnO, CeO2, 
TiO2, SiO2 and Fe2O3) on cell viability in A549 and HaCaT cells (Horie et al., 2009). They 
hypothesized and showed that after incubating cells with supernatants (obtained after 
centrifuging the NP and media mixture), significant decrease in cell viability was observed. 
They also showed that the decrease in cell viability was specifically induced by loss of 
protein from media because the decrease in cell viability was not observed from incubation 
with supernatants (when NPs were pre-incubated with FBS (fetal bovine serum)). The loss in 
cell viability due to protein adsorption by NPs was specifically relevant for inherently low 
toxicity NPs such as TiO2 compared to ZnO NPs where release of Zn2+ ions can also induce 
toxicity. 
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Monteiller et al. evaluated in their studies with TiO2 NPs and fine particles, the 
comparative correlation of descriptors (surface area versus mass) of concentration with 
toxicity (Monteiller et al., 2007). They dosed equal masses of TiO2 NPs and fine particles to 
A549 cells and found that at equivalent mass, TiO2 NPs produced much stronger pro-
inflammatory and oxidative stress response than fine particles. They concluded that surface 
area descriptor better correlated with toxicity and plays an important role in reactivity and 
inflammatory potential as particle size decreases. 
Limbach et al. have shown that NPs containing active and reactive metals can act as 
“trojan horses” for carrying the reactive metal in cells (Limbach et al., 2007). The authors 
systematically tested a series of similarly shaped and sized SiO2 NPs containing Fe, Co, Mn 
and Titania and respective metal salts for their potential to induce oxidative stress in-vitro. 
They reported that the oxidative stress induced upon treatment with metal containing SiO2 
NPs was much higher than salt solutions. They concluded that NPs carrying catalytically 
active metal sites can induce oxidative stress by a “trojan horse” type mechanism. 
1.6    Need for Systematic Studies Correlating Metal NP Toxicity/Mechanisms with 
Metal NP Physico-chemical Characteristics 
Metal NPs have seen tremendous growth in both production and applications in recent 
years. The increasing use and exposure of metal-based NPs warrants rigorous and systematic 
toxicity evaluations to maximize the benefit/risk ratio of the immense advancements, the 
metal NPs have to offer. Although the field of nanotoxicology is still in its infancy, many 
research efforts have been dedicated to understanding the mechanisms underlying toxicity of 
metal-based NPs in-vitro in cell lines of different origins. The challenges associated with 
determining toxicity of metal NPs are multifold and include factors such as size, zeta 
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potential, surface area, composition, hydrophobicity, impurities and importantly release of 
toxic metal ions that might contribute to the toxicity (Figure 1.2). Many studies outlined in 
literature review above investigated the detailed mechanisms of toxicity of a single metal NP 
or a group of metal NPs, however only a few studies have shown the correlation of NP 
physico-chemical characteristics with the observed toxicity. Thus, systematic studies that can 
deconvolute the reasons underlying toxicity of metal NPs are required to aid in understanding 
“which physico-chemical properties result in toxicity” so that manufacturing of safe and 
applicable NPs could be directed.  
Copper and nickel NPs are being used in a variety of applications. Various applications 
of Cu and Ni NPs are summarized in Table 1.1. Oxidation of Cu and Ni NPs can alter the 
surface properties and hence carbon coating on the surface of metal NPs can help protect 
them against oxidation (Luechinger et al., 2008). Although surface carbon coating preserves 
the functionality, it can result in a change in physico-chemical properties and toxicity of Cu 
and Ni NPs and it is important that the effect of surface coating on the physico-chemical 
properties and toxicity of metal NPs is investigated. Therefore, it was decided to investigate 
the physico-chemical characteristics and toxicity of matched pairs of non-coated Cu and Ni 
NPs and carbon-coated Cu and Ni NPs. The hypothesis was that carbon coated NPs will have 
different physico-chemical properties including their interactions with the surrounding media 
and cells than non-coated NPs, which will influence the resultant toxicity in cell-based 
assays.  
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Table 1.1 Metal NPs and their Diverse Applications 
 
 
NP Type Applications Reference 
Al, Al2O3 Wear resistant coatings, fuel and drug delivery systems 
(Tyner et al., 2004; 
Wagner et al., 2007) 
Ag, C-Ag Antimicrobial agent in medical devices, wound dressing, clothing and water purification systems 
(Chaloupka et al., 2010; 
Choi et al., 2011) 
Au Imaging, radiotherapy enhancement (Boisselier and Astruc, 2009; Cai et al., 2008) 
Cd Quantum dots, bioimaging, diagnosis (Chen et al., 2012; Su et al., 2011) 
Cu, C-Cu Bacteriostatic and antifungal agents, conducting inks, batteries, fuel cells, catalysts and antifouling agents 
(Barrabes et al, 2006; 
Nicola et al., 2005; 
Tarasov et al., 2002; Yoon 
et al., 2007; Zhang et al., 
2007) 
Co Information storage, magnetic fluid, catalyst (Puntes et al., 2001) 
Fe2O3, Fe3O4 Drug delivery, imaging and diagnosis 
(Kumar et al., 2007; 
Lanone et al., 2009; Na et 
al., 2009) 
      MgO Antimicrobial agents (Jin and Yiping, 2012) 
Mn, MnO Catalyst, fuel additive, colorant (Han et al., 2005) 
Ni, C-Ni Catalyst and magnetic properties (Park et al., 2005; Wang etal., 2008) 
TiO2 
Sunscreen, photovoltaic devices, degradation of 
organic environmental contaminants 
(Klaine et al., 2008; Kwon 
et al., 2008; Muneer et al., 
2002) 
ZnO Cosmetics, catalysts, composite materials (Veranth et al., 2007) 
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Figure 1.1 Percent surface molecules versus size relationships for NPs. The percentage of 
surface molecules in NPs increases exponentially as their size decreases below 100 nm. This 
can have profound implications on the reactivity of NPs and their resultant toxicity. Figure 
from Oberdorster et al. (Oberdorster et al., 2005) 
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Figure 1.2 Nanoparticle physico-chemical properties and toxicity mechanisms. Various NP 
physico-chemical properties such as size, surface charge, release of toxic metal ions and 
surface coating can influence their interaction with surrounding media and cells during in-
vitro toxicity testing and lead to differences in toxicity end-points. Therefore, it is imperative 
to carefully study the physico-chemical characteristics of NPs before and during toxicity 
analysis. 
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Chapter II 
 
Studies on Nanotoxicity Motivate and Lead to Studies on Anticancer Nanotherapeutics 
 
Chapter I describes the emergence of the nanotoxicology field and the importance of 
correlating the physico-chemical properties to mechanisms of cell death. For this purpose, 
Cu, C-Cu, Ni and C-Ni were chosen as model NPs and Chapter IV will describe the studies 
on these NPs in detail. In nanotoxicology studies, the mechanisms that induce cell death are 
studied and cell death is an undesirable effect. In contrast, anticancer agents aim to induce 
cell death in cancer cells because they have a tendency to proliferate abnormally. Induction 
of apoptosis (a form of cell death) is one of the mechanisms by which anticancer agents act. 
Therefore, the knowledge gained from understanding mechanisms of cell death such as 
apoptosis can be applied to devise anticancer nanotherapeutics. Cytochrome c (Cyt c) is an 
endogenous protein involved in inducing apoptosis, thus nanocarrier-based approach will be 
used for delivering Cyt c (an anticancer agent) intracellularly for inducing cell death in breast 
cancer cells. Although, it at first may seem that studies on nanotoxicity and intracellular 
delivery of Cyt c are unrelated, essentially they are the two sides of the same coin (Figure 
2.1). Chapter III will describe various aspects of intracellular protein delivery and Chapter V 
will focus on specific studies to demonstrate stability and intracellular delivery of Cyt c. 
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Figure 2.1 Mechanisms of cell death: The common link between nanotoxicology and 
anticancer nanotherapeutics. In nanotoxicology, cell death is an undesirable effect whereas in 
anticancer therapeutics, mechanisms to induce cell death are sought. Apoptosis is one of the 
mechanisms by which cell death occurs. Cytochrome c is an endogenous protein involved in 
inducing apoptosis. Therefore, intracellular delivery of Cyt c will be studied to induce 
apoptosis in breast cancer cells. 
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Chapter III 
 
Nanocarrier-based Intracellular Protein Delivery: Challenges and Opportunities  
 
3.1    Background  
Though only accounting for 8% of currently marketed therapeutic products, biologics 
represent more than 42% of the global pharmaceutical pipeline and are positioned to surpass 
small molecules as the top grossing drugs by 2014 (Evaluatepharma, 2012). Proteins, the 
cellular workhorses of cells and largest class of marketed and pipeline biologics, play a role 
in almost every biochemical process, including digestion, respiration, cellular signaling and 
homeostasis. With exquisite specificity and biological activity, proteins find broad 
applications as leading therapies for cancer, infectious disease, and many autoimmune 
diseases. As of 2011, the Pharmaceutical Research and Manufacturers of America’s report on 
“Biotechnology Medicines in Development” listed 901 new biotechnology medicines 
currently in development, of which monoclonal antibodies and therapeutic proteins account 
for almost 400 – up by 40% in just 3 years (PHRMA, 2012).  
The field of drug discovery has progressed remarkably over the last two decades, yet 
challenges remain in intracellular protein delivery. Technological advances in high 
throughput screening and studies on cellular, metabolic, and signaling pathways have rapidly 
and reliably identified vast libraries of new drug targets; however, these targets localize in  
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the cellular or sub-cellular environment, making access a new and noteworthy challenge. 
Intracellular targets remain elusive for all classes of drugs, but especially for proteins, which 
are often too large and too polar to permeate the cell membrane alone (Torchilin and 
Lukyanov, 2003).  
Research groups have utilized a variety of strategies to deliver therapeutic proteins 
intracellularly. More than two decades ago, Robert Langer suggested that therapeutic 
proteins would necessitate novel delivery systems, in part because they are inherently more 
complex than their conventional small molecule counterparts (Langer, 1990). Differences in 
size and physico-chemical properties between small molecules and proteins naturally demand 
a completely new set of strategies to formulate and deliver proteins. In fact, proteins with 
remarkable homogeneity display markedly different physico-chemical properties. Slight 
changes in amino acids on an antibody can display huge differences in solubility, viscosity, 
and thermodynamic stability (Yadav et al., 2012).   
In theory, protein drugs need only be delivered in low doses due to their relatively 
specific mode of action; however, therapeutic potential and clinical application of protein 
drugs are frequently hampered by various obstacles to successful delivery (Frokjaer and 
Otzen, 2005; Wang, 1999), and these obstacles compound when delivering to intracellular 
targets. Rapid elimination of proteins from the systemic circulation due to renal clearance, 
enzymatic degradation, uptake by the reticuloendothelial system (RES), and accumulation in 
non-target tissues have been described as the primary hurdles for protein delivery (Torchilin 
and Lukyanov, 2003). Additionally, serious concerns for protein immunogenicity (due to 
protein unfolding and aggregation) and low efficacy (often due to inefficient cell entry) limit 
the landscape of protein therapeutics (Torchilin and Lukyanov, 2003). Thus, two major 
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challenges in intracellular delivery of therapeutic proteins are (a) limited cellular permeation 
and endosomal release into cytosol and (b) their susceptibility to undergo physical and 
chemical degradation which may lead to loss of activity and pose a risk of immunogenicity. 
Utilizing nanocarrier-based carriers to deliver therapeutic proteins to the cytoplasm and 
subcellular compartments of the cell represents a promising strategy to expand the landscape 
of therapeutic products for some of the most debilitating diseases (Gu et al., 2011). Many 
factors determine the success of a nanocarrier based system including entrapment of 
therapeutic cargo in the nanocarrier as well its efficient cellular uptake. Several review 
papers have emphasized the factors important in nanocarrier based drug delivery (Li et al., 
2012; Torchilin, 2006). However, most of the research efforts in intracellular protein delivery 
have been dedicated towards developing strategies to enhance cell permeation and 
endosomal release and less attention has been paid to formulation and process related stress 
conditions that may lead to instability of protein therapeutics. Therefore, the following 
sections will focus on: (1) review of literature pertaining to approaches used for intracellular 
delivery of proteins for the last twenty years, paying special attention to whether or not 
protein stability was assessed, (2) common pathways for physical and chemical instability of 
proteins, (3) need for evaluating protein stability as part of protein delivery approach, (4) 
importance of endosomal release in intracellular protein delivery and (5) finally, this chapter 
will end with the introduction of Cyt c which serves to highlight the opportunity to deliver a 
potentially therapeutic protein intracellularly as an anti-cancer therapeutic.  
3.2    Literature Review  
Many research efforts have been dedicated in recent years towards intracellular 
delivery of therapeutic proteins. The following section provides a review of intracellular 
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protein delivery literature for the last twenty years. During review, the focus was to cover the 
approaches used for intracellular delivery of proteins and to assess whether or not protein 
structural stability and activity was evaluated as part of that approach. The review follows a 
chronological order starting with most recent reports. 
Bacterial inclusion bodies have been suggested as protein delivery systems recently 
(Villaverde et al., 2012). Bacterial inclusion bodies are aggregates of recombinant proteins 
formed in (Escherichia coli) E. coli during their recombinant protein production. Leukemia 
inhibitory factor and catalase are some of the proteins that have been reported to be delivered 
in-vitro in cytosol using this approach to rescue cells from serum starvation and oxidative 
stress (Vazquez et al., 2012). The authors (Villaverde et al., 2012) reported that inclusion 
bodies holds promise in intracellular protein delivery due to their mechanically robust nature 
and biocompatibility, but questions remain regarding use of inclusion bodies as protein 
delivery systems due to the inherent nature of inclusion bodies, which contains both partially 
unfolded aggregated proteins and native folded proteins. Aggregation of therapeutic proteins 
is a huge challenge to the successful application of therapeutic proteins and inclusion bodies 
are protein aggregates by their nature (Ventura and Villaverde, 2006; Wang, 2005). Another 
class of delivery agents reported recently was peptides stapled with hydrophobic moieties. 
The approach used in the development of this class of agents was to increase the permeation 
and stability of small peptides by chemically introducing a hydrophobic moiety (stapling) to 
inherently hydrophilic peptides to form conformationally stable mini-proteins which had 
potent biological activity and permeation characteristics.  Many stapled peptides for 
disruption of protein-protein interactions have been applied for both in-vitro and in-vivo 
applications (Bernal et al., 2010; Moellering et al., 2009). A detailed review by Verdine et 
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al., provides information on recent developments in stapled peptides (Verdine and Hilinski, 
2012). Nanoporous silicon particles (NSP) with agarose coating were reported for 
intracellular delivery of model protein bovine serum albumin (BSA) (De Rosa et al., 2011). It 
was reported that BSA from agarose coated NSP’s was more stable against trypsin digestion 
challenge compared to BSA from bare NSP’s as tested via sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS PAGE) and high performance liquid 
chromatography (HPLC). It was also reported that agarose coating enhanced intracellular 
delivery of BSA. Intracellular delivery of proteins via layer-by-layer (LBL) polyelectrolyte 
nanocarriers was investigated by Shu et al. (Shu et al., 2010). They studied the encapsulation 
of a model protein BSA by the LBL method. The particles consisted of various layers of 
poly-electrolytes on a core. A silica nanoparticle with β-cyclodextrin shell was the core. BSA 
was adsorbed onto the β-cyclodextrin shell. Layers of positively charged cysteamine 
conjugated chitosan and negatively-charged dextran sulfate were deposited on BSA coated 
silicon core and crosslinking between various layers of chitosan was achieved by inducing 
disulfide linkage of cysteines. The authors showed that BSA retained its structural integrity 
after release from this nanocarrier system as the α-helix content of native and released BSA 
was similar. They also showed that maintenance of structural integrity was dependent on 
number of layers of chitosan because structural changes in BSA were observed when 
chitosan layer was present in close proximity to BSA. Foltopoulou et al. reported the delivery 
of recombinant Sco2 (synthase of Cytochrome c oxidase) protein in-vitro in various cell lines 
and also primary fibroblast cells using a recombinant fusion protein of TAT with Sco2 
expressed in E.Coli (Foltopoulou et al., 2010). The authors reported partial recovery of 
functions associated with Sco2 protein in cells deficient of Cytochrome c oxidase.  It was 
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also reported that the TAT Sco2 fusion protein was highly aggregated in inclusion bodies and 
had to be dissolved in 1 M arginine after which, it was relatively stable for 2 months at room 
temperature as determined by western blotting. Kundu et al. reported the use of silk fibroin 
protein from mulberry silkworms bombyx mori as carriers for VEGF (Kundu et al., 2009). 
Silk fibroin protein is a biomacromolecule composed of 5507 repeated sequence of Gly-Ala-
Gly-Ala-Gly-Ser amino acids. They loaded VEGF protein (which is positively charged) onto 
preformed negatively-charged silk NPs (which were formed using a DMSO dehydration 
method), and reported sustained release of VEGF over three weeks. However, no stability or 
activity assays were used to characterize released VEGF. Single protein nanocapsules with a 
protein core and a shell of polymeric film have been proposed as intracellular protein 
delivery systems (Yan et al., 2010). Enhanced Green Fluorescent Protein (EGFP), caspase, 
BSA and Horse Radish Peroxidase (HRP) were surface modified with acrylamide groups and 
cross polymerized with degradable or non-degradable functional moieties and delivered to 
Hela cells. During the process of acrylamide attachment on protein surface and crosslinking, 
exposure to DMSO and alkaline conditions were used. The authors reported that fluorescence 
spectra of EGFP resembled native EGFP, however, no other assay for studying protein 
stability was used. 
Recombinant secretory leukocyte protease inhibitor (r-SLPI) delivery in-vitro in lung 
derived cells for potential treatment of inflammatory lung diseases was investigated by 
Gibbons et al. (Gibbons et al., 2009). The authors reported high (74%) encapsulation of r-
SLPI (11.7 KDa) in 1,2-dioleoyl-sn-glycero-phospho-serine  and cholesterol liposomes 
(DOPS-Chol). The stability of liposomal r-SLPI was confirmed using western blotting and 
protection from cathepsin mediated r-SLPI degradation was also tested. Subsequently, 
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delivery and pharmacokinetics of aerosolized liposomal r-SLPI was also investigated in 
asthma guinea pig models and it was reported that liposomal r-SLPI had lower clearance and 
higher intracellular residence times than free r-SLPI (Gibbons et al., 2011).  
Son et al. studied the optimization of an anti DNA antibody 3D8scFv for potential 
intracellular delivery using poly lactic-co-glycolic acid (PLGA) NPs prepared by a water-in-
oil-in- water (w/o/w) encapsulation process (Son et al., 2009). A systematic study was 
undertaken to understand the effect of exposure of antibody to organic solvents and shear 
stress conditions. The antibody was recovered from the primary emulsion and assessed for 
structural integrity using circular dichroism (CD) and fluorescence techniques and 
functionality was assessed using ELISA and agarose gel electrophoresis. The authors also 
studied the effect of various stabilizers like PEG, trehalose, mannitol and heparin on 
structural integrity and functionality and concluded that mannitol provided most protection of 
antibody against various stress conditions. Lee et al.  proposed use of polyionic complex 
(PIC) micelles composed of copolymers of PEG as the neutral block and poly[N-(N’-(2-
aminoethyl)-2-aminoethyl)aspartamide] as the anionic block (Lee et al., 2009). They 
modified Cyt c with citraconic acid and cis-aconitic acid as Cyt c citraconamide and Cyt c 
cis-aconitic amide and encapsulated the modified Cyt c in PIC micelles. The modification of 
Cyt c lysines with citraconic acid and cis-aconitic acids was reported to change the PI of Cyt 
c from 9.6 to 3.7 and 3.4 and facilitate encapsulation. The authors also reported that in-vitro 
at pH 5.5 (endosomal pH),  50-80% of Cyt c reverted back to unmodified Cyt c and that the 
activity of  released Cyt c was similar to native Cyt c as measured by 2,2’-azino-bis(3-
ethylbenzthiazoline-6-sulfonic acid) (ABTS) assay. The authors also studied the uptake of 
modified Cyt c micelles in HuH cells, but no assay to assess the apoptotic activity of PIC 
 38 
 
encapsulating modified Cyt c was performed.  It is interesting that lysine groups of Cyt c 
were modified since it is well known that lysine groups of Cyt c play an important role in 
mediating its apoptotic activity. Furthermore, only 50 to 80 % modified Cyt c reverted to the 
unmodified form. Therefore there is a high likelihood that only part of delivered Cyt c would 
be available for activity. Also, the ABTS assay used to test activity of Cyt c is a non-specific 
assay which only tests the ability of Cyt c to oxidize/reduce the ABTS reagent and may not 
be the ideal assay to measure the apoptotic ability of Cyt c. Reddy et al. reported the 
intracellular delivery of superoxide dismutase (SOD) using PLGA NPs for intracellular 
delivery of SOD in-vitro in human brain neurons against H2O2 induced oxidative stress 
(Reddy et al., 2008). A double emulsion method was used to prepare NPs. SOD and rat 
serum albumin aqueous solution was exposed to PLGA solution in chloroform and also 
probe sonicated. Authors included rat serum albumin with SOD based on previous reports 
which concluded that inclusion of human serum albumin (HSA) protected ribonuclease 
(RNAse) protein against aggregation and conformational changes by competing for 
interfaces in the emulsification process (Sah, 1999). The authors reported that SOD-PLGA 
NPs offered higher protection in human brain neurons against H2O2 induced oxidative stress 
compared to SOD solution but no structural stability investigations were conducted. Dalkara 
et al. suggested for intracellular delivery of proteins use of dimerizable amphiphile-
cholesterol conjugated to spermine with a cysteine group which could dimerize to form 
(cholesterol-spermine)2 (Dalkara et al., 2006). They reported formation of a complex of 
(cholesterol-spermine)2 with DOPE and also used phycoerytherin as a model protein to 
demonstrate in-vitro intracellular delivery potential of this complex. Soane et al. reported on 
the intracellular delivery of B-cell lymphoma 2 (Bcl2) proteins in neuronal cells using TAT 
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peptide to enhance cell survival (Soane and Fiskum, 2005). They expressed the fusion 
protein TAT-Bcl-2Δloop (with loop deletion in Bcl) in E.Coli and the purified fusion protein 
integrity was verified using SDS-PAGE. Intracellular delivery of the fusion protein was 
shown to protect the neuronal cells against staurosporine induced apoptosis in neuronal cells.  
Abbing and coworkers utilized a virus-like particle approach to intracellularly deliver 
green fluorescent protein (GFP) by conjugating the inner core polyoma virus protein VP2 
with GFP to create an inward-facing fusion protein within the VP1 pentamer cavity. This 
capsoid was internalized into cells and showed regular structure and stability for several 
months (Abbing et al., 2004). CA Lackey and colleagues studied the delivery of streptavidin 
to the cytosol of Jurkat T-cell lymphoma cells utilizing an antibody-targeted polymer-protein 
conjugate (Lackey et al., 2002).  The anti-CD3 antibody bound to the CD3 receptor, which 
rapidly internalized the streptavidin-biotinylated poly(propylacrylic acid) complex (PPAAc).  
The PPAAc was reported as a pH-sensitive polymer capable of disrupting membranes at the 
lowered pH within endosomes.  This process released streptavidin into cytosol of the cell 
while trafficked the monoclonal anti-CD3 antibody to the lysosome for degradation. The 
uptake was shown to be dose dependent and endosomal release was also demonstrated. The 
ternary complex showed 73% of the delivered streptavidin was released into the cytoplasm, 
whereas the binary complex (without PPAAC) showed only 29% release into the cytoplasm. 
A western blot to quantify streptavidin activity in the cytoplasm of the cells was also carried 
out. The authors also reported no degradation of the delivered streptavidin as demonstrated 
by an identical cytoplasmic band from the crude cell homogenate.  
Lin-Lee et al. demonstrated the intracellular delivery of a bacterial cytosine deaminase, 
a 45 kDa enzyme which upon co-administration of 5-fluorocytosine is capable of 
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synthesizing the potent cell killer 5-fluorouracil (Lin-Lee et al., 2002). The simple 
recombinant fusion strategy proved successful at retaining the function and stability of the 
protein for several days, likely due to cytoplasmic compartmentalization from degradative 
enzymes.  Given the mechanism of entry provided by the malaria circumsporozoite (CS) 
protein, a membrane ligand that mediates liver-specific invasion, this prodrug strategy 
showed promise as a strategy for the treatment of liver diseases, like hepatocellular 
carcinoma and mild-to-moderate chronic cholestatic liver disease.  Two different cell lines 
were utilized to verify that entry was facilitated by receptor-mediated endocytosis: HepG2, 
which contains receptors for CS protein, and HL60, which does not. Additionally, cell-killing 
experiments were performed with various treatments. Although cell death was observed 
through the study range, neither specific activity nor biophysical characterization of the 
internalized protein was performed.  
In the last decade, protein transduction domains stand out as a popular method to 
deliver therapeutic proteins to the cytoplasm and nucleus of cells. Morris et al. successfully 
delivered 30 kDa green fluorescent protein (GFP), 119 kDa beta-galactosidase (B-Gal) 
proteins, and two full-length specific antibodies intracellularly in a fully biologically active 
form utilizing a novel protein transduction domain (PTD) – peptide sequences that efficiently 
crossed biological membranes independent of transporters or receptor-mediated endocytosis 
– coined Pep-1 (Morris et al., 2001).  Importantly, the proteins required no chemical coupling 
or denaturation steps.  To mediate intracellular delivery, Pep-1 condenses on and around the 
protein through noncovalent hydrophobic interactions to form stable complexes.  Interaction 
between the Pep-1 carrier and each protein was measured by size exclusion chromatography, 
which eluted primarily as 65-70 kDa protein with a small fraction eluting as large aggregates 
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greater than 160 kDa. An optimum ratio of Pep-1:protein was reported for maximal 
transfection efficiency, where too few Pep-1 molecules resulted in no delivery and too many 
resulted in precipitation or aggregation of the protein.  Greater than 80% transfection 
efficiency was observed for GFP and B-Gal. Pep-1 also delivered both FITC-conjugated anti-
Lamp-1 and monoclonal anti-beta-actin antibodies into cells, while preserving their ability to 
recognize their respective antigen observed via characteristic labeling of actin and lysosomes 
of the cells. Quantitative activity assessments and biophysical evaluation of structural 
integrity of the delivered protein were not performed.  
Briscoe and colleagues delivered superoxide dismutase (SOD) to pulmonary 
epithelium using a pH-sensitive liposome (Briscoe et al., 1995). Enzymes such as SOD may 
help control the production of oxygen radicals, which develop as a result of respiratory 
insufficiency or exposure to pulmonary toxins.   The group was able to entrap between 5 and 
15% of initially added SOD in DOPE and DOSG (1-oleoyl-2-oleoyl-sn-glycero-3-succinate) 
liposomes, which released their contents between pH 4.5 and 5.5.  SOD activity (assayed by 
enzymatic measurement), increased by 5-fold when fetal rat lung distal epithelial cells were 
incubated with untargeted DOPE-DOSG liposomes and by 6-fold with surfactant protein. A 
targeted DOPE-DOSG liposomes. Expectedly, the addition of a targeting modality increased 
delivery of the enzyme to the lung cells, but did not necessarily improve the delivery of 
active enzyme.  
Mumtaz and Bachhawat described an effective in-vivo method to intracellularly deliver 
dextranase, an enzyme that degrades dextran (Mumtaz and Bachhawat, 1994).  The group 
prepared liposomes to encapsulate dextranase and PEG-dextranase conjugates.  It was shown 
that free dextranase, liposomal dextransase or free PEG-dextranase were not able to degrade 
 42 
 
the FITC-dextan injected after the administration of the enzyme. In contrast, only 
liposomally delivered PEG-dextranase was catalytically active inside the cell after 
administration, yet only 10% was active after 24 hours. Importantly, PEG provided a 
stabilizing influence on the enzyme against intracellular degradation.  
Various issues in physical and chemical stability of proteins that can arise during 
formulation and processing of protein drugs in nanocarriers are discussed below. 
3.3   Common Physical and Chemical Instability Issues in Proteins 
3.3.1   Physical Instability 
Stabilizing and destabilizing forces in protein folding  
Folded proteins have marginal stability as the free energy change between the unfolded 
and folded state is very small, typically in the range of 5-20 Kcal /mol (Dill, 1990; Pace et 
al., 1996). This explains the sensitivity of proteins to changes in their environment and also 
highlights the  need to understand the effect of various process and formulation conditions on 
conformational stability of protein drugs. Many theories have been proposed to explain the 
forces involved in folding of proteins. Electrostatic, van der Waal’s attractive forces, 
hydrogen bonding and hydrophobic forces have been proposed to explain protein folding. 
Although there are discrepancies in the literature as to which forces play a dominant role in 
protein folding, hydrophobic forces have been proposed to predominantly contribute to 
protein folding (Kauzmann, 1959). It was suggested that burial of non polar amino acids in 
the protein core away from water on the surface leads to folding. Further evidences in 
support of this theory have been site directed mutagenesis studies where replacement of an 
amino acid leads to change in protein stability proportional to oil-water partitioning behavior 
of the changed amino acid (Matsumura et al., 1988). The major factor that opposes protein 
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folding is entropy. Positive entropy refers to increase in randomness and disorder. Since 
protein folding involves collapse into restricted conformations in small volumes of space, 
this leads to restricted rotation in side chains and backbone.  However, in the unfolded state 
there is no restriction and freedom of rotation (Dill, 1990).  
Aggregation 
One of the most common and initial stages of physical protein instability is protein 
aggregation. Aggregation refers to the formation of higher order protein structures such as 
oligomers or multimers which eventually lead to precipitation and loss of activity. 
Aggregates can form from either native or non-native proteins (Chi et al., 2003b; Philo and 
Arakawa, 2009). In native aggregation, proteins associate with each other to form oligomers 
or multimers due to their tendency to stick to each other in complementary regions. Insulin is 
one protein that undergo native type aggregation (Pekar and Frank, 1972). Non-native 
aggregates are formed from partially or completely unfolded proteins (Chi et al., 2003b). 
Non-native type of aggregation is more likely to occur during formulation and processing of 
protein during encapsulation in delivery systems.  
In protein delivery, polymeric carriers such as PLGA has been the most commonly 
used system (Jiskoot et al., 2011). During preparation of PLGA NPs, water-in-oil emulsion 
(w/o) or w/o/w type emulsions are commonly used. Organic solvents such as 
dichloromethane, acetone, methanol, ethanol or a mixture of these are used to dissolve the 
polymer. Along with exposure to organic solvents, additional stresses experienced by 
proteins during the preparation process are high temperatures, sonication and stirring 
/shearing stresses. Therefore, it is highly likely that during the encapsulation process, either 
partial or complete unfolding occurs which can lead to aggregation and loss of activity of 
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protein and may also lead to lower encapsulation of proteins since a part of protein mass 
would be present as aggregates. Various mechanisms through which aggregation can occur 
are summarized in a review by Philo et al. (Philo and Arakawa, 2009) and Figure 3.1 
illustrates these mechanisms. Precipitation of aggregates and physical adsorption of the 
partially or completely unfolded proteins may also occur as a result of protein unfolding. 
3.3.2   Chemical Instability  
Chemical instability refers to either breakage or formation of a new bond in the protein 
structure.  Most common types of chemical instability encountered with proteins are 
summarized below. 
Deamidation 
Deamidation is the breakage of the side chain amide bond in side chains of glutamine 
(Gln) and asparagine (Asn) residues. Deamidation reaction involves the formation of five 
membered cyclic imide and subsequent hydrolysis of the amide functional group. (Manning 
et al., 1989; Wang, 1999). Since the hydrolysis of the amide bond involves succeeding amino 
acid, deamidation is dependent on the steric hindrance of the neighboring amino acid 
residues. Studies in peptides where the neighboring amino acid to Asn was changed from 
Glycine (Gly) to Leucine (Leu), the rate of deamidation slowed down by 50-fold due to 
increased steric hindrance of Leu compared to Gly (Geiger and Clarke, 1987). Deamidation 
of Asn is more common in alkaline pH solutions (Haley et al., 1966). The effects of 
deamidation on biological activity of proteins have been highly variable. Deamidation may 
lead to decrease or loss of biological activity (Charache et al., 1977; Friedman et al., 1991; 
Moss et al., 2005), no change in biological activity (Brange et al., 1992) or may even lead to 
increase in biological activity (Furaya et al., 2006). In some cases, extensive aggregation 
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resulting from initial deamidation has also been observed (Nilsson et al., 2002). Thus, any 
potential for deamidation of protein should be confirmed if formulation conditions if alkaline 
pH is employed during formulation of proteins in nanocarriers. 
Oxidation 
Methionine (Met), Cysteine (Cys), Histidine(His), Tyrosine (Tyr) and Tryptophan 
(Trp) are the most common sites of oxidation in proteins. Oxidation may occur due to 
atmospheric oxygen, dissolved oxygen radicals in solution, metal ions and light 
(photooxidation). Met and Cys are more susceptible to oxidation due to the presence of thiol 
groups. Met oxidation results in formation of methionone sulfoxide and methionine sufone 
and Cys oxidation leads to the formation of sulfenic acid and cysteic acid (Manning et al., 
1989; Wang, 1999). Depending on the location of oxidation susceptible amino acids, 
formation of intermolecular and intramolecular disulfide bonds are possible. Intramolecular 
disulfide linkage may lead to changes in conformation of proteins which results in 
aggregation and intermolecular crosslinks and then possibly to the formation of higher order 
aggregates (Astafieva et al., 1996; Li et al., 1995). Bityrosine intermolecular linkages have 
also been reported (Cromwell et al., 2006). The position of the amino acid susceptible to 
oxidation also influences extent of oxidation. For example, Met170 in human growth hormone 
is not susceptible to hydrogen peroxide exposure whereas Met14 oxidation has been observed 
in biosynthetic human growth hormone (Becker et al., 1988; Teh et al., 1987). Methionine 
oxidation has also been reported to lead to loss of biological activity in parathyroid 
hormone(Nabuchi et al., 1995), human stem cell factor (Hsu et al., 1996), calcitonin (Riniker 
et al., 1968) and corticotropin releasing factor (Vale et al., 1981) . Thus, it is important to 
monitor for oxidation of proteins if the protein under consideration is susceptible to oxidation 
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or conditions employed during formulation (as alkaline pH, metal catalysts and oxidants) 
promote oxidation. 
Hydrolysis/Proteolysis 
Hydrolysis, or proteolysis, refers to the breakage of peptide bond in the amino acid 
backbone of protein. Although, peptide linkage is very stable, X-Asp-Y type bonds are most 
susceptible to hydrolysis (Manning et al., 1989; Wang, 1999). It has been reported that the 
susceptibility of hydrolysis of Asp residues are 100-fold greater than other residues in dilute 
acids (Schulz, 1967). Aspartic acid-Proline and Asp-Gly peptide bonds are known to be 
particularly susceptible (Powell, 1994). Proteolysis at Asp residues has been reported in 
lysozyme (Ahern and Klibanov, 1985) and ribozyme (Zale and Klibanov, 1986) in acidic 
conditions. In insulin, deamidation reactions at Asn  (A-21 or B3) leads to formation of Asp 
or iso-Asp  which then leads to hydrolysis (Brange et al., 1992).   
A summary of the most common conditions that can lead to physical and chemical 
instability in proteins are presented below. Understanding the factors that lead to protein 
unfolding can help minimize the exposure of proteins to these conditions during nanocarrier 
formulation. 
Organic Solvents 
The major force behind maintaining protein stability is hydrophobic interactions in the 
protein core. Thus, it has been proposed that exposure of proteins to organic solvents leads to 
denaturation because organic solvents decrease the free energy of unfolding of the non-polar 
residues in proteins and therefore decreases the free energy difference between folded and 
unfolded states (Kauzmann, 1959). Rees et al. showed with 23 proteins and 37 different non-
aqueous solvents that protein structures are unfolded and elongated in non-aqueous solvents 
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compared to aqueous solvents (Rees and Singer, 1956). Interestingly, Griebenow et al. 
showed with lysozyme and subtilisin that mixtures of organic solvents and water induce 
more unfolding of proteins compared to organic solvents alone (Griebenow and Klibanov, 
1996). They used acetonitrile, propanol and tetrahydrofuran as organic solvents and showed 
that with 60% (v/v) mixtures of organic solvents in water that the α-helix content of proteins 
was much lower than in pure organic solvents. They attributed this effect to much restricted 
motion of protein chains in anhydrous environment compared to organic solvent-water 
mixtures. This observation is also pertinent to presence of organic-water mixtures during 
preparation of polymeric NPs in w/o or w/o/w emulsions (Sah, 1999). 
Temperature 
The tendency of proteins to unfold with temperature shows a parabolic relationship. It 
has been shown that both low and high temperatures tend to induce protein unfolding 
(Graziano et al., 1997; Privalov, 1990; Privalov and Gill, 1988). Unfolding associated with 
increase in temperature results from increase in enthalpy and entropy of the system. The 
increase in unfolding and aggregation upon heating has been observed for many 
therapeutically relevant proteins like streptokinase (Azuaga et al., 2002) and recombinant 
human interferon-γ (Mulkerrin and Wetzel, 1989). Higher temperatures (~ 60 oC for 1 h) 
have also used in introducing pegylated lipids into preformed liposomes (Iden and Allen, 
2001). Thus, the effect of exposure to high temperatures on encapsulated proteins should be 
evaluated. At low temperatures, interaction of non polar residues with water has been 
suggested to drive the unfolding of proteins. It has been proposed that the penalty of 
unfavorable interaction between non polar residues in proteins and water decrease with 
decrease in temperature and results in unfolding. This low temperature induced unfolding 
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phenomenon has been termed as cold denaturation (Graziano et al., 1997; Privalov, 1990; 
Privalov and Gill, 1988). An assessment of effect of freeze thaw cycles on protein stability 
during lyophilization cycle development of therapeutic proteins is very common (Carpenter 
et al., 1997; Tang and Pikal, 2004). Cold denaturation is also very pertinent to encapsulation 
of proteins in liposomes as use of freeze thaw cycles has been suggested as a method to 
increase entrapment of protein in liposomes (Mayer et al., 1986; Mayer et al., 1985; Pick, 
1981). As proteins are sensitive to both high and low temperatures, the effect of freeze thaw 
on protein stability should also be considered. 
Solution conditions (pH, ionic strength and salts) 
Proteins are composed of both positively-charged (eg. lysine, arginine) and negatively-
charged (eg. glutamic acid, aspartic acid) amino acids. The pH at which a protein carries 
equal negative and positive charge is known as isoelectric point (PI). The overall charge of 
the protein depends on solution pH. If the pH of solution is below the PI of the protein, 
protein carries a net positive charge and if the solution pH is above the PI of the protein, the 
net charge on protein is negative. pH and charge density plays an important role in protein 
unfolding (Chi et al., 2003b). At extremes of pH, protein unfolding is observed because the 
charge density on the folded protein is higher than in unfolded form (Dill, 1990). At a pH 
near the PI of the protein, aggregation can be observed because the overall charge of protein 
is very low near its PI and can be insufficient for maintaining colloidal stability. Colloidal 
stability between two protein particles can be explained on the basis of DLVO theory 
(Derjaguin and Landau, 1941; Verwey and Overbeek, 1948). According to this theory, the 
overall potential energy on a particle is a sum of opposing electrostatic repulsive and van der 
Waals attractive forces. Particles can be colloidally stable if they are sufficiently charged to 
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maintain repulsive forces and maintain a separation distance. However, if the repulsive forces 
of the particles are not sufficient to keep them apart then they can collide and aggregate. 
Apart from pH, ionic strength can also play an important role in protein stability and 
aggregation as it has been reported that under high salt concentrations, ions can shield the 
inherent charge of the protein and decrease the repulsive forces leading to aggregation (Chi et 
al., 2003a). The effect of salt type on protein stability has been explained on the basis of 
hoffmeister series in which ions are arranged according to their potential to stabilize or 
destabilize proteins. Altering the structure of water bound to proteins and direct binding of 
ions to macromolecules have been suggested to be the causes of the ranking of ions in the 
series (Zhang and Cremer, 2006). Additionally, as mentioned above, the pH can also 
influence chemical stability of proteins. Therefore, the evaluation of pH, ionic strength and 
salt conditions on physical and chemical stability of proteins is important.  
3.4    Need for Evaluating Protein Stability as Part of Protein Delivery Approach 
Proteins are polymers of amino acids which fold into specific compact three 
dimensional structures in their native state.  Proteins are very susceptible to change in their 
environment and can participate in many different interactions, from non-specific 
hydrophobic interactions to van der Waals attraction to electrostatic repulsion. These 
interactions can lead to proteins degradation, typically classified as physical or chemical 
degradation, through a variety of mechanisms: unfolding, aggregation, or change in chemical 
integrity. Each of these paths is deleterious and ultimately leads to decreased activity of the 
therapeutic. As listed above, many delivery strategies ranging from classic PLGA NPs, 
liposomes to newer approaches like fusion proteins and stapled peptides have been proposed 
for enhancing intracellular delivery of proteins, however these strategies impose a variety of 
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stresses on the protein during formulation and regardless of method, primarily the focus of 
studies is on the delivery of the biologic to the site of action; rarely conformational stability 
and chemical integrity of the delivered biologic was addressed. Three dimensional protein 
structure (or conformation) and chemical integrity plays an important role in execution of 
their biological function. Thus, factors that may lead to physical and chemical instability in 
proteins should be addressed in conjuction with approaches being investigated to enhance 
intracellular protein delivery.  
3.5   Importance of Inducing Endosomal Release in Intracellular Protein Delivery  
Internalization of therapeutic cargo in cells often involves endocytosis, a pathway 
where various therapeutic cargo is taken up by cells into intracellular vesicles called 
endosomes. One of the major challenges in intracellular protein delivery is inducing release 
of therapeutic cargo from endosomes to cytosol. Early endosomes have an acidic 
environment (pH 5) and mature to late endosomes which can fuse with lysosomes (cellular 
organelles rich in proteolytic enzymes (Bareford and Swaan, 2007). A schematic of 
endocytic pathway is shown in Figure 3.2. To overcome the challenge of therapeutic cargo 
entrapped in endosomes, researchers have focused on understanding mechanisms of 
endosomal release and on agents that can induce endosomal release. Much inspiration in this 
area comes from viruses, which are naturally engineered with components capable of 
inducing endosomal release. Fusion of viral components with endosomal lipid membranes 
and pore formation in the endosomal membrane have been suggested as mechanisms used by 
viruses to induce release of viral proteins in cytosol of cells (Greber et al., 1993; Hogle, 
2002). Various natural and chemical agents have been researched and used for inducing 
endosomal escape for intracellular delivery of proteins. The mechanisms by which these 
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natural and chemical agents induce endosomal release are pore formation in endosomal 
membrane, fusion with endosomal membrane, and disrupting endosomal membrane by 
proton sponge effect or photochemical sensitizers (Cho et al., 2003; Liang and Lam, 2012; 
Varkouhi et al., 2011). Some examples of agents which have been used for intracellular 
protein delivery include cationic lipids such as DOTAP where tertiary amine groups interact 
with anionic endosomal lipids to form inverted hexagonal structures (HII) and induce 
endosomal release of cargo. Inclusion of cholesterol and dioleoyl-sn-glycero-
phosphoethanolamine (DOPE) with DOTAP has been suggested to enhance HII phase 
formation and enhance endosomal release (Cho et al., 2003; Hafez et al., 2001). Trans-
activating transcriptional activator (TAT) peptide has been used for both internalization of 
hydrophilic protein cargo through plasma membrane and induction of endosomal release. 
TAT peptide contains arginine and lysine amino acid residues which help in membrane 
penetration and destabilization (Trabulo et al., 2010). Polymers like polyethyleneimine (PEI) 
have titratable amine residues which upon protonation can induce influx of ions and water 
from cytosol to endosome and induce endosomal rupture. PEI polymers have been used for 
protein delivery but suffer from disadvantages of high toxicity (Didenko et al., 2005). 
Various small molecules like chloroquine and methylamine can also induce endosome 
rupture but also have high toxicity (Mellman et al., 1986). These mechanisms and various 
agents for inducing endosomal release have recently been reviewed and should be referred 
for further details (Bareford and Swaan, 2007; Liang and Lam, 2012; Varkouhi et al., 2011). 
The above discussion emphasizes the importance of pursuing a holistic approach to 
intracellular delivery of proteins where intracellular protein delivery approach should focus 
on developing strategies that overcome challenge of protein entrapment and stability in 
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delivery system, its cellular uptake and inducing endosomal release. Therefore, the 
evaluation of structural and chemical integrity of the protein cargo should be an integral part 
of assessment of the success of the delivery system.  The following sections will focus on the 
protein Cyt c as its intracellular delivery to induce apoptosis in breast cancer cells in-vitro 
was studied.  
3.6   Cytochrome C Structure and Properties 
Cytochrome c is a 12 KDa heme protein, composed of 104 amino acids. It is a basic 
protein with 8 positive charges at physiological pH. It is an almost globular protein with a 
channel running from outer surface up to the heme atom known as the “heme crevice” 
(Dickerson, 1971). Heme in Cyt c is bound covalently to two cysteines (Cys 14 and Cys 17) 
and also bound co-ordinatively to Met 80 and His18   (Mirkin et al., 2007). Cytochrome c 
amino acid sequences have been extremely conserved across various species. Additionally, 
the charge distribution of lysines on the sides of the molecule lining the hydrophobic core 
and negative character on one side of molecule is also conserved (Dickerson, 1971) (Figure 
3.3). Cyt c plays a very important role in respiration as an electron carrier between complex 
III and complex IV in mitochondria and recently, Cytochrome c has also been implicated to 
play a very important role in apoptosis (Ow et al., 2008).   
3.7   Role of Cyt c in Apoptosis  
Apoptosis is a tightly regulated form of cell death, triggered when a cell senses that it is 
in its best interest to quietly die rather than passing the harmful metabolites or signals to 
neighboring cells. The concept of apoptosis or programmed cell death has evolved over the 
years and it is understood now that apoptosis (Figure 3.4) occurs via an intrinsic pathway or 
extrinsic pathway (Kasibhatla and Tseng, 2003). Intrinsic apoptosis pathway is initiated via 
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growth factors, cytokines, DNA damage and proceeds through mitochondria. The intrinsic 
apoptotic signals such as increased reactive oxygen species (ROS) levels in cells triggers 
release of Cyt c, a mitochondrial protein into cytoplasm where Cyt c participates and 
facilitates apoptotic protease activating factor 1 (APAF1) and caspase 9 recruitment into a 
complex known as apoptosome. This then leads to activation of caspase 9 and further 
activation of effector caspases. Members of the BCL2 gene family are important players in 
execution of intrinsic apoptosis. They are classified into the pro-apoptotic members Bax 
(BCL-2 associated X protein), Bak (BCL-2 homologous antagonist/killer) and BID (BCL-2 
Interacting Domain) and anti-apoptotic members BCL2, BCL-xl (Basal cell lymphoma-extra 
large), MCL1 (Myeloid cell leukemia sequence 1).  
The antiapoptotic members complex with the pro-apoptotic proteins and prevent them 
from initiating the caspase cascade. Once activated, t-BID helps Bax and Bak 
oligomerization and these oligomerized proapoptotic proteins form pores in the 
mitochondrial membrane through which proteins such as Cyt c move into cytoplasm and 
initiate apoptosome formation and caspase activation (Hickman, 1992; Kasibhatla and Tseng, 
2003; Lowe and Lin, 2000). Extrinsic apoptosis pathway includes death receptors such as 
Fas/CD95, TNFR1, DR3, DR4 and DR5. Activation of these pathways leads ultimately to 
caspase 8 activation which activates the effector caspases such as caspase 3 ultimately 
responsible for cellular protein digestion and cell shrinkage. Caspases are a group of enzymes 
in the cells abbreviated for cysteine aspartate proteases. Apoptosis also involves translocation 
of phosphatidyl serine from inner to outer leaflet of the plasma membrane.  
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3.8   Altered Apoptosis Pathways in Breast Cancer  
As mentioned above BCL2, BCL-xl, MCL1 belong to antiapoptotic family proteins 
and Bax, Bak and BID belong to proapoptotic protein family members. There are several 
studies indicating an imbalance between antiapoptotic and proapoptotic proteins in breast 
cancer. Reduction in expression of Bax, an important protein required in mitochondrial pore 
formation and Cyt c release has been observed in primary breast cancer tissues which also 
correlated well with overall survival (Krajewski et al., 1995). The expression of Bax in 119 
women with metastatic breast cancer was studied via immunohistochemical analysis. Results 
from the studies of Bargou et al. in human breast tumors grown in-vivo in SCID mice also 
showed decreased Bax expression and that the expression was revived by gene transfer 
(Bargou et al., 1996). As far as BCL-2 protein is concerned, over expression of BCL-2 and 
BCL-xl in breast cancer has been observed in number of studies (Callagy et al., 2008; 
Krajewski et al., 1999; Nadler et al., 2008; Reed, 1996; Teixeira et al., 1995; Thomadaki and 
Scorilas, 2008). In a study by Krajewski et al. BCL-2 protein over expression was found in 
80% of tumors tested which included both node positive and negative primary tumors. 
3.9  Potential of Delivering Cyt C as an Anticancer Nanotherapeutic in Breast Cancer 
cells  
Cytochrome c microinjected in various cancer cells has shown to activate apoptotic cell 
death.(Li et al., 1997; Schafer et al., 2006; Zhivotovsky et al., 1998) Zhivotovsky et 
al.(Zhivotovsky et al., 1998) showed induction of apoptosis after microinjection of 20 uM 
Cyt c in normal rat kidney cells (NRK cells). Li et al. (Li et al., 1997)  also observed 
apoptosis after microinjection of Cyt c in human embryonic kidney 293 cells. They also 
tested other heme containing proteins such as myoglobin, hemoglobin in order to check for 
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specificity of Cyt c in inducing apoptotic cell death and only Cyt c was shown to induce 
apoptosis. Interestingly, breast cancer cells show unique sensitivity to apoptosis to 
exogenously administered Cyt c. It has been shown that when cytosolic extracts from various 
cell lines were supplemented with exogenous Cyt c and monitored for caspase activity, 
higher caspase activity was observed in a series of malignant mammary epithelial cell lines 
compared to cancer cells from other origin such as lung, prostate, colon and ovary(Schafer et 
al., 2006). Thus, Cyt c is a direct and specific apoptogen and a viable anticancer agent 
especially for the treatment of breast cancer.  
However, due to its hydrophilic, positively charged nature and propensity for 
degradation by plasma proteases, Cyt c lacks the physicochemical characteristics required for 
successful permeation and delivery to cancer cells. Thus, it requires a carrier to mediate its 
intracellular delivery.   
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Figure 3.1 Schematic illustrating common protein aggregation mechanisms (1) native 
protein aggregation, (2) aggregation of conformationally altered protein, (3) aggregation of 
chemically altered protein, (4) nucleus assisted protein aggregation and (5) aggregation due 
to inceased air water interface and adsorption on container walls. Figure from Philo et al. 
(Philo and Arakawa, 2009).   
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Figure 3.2 Schematic illustrating endosomal release as major challenge in intracellular 
protein delivery. Therapeutic protein cargo (different colored spheres) can be taken by 
endocytic pathway into early endosomes which later mature into late endosomes and fuse 
with lysosomes. Lysosomes are cellular organalles rich in proteolytic enzymes and can 
denature protein. Therefore, efficient endosomal release is central to efficacy of protein 
delivery systems. Figure from Varkouhi et al. (Varkouhi et al., 2011) 
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Figure 3.3 Cytochrome c (Cyt c) - three dimensional structure. Cytochrome c is a globular 
protein with a heme moiety in the centre. Cytochrome c is lined with positively-charged 
lysines on either side of heme crevice and negatively-charged amino acids on one end. Figure 
from protein data bank (Bushnell et al., 1990; www.rcsb.org)  
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Figure 3.4 Schematic illustrating mechanisms of apoptosis. Intrinsic apoptosis mediates via 
release of Cyt c from mitochondria and extrinsic apoptosis via death receptors TNF and Fas. 
Figure from Kashibhatla et al.(Kasibhatla and Tseng, 2003). 
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Chapter IV 
 
Effect of Carbon Coating on the Physico-chemical Properties and Toxicity of  
 Copper and Nickel Nanoparticles 
 
4.1    Summary 
The primary aim of these interdisciplinary studies was to investigate the effect of a 
distinguishing characteristic, i.e., surface carbon coating on the physico-chemical properties 
and toxicity of matched pairs of carbon-coated and non-coated copper and nickel NPs (Cu, 
C-Cu, Ni and C-Ni) in A549 alveolar epithelial cells. The effect of carbon coating on particle 
size, zeta potential, oxidation state, cellular uptake, release of soluble metal and 
concentration dependent toxicity of Cu and Ni NPs was systematically evaluated. A 
significant effect of carbon coating was observed on the physico-chemical properties, 
interaction with cellular membranes, and overall toxicity of the NPs. Compared to Cu NPs, 
C-Cu NPs showed protection against surface oxidation, ten-fold higher cellular uptake and 
4.4-fold lower release of soluble Cu. Similarly, in toxicity assays significant differences were 
observed between Cu and C-Cu NPs.  Specifically, while C-Cu NPs elicited a pronounced 
effect on mitochondrial function, Cu NPs were associated with a significant damage to 
plasma membrane integrity. Compared to Cu and C-Cu NPs, Ni and C-Ni NPs were less
S. Minocha, and R.J. Mumper, “Effect of Carbon Coating on the Physico-chemical Properties and Toxicity 
of Copper and Nickel Nanoparticles.” Small, 2012 Jul 26. doi: 10.1002/smll.201200478. [Epub ahead of 
print].  
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toxic as evaluated by their effect on mitochondrial function and lysosomal membrane 
integrity. These studies demonstrated that correlations can be drawn between physico-
chemical properties and resultant toxicity of NPs as a function of unique NP characteristics 
such as surface carbon coating.  
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4.2    Introduction 
NPs are being produced in high tonnage for their applications in semiconductor, textile, 
agricultural and pharmaceutical industries. The estimated market for nanotechnology 
containing products is expected to reach $ 1 trillion by 2015 (Nel et al., 2006; Roco, 2005). 
Although the unique properties of NPs such as their higher surface area to volume ratio 
compared to their bulk counterparts offer exciting opportunities for applications as catalysts, 
conducting materials, semiconductors and targeted nanotherapeutics, the same unique 
properties also predispose them to interact more closely with cellular and sub-cellular 
structures which may lead to a variety of toxicological end points (Magrez et al., 2006; Nel et 
al., 2006; Oberdorster, 2004).  Therefore, much emphasis has been placed upon 
understanding the toxicity profiles of NPs in order to fully realize the potential of 
nanotechnology. The concern among industrialists, regulatory authorities, academicians and 
researchers about the potential health impact of nanotechnology is understandable as 
exposure to airborne ultrafine particulate material and asbestos has been linked to the 
occurrence of cardiovascular diseases and mesothelioma, respectively (Seaton et al., 2010). 
The field of nanotoxicology is still in its infancy and several questions regarding relevant 
dose and exposure are under debate and unanswered (Rivera Gil et al., 2010; Warheit, 2010). 
Workplace safety has already been questioned after a recent report that showed possible links 
between the exposure of workers to NPs and toxicity symptoms (Song et al., 2009). Many 
challenges are associated with determining the underlying cause of NP toxicity since various 
particle characteristics such as size, shape, surface area, charge, surface dissolution and 
coatings can contribute towards toxicity and their role in assessing NP toxicity has been 
much emphasized (Rivera Gil et al., 2010; Warheit, 2010; Zhao et al., 2011). Therefore, it 
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becomes difficult to assess the contribution of nanoparticulate state towards a specific 
observed toxic effect. It has also been reported that the nanometer size range is not always 
the primary factor that best correlates with NP toxicity. Sayes et al. (2006) showed that when 
toxicity of rutile, anatase and rutile/anatase forms of TiO2 NPs were compared in cell-based 
assays, the anatase TiO2 polymorph showed higher lactate dehydrogenase (LDH) release in 
HDF and A549 cells as compared to the rutile polymorph (Sayes et al., 2006). Another 
important consideration in evaluation of NP toxicity studies is the characterization of NPs in 
relevant biological media since NPs are usually dispersed in biological media before toxicity 
testing in vitro. Depending on the media composition such as the presence of serum proteins 
and varied ionic strength, NP size profiles may be different than that observed in water 
(Maiorano et al., 2010; Murdock et al., 2008; Warheit, 2008).  
Reproducibility of results across different labs is another concern in nanotoxicity 
studies (Lanone et al., 2009). The variation in toxicity data of NPs in general can be 
attributed to source, method of dispersion, interference with absorbance or fluorescence and 
most importantly lack of detailed characterization. For instance, both false positive and false 
negative results have been reported when carbon nanotube toxicity was tested with MTT (3-
(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay (Ali-Boucetta et al., 
2011; Worle-Knirsch et al., 2006). Similar results were observed while testing carbon NP 
toxicity with neutral red dye (Monteiro-Riviere and Inman, 2006). As carbon NPs have large 
surface area and adsorptive properties, neutral red adsorbed on the NP surface showed false 
negative results. Special precautions, proper controls and use of multiple cytotoxicity assays 
have been suggested to possibly overcome conflicting results (Stone et al., 2009). 
Considering that multiple factors can affect NP toxicity, it is increasingly important to 
 73 
 
systematically evaluate the toxicity of NPs such that the effect of one characteristic can be 
studied at one time. Metal based NPs have gained widespread application in several 
industries. Copper and nickel NPs are commercially relevant and currently used in a variety 
of applications. Copper NPs are used as bacteriostatic and antifungal agents, conducting inks, 
batteries, fuel cells, as catalysts and antifouling agents (Barrabes N, 2006; Nicola Cioffi, 
2005; Tarasov S, 2002; Yoon et al., 2007; Zhang XF, 2007).  Nickel NPs are used for their 
catalytic and magnetic properties (Park J, 2005; Wang H, 2008). Carbon coating on the 
surface of metal NPs is a means to protect them against oxidation (Luechinger et al., 2008).  
Thus, it becomes important to evaluate the effect of surface coating on the physicochemical 
properties and toxicity of metal NPs. A previous study on copper oxide and C-Cu NPs 
ascribes differences in toxicity of these NPs to differences in intracellular solubility of copper 
oxide and C-Cu NPs in buffer acidic solutions mimicking lysosomal conditions (Studer et al., 
2010). The conditions for this comparison are buffered systems which do not compare with 
realistic scenarios where more complex factors such as sonication of particles before 
suspension and presence of serum can affect solubility and bring about differences in 
extracellular release of metal ions which can also affect uptake and toxicity of NPs. 
Therefore, we systematically investigated the effect of surface carbon coating on the physico-
chemical properties and toxicity of carbon coated and non-coated copper and nickel NPs in 
vitro by studying particle size, zeta potential, oxidation state, cellular uptake, release of 
soluble metal and concentration dependent toxicity of Cu and Ni NPs  in cell culture relevant 
conditions. Our group has been involved in the continuous assessment and prediction of 
physico-chemical properties of NPs in relation to their biological effects using quantitative – 
nanostructure activity relationships (Fourches et al., 2010). In this investigation, the 
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hypothesis was that compared to non-coated Cu and Ni NPs, carbon-coated Cu and Ni NPs 
will have different physico-chemical properties including their interactions with the 
surrounding media and cells which will influence the resultant toxicity in cell-based assays. 
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4.3    Materials and Methods 
Materials 
Copper, C-Cu, Ni and C-Ni NPs were purchased from Nanostructured and Amorphous 
Materials Inc. (NanoAmor, Houston, TX). According to NanoAmor, Cu, C-Cu, Ni and C-Ni 
particles were synthesized using Chemical Vapor Deposition (CVD) method.  For coating 
carbon on the metal, metal and carbon source were electrically heated at the same time (Jiao 
and Seraphin, 1997; Li et al., 2009).  MTT reagent and neutral red dye were purchased from 
Sigma Aldrich (St. Louis, MO). Ethidium homodimer/calcein AM cell viability kit and 
DMEM were purchased from Invitrogen (Carlsbad, CA). Cu and Ni ICP/MS standards were 
purchased from Spex CertiPrep (Metuchen, NJ). A549 alveolar epithelial cell line, Penicillin-
streptomycin solution and Fetal Bovine Serum (FBS) were purchased from ATCC. 
Plasmocin was purchased from Invivogen (San Diego, CA). All chemicals were used without 
any further purification. 
Particle Size and Zeta Potential 
Particle size was measured in DI water and DMEM (with and without 10% FBS). 
Stock of NPs (1 mg/mL) was prepared in DI water after dispersing them using bath 
sonication (Branson 3510) for three minutes. NPs were further diluted in either DI water or 
DMEM (+/- 10% FBS) (0.6 μg/mL) for particle size analysis using Beckman Coulter N5 
Submicron Particle Size Analyzer. Three independent runs were performed for each sample. 
Particle size in DI water was also confirmed using TEM (JEOL 100CX II, JEOL USA, Inc., 
Peabody, MA). Briefly, a droplet of NPs (10 μg/mL) was placed onto a 200 mesh copper grid 
and allowed to air dry. At least five images were captured for each sample. Zeta potential 
was measured in DI water (10 μg/mL) using a Malvern Zeta Sizer Nano Z. Viscosity, 
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refractive index and dielectric constant of water at 25 ºC were used for calculating the zeta 
potential using the Smoluchowski Model. Zen 1002-Zeta Dip Cell was used for all 
measurements.  
Cell Culture and Incubation with NPs 
A549 alveolar epithelial cells were maintained in DMEM with 10% FBS, plasmocin (5 
µg/mL), penicillin (100 U/mL) and streptomycin (100 µg/mL) (complete culture medium) in 
75 cm2 flasks and were passaged every two days. For all cell culture studies, cells up to 25 
passages were used.  NP stock solutions (1 mg/mL) were prepared fresh for all studies by 
dispersing the NPs in DI water using bath sonication for 3 min. For dose dependent studies, a 
ten-fold dilution in complete cell culture medium was achieved by using a concentrated NP 
stock prepared in DI water. 
Qualitative NP Cell Uptake using TEM 
A549 cells (1 x 106 cells/well) were seeded in complete culture medium in six well 
plates and allowed to attach for 24 h. The cells were washed twice with PBS and treated for 8 
h in complete culture medium with Cu, C-Cu, Ni and C-Ni NPs (10 μg/mL). The cells were 
then washed twice with PBS to remove excess NPs and fixed with glutaraldehyde (2%) in 
sodium cacodylate buffer (0.1 M) for 24 h at 4 oC. The samples were post fixed in Osmium 
tetraoxide (2%) in sodium cacodylate buffer (0.1 M) for 1 h at room temperature (RT). 
Samples were then en bloc stained with uranyl acetate (2%) for 15 min followed by lead 
citrate (1%) for 5 min. Dehydration of the samples followed in series of ethanol (50%, 75% 
and 95% ) for 5 min each followed by ethanol (100 %) two times for 10 min each, after 
which the samples were embedded using polybed epoxy resin. Ultrathin sections (90-100 
nm) were examined by placing them on 200 mesh carbon coated copper grids using TEM. 
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Quantitative NP Cell Uptake using ICP-MS  
For quantitative analysis of metal NP uptake/association with the cells, ICP-MS was 
used. A549 cells (1 x 106 cells/well) in complete culture medium were allowed to attach for 
24 h in six well plates. The cells were then washed twice with PBS and treated for 8 h in 
complete culture medium with Cu, C-Cu, Ni and C-Ni NPs (10 μg/mL). The cells were then 
washed twice with PBS to remove excess NPs, trypsinized, counted using a hemacytometer 
(Bright-Line; Hausser Scientific, Horsham, PA) and centrifuged in glass centrifuge tubes to a 
pellet which was dried overnight in the oven to remove any moisture. The dried cell pellet 
was dissolved by adding concentrated nitric acid (0.4 mL) and heating on a water bath at 80 
oC for 20 min. All samples were diluted to a final concentration of nitric acid (2.6%) with DI 
water. For assessing the amount of Cu and Ni in untreated A549 cells (4 x 106) were seeded 
in a 100 mm x 20 mm petridish in complete culture medium and allowed to attach for 24 h. 
The cells were then washed twice with PBS and incubated for 8 h in complete culture 
medium at 37 oC and treated the same way as the samples. Cu and Ni standards were 
prepared by serial dilution of Cu and Ni ICP-MS standards (1000 μg/mL from Spex 
CertiPrep) in nitric acid (2.6%). The solutions were then analyzed using Varian 820 ICP-MS 
(Agilent Technologies, Santa Clara, CA) and In-115 was used as an internal standard for all 
measurements. 
Assessment of Metal Ion Release from NPs using ICP-MS 
Metal ion release from Cu and C-Cu NP (50 μg/mL) was performed in complete 
culture medium and medium without FBS at 37 oC. Released fraction was assessed at 0 h, 2 
h, 12 h and 24 h. Briefly NP suspension (100 μL) from freshly prepared stocks in DI water (1 
mg/mL) was added to media (1.9 mL) (with and without 10% FBS) in a six well plate, 
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slightly shaken to mix the contents and incubated for the required time period at 37 oC. For 0 
h time point, NPs were allowed to incubate for 1 min with the media. After incubation for the 
required time period, NPs with the media were collected in a centrifuge tube and centrifuged 
at 22,000 g for 20 min at 4 oC using an Eppendorff Centrifuge. After centrifugation, 
supernatant (1.5 mL) was carefully removed and transferred to an Amicon Ultra Centrifugal 
Filter Tube with 100,000 molecular weight cutoff (Millipore, Billerica, MA) and centrifuged 
at 1200 g for 15 min using an IEC CL40R centrifuge (Thermo Electron Corporation, 
Ashville, NC). The filtration step was added after the centrifugation step to ensure complete 
separation of NPs from dissolved fraction. The separation was also confirmed after the 
intensity measurements using the dynamic light scattering measurements with Beckman 
Coulter N5 submicron particle size analyzer. Dilutions from the filtrate were made with nitric 
acid (3%) solution and analyzed using Varian 820 ICP-MS (Agilent Technologies, Santa 
Clara, CA) using In115 as an internal standard. The data are reported as wt % Cu (mg) 
released from Cu NP (mg) normalized by particle size (nm) in DMEM media in the presence 
or absence of 10% FBS.  
Composition Analysis using XPS and XRD 
Surface composition for Cu, C-Cu, Ni, C-Ni NPs were analyzed using Kratos AXIS 
Ultra DLD Photoelectron Spectrometer (Kratos Analytical, Manchester, UK). Analysis was 
carried out on gold sputtered silicon wafers on which a droplet of NP suspension (2 mg/mL) 
was placed and allowed to air dry. Energy source was Al Kα rays (1486.6 eV) and the area 
analyzed for XPS was 300µ x 700 µm2. For each sample, full spectrum as well as high 
resolution spectrum was obtained for the metal of interest, carbon and oxygen. In addition, 
Cu auger peaks were analyzed as well. A charge neutralizer was used and the energy of the 
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spectra was corrected to C 1s peak at 284.8 eV. X-ray diffraction analysis was performed 
using Rigaku Miniflex II instrument. X-ray diffraction spectrum were recorded from 2θ = 10o 
to 100o with a step size of 0.02o and a scan time of 1 sec per step using CuKα radiation with a 
wavelength of 1.5406 Å. The data was analyzed by comparing diffractograms of samples 
with reference spectra using ICDD PDF-2 database. 
Mitochondrial Function Assay 
In cells with functional mitochondria, MTT (yellow colored) is reduced to a formazan 
derivative (blue color) which is quantified after solubilization of the formazan derivative in 
DMSO. MTT was used to evaluate the mitochondrial function of A549 cells (25,000 
cells/well in a 96 well plate) after 24 h incubation with Cu, C-Cu, Ni and C-Ni NPs (0.01, 
0.1, 1, 10 and 100 µg/mL). All dilutions for different doses were made 10X in DI water and 
the desired concentration in well was achieved after a ten-fold dilution. After 24 h treatment, 
cells were washed twice with PBS to remove excess NPs and MTT reagent in media (0.5 
mg/mL) was allowed to incubate with the cells for 4 h. After 4 h, the MTT reagent was 
aspirated and the reduced formazan derivative was solubilized using DMSO (200 µL), after 
which the plate was centrifuged for 10 min and DMSO (100 µL) was transferred to a new 
plate and absorbance was measured at 570 nm. NPs with MTT reagent and without cells 
were used as controls to account for any interference. A549 cells without any treatment were 
the negative control for this experiment. The results were reported as percent mitochondrial 
function compared to negative control.  
Neutral Red Lysosomal Membrane Integrity Assay 
Neutral red is permeable to all cells but is retained only in cells with intact lysosomal 
membrane as its binds to the anionic sites in the lysosomes (Repetto et al., 2008). Any insult 
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to cell resulting in lysosomal membrane damage results in decreased uptake of neutral red; 
which is also the principle of this assay. Briefly, A549 cells (25,000 cells/well in a 96 well 
plate) were allowed to attach 24 h. For 24 h, cells were treated with Cu, C-Cu, Ni and C-Ni 
NPs (0.01, 0.1, 1, 10 and 100 µg/mL). All dilutions for different doses were made 10X in DI 
water and the desired concentration in well was achieved after a ten-fold dilution. After 24 h 
treatment, cells were washed twice with PBS to remove excess NPs after which neutral red 
dye (40 μg/mL) in media was added and allowed to incubate with the cells for 4 h. NPs with 
neutral red dye without cells were used as controls to account for any interference. A549 
cells without any treatment were the negative control for this experiment. After washing the 
cells once with PBS, the incorporated neutral red dye was extracted using a mixture of water, 
ethanol and glacial acetic acid. The absorbance was measured at 540 nm and results were 
reported as percent membrane integrity compared to negative control.  
Ethidium Homodimer/Calcein AM Plasma Membrane Integrity Assay 
In order to determine plasma membrane damage, membrane integrity was assessed 
using ethidium homodimer/calcein AM dyes. Ethidium homodimer enters cells with 
damaged plasma membranes and fluorescence enhancement occurs after binding with nucleic 
acids. Calcein AM is cell permeable and by the action of cellular esterases, it gets converted 
into anionic calcein which is fluorescent and trapped inside the cells. Thus, one can 
distinguish between cells with compromised plasma membrane from the cells with intact 
membranes. Manufacturer’s protocol was followed for this assay. Briefly, 100,000 A549 
cells were plated/well in Lab-Tek II chambered cover glass slides and allowed to attach for 
24 h. Copper, C-Cu, Ni, C-Ni NP and CuCl2 treatments with equivalent dose (5, 10 and 25 
µg/mL) were added and allowed to incubate with the cells for 2 h. Untreated A549 cells were 
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used as negative control and 5 min treatment with Triton® X-100 (0.1%) was used as a 
positive control. After treatment, cells were washed twice with PBS followed by addition of 
ethidium homodimer (4 µM) and calcein AM (2 µM) in PBS. After 20 min of incubation at 
RT, images were taken using Olympus 1X51 Fluorescence Microscope and analyzed using 
Olympus DP2BSW Software. 
Statistical Analysis 
Statistical analysis was performed using either one-way analysis of variances 
(ANOVA) followed by pair-wise comparison using Tukey’s multiple comparison test or two 
way ANOVA followed by bonferroni post tests using GraphPad Prism software. Data were 
considered statistically significant when p value was less than 0.05. 
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4.4    Results 
Physico-Chemical Characterization of NPs 
According to the manufacturer, the particle size of Cu NPs and C-Cu NPs was 25 nm 
and Ni NPs and C-Ni NPs was 20 nm. Particle size analysis in de-ionized (DI) water and 
DMEM (Dulbecco’s Modified Eagle Medium) (with and without 10% FBS) using dynamic 
light scattering (Table 4.1) and Transmission Electron Microscopy (TEM) (Figure 4.1) show 
that NPs were aggregated upon suspension in various media. The particle size of NPs was 
highly influenced by the surrounding medium and was orders of magnitude higher than that 
reported by the manufacturer. The addition of 10% FBS to the medium decreased the 
aggregation of NPs as the average particle sizes were lower than that observed in DI water. 
For surface composition analyses of NPs, XPS (X-ray Photoelectron Spectroscopy) 
measurements were performed. In XPS analysis (Figure 4.2), characteristic peaks from 
copper, oxygen and carbon were observed for both Cu and C-Cu NPs. The presence of 
carbon in the Cu NP samples was attributed to atmospheric contamination. There was much 
more carbon present on the C-Cu NPs than the Cu NPs, as evidenced by the C:Cu atomic 
concentration ratio in these samples (1.87 ± 0.05 and 0.61 ± 0.04 for C-Cu and Cu NPs, 
respectively). In addition, much more oxygen was observed in the Cu NP samples; O:Cu 
ratios were 0.6 ± 0.3and 0.99 ± 0.02 for the C-Cu NPs and Cu NPs, respectively. These data, 
in combination with the Cu 2p3/2, Cu auger, O1s, and C 1s peak positions in Table 4.2, 
indicate that the C-Cu NP sample contained a significant amount of Cu metal with some 
oxidized Cu attributed to Cu2O, while the Cu NP surface had been largely oxidized and was 
mostly composed of Cu2O and some oxidized carbon. 
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For Ni and C-Ni NPs (graphs not shown), similar trends were observed. The ratio of 
percent atomic concentration of carbon:nickel in C-Ni NPs and Ni NPs were 6.8 ± 0.5 and 
2.0 ± 0.2, whereas the ratio of percent atomic concentration of O:Ni in C-Ni NPs and Ni NPs 
were 1.5 ± 0.3 and 2.7 ± 0.2, respectively. The peak positions in Table 4.2 suggest that the 
C-Ni NP surface is composed mostly of Ni metal although the presence of some surface 
NiO/Ni2O3/Ni(OH)2 cannot be ruled out. The Ni NP sample was significantly more oxidized 
compared to C-Ni NPs and was composed predominantly of NiO (854.35 ± 0.08), and Ni2O3 
and/or Ni(OH)2 (856.20 ± 0.07), but some residual Ni0 (852.81 ± 0.03) was also observed. A 
diffraction pattern characteristic of Cu was observed in both Cu and C-Cu NPs with the 
strongest characteristic peak of Cu at d = 2.087, 2Ɵ = 43.3158. A Cu2O peak was observed in 
Cu NPs at d = 2.453. A small Cu2O peak was also observed in C-Cu NPs at d = 2.4601. The 
ratio of intensities of strongest Cu peak to strongest Cu2O peak was three-fold higher in C-Cu 
NP compared to Cu NP.  
Differential Effects of Carbon-Coated and Non-Coated NPs on Mitochondrial Function 
and Lysosomal Membrane Integrity  
The effect of NPs on mitochondrial function and lysosomal membrane integrity was 
assessed using the MTT and neutral red assays, respectively (Figure 4.3A and 4.3B). After 
24 h incubation with various doses, Cu and C-Cu NPs had similar effects on lysosomal 
membrane integrity. Major differences were observed between the effects of carbon-coated 
versus non-coated Cu NPs on mitochondrial function. Upon treatment with low 
concentrations of C- Cu NPs (0.01, 1 and 1 µg/mL) an effect on mitochondrial membrane 
was evident whereas with Cu NPs, no mitochondrial effect was observed.  A similar effect on 
mitochondrial membrane was observed at 100 µg/mL for both Cu NP and C-Cu NPs. C-Cu 
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NP treated cells displayed 30% and 45% decrease in mitochondrial function at doses of 1 and 
10 µg/mL compared to control untreated cells, respectively. However, only a 18% decrease 
in mitochondrial function was observed with Cu NPs at10 µg/mL. Interestingly, Ni and C-Ni 
NPs had no measurable effect on membrane integrity. C-Ni NPs treatment at 10 µg/mL 
resulted in a 40% decrease in cell mitochondrial function followed by a plateau in the 
response with increasing dose. In contrast, Ni NPs did not have any effect on mitochondrial 
function. 
Cellular Uptake and Release of Soluble Metal from NPs 
In order to understand the underlying reasons for differences observed in cell-based 
toxicity assays, it was decided to qualitatively and quantitatively assess the uptake of NPs in 
A549 cells using TEM and ICP-MS, respectively. Cell uptake by ICP MS measures Cu/Ni 
content in cells from NPs both associated with cell surface and internalized fractions. TEM 
images in Figure 4.4 show that all four types of NPs were taken up by A549 cells. 
Nanoparticles were mostly centered around the nuclear membranes and in the vicinity of the 
mitochondria. To better understand the interaction of carbon-coated versus non-coated NPs, 
the amount of NPs associated with the cells was quantified after 8 h of incubation with A549 
cells using ICP-MS (Inductively Coupled Plasma Mass Spectroscopy). Significant (P < 0.05) 
differences exist between the uptake of Cu and C-Cu NPs as C-Cu NPs shows almost a ten-
fold higher uptake (4261 ± 553 ng Cu/million cells) than Cu NPs (302 ± 33 ng Cu/million 
cells) (Figure 4.5). However, this trend was not seen in the case of Ni and C-Ni NPs where 
the uptake of both NPs was similar and the differences were not statistically significant (P > 
0.05). Since a significant difference was observed in the uptake C-Cu and Cu NPs, it was 
decided to investigate in more detail the effect of carbon coating on the release of Cu from 
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Cu and C-Cu NPs in cell culture medium using ICP-MS. A kinetic assessment of the amount 
of released Cu from NPs is shown in Figure 4.6. Consistent with the uptake data, the 
presence of carbon coating on the surface of Cu NPs had a significant impact on the amount 
of Cu released from these NPs. After 2 h of incubation four-fold less Cu was released from 
C-Cu NPs in DMEM ± FBS compared to Cu NPs + 10% FBS.  Furthermore, the presence of 
serum enhanced the release of Cu from Cu NPs as two-fold greater Cu was released from Cu 
NPs in DMEM with 10% FBS compared to Cu NPs in DMEM (no FBS) after 2 h incubation. 
Plasma Membrane Integrity Analysis using Ethidium homodimer and Calcein AM 
To gain insight into the mechanisms of toxicity, plasma membrane integrity was 
evaluated at time points as early as 2 h. Ethidium homodimer only enters cells with 
compromised membranes and calcein AM is taken up by all viable cells by passive 
absorption. Using a fluorescence microscope, images were taken for each treatment. 
Representative images from each treatment are shown in Figure 4.7A. The average ethidium 
homodimer positive cells (cell membrane compromised) from four fields selected randomly 
are plotted in Figure 4.7B. After 2 h incubation, Cu NPs started inducing membrane damage 
at doses as low as 5 µg/mL and 10 µg/mL. In Cu NP treated cells, ethidium homodimer 
positive cells (red cells) were present in clusters. After 2 h treatment with 25 µg/mL Cu NPs, 
40% cells were positive for ethidium homodimer whereas only 1-3% of cells stained positive 
for ethidium homodimer when treated with C-Cu NPs and CuCl2 at 25 µg/mL. This 
experiment was also carried out for Ni and C-Ni NPs but no effect on plasma membrane 
integrity was observed. 
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4.5    Discussion 
The questions asked in these studies pertained to how the carbon coating affected i)  
the physicochemical properties of  metal NPs, ii) the toxicity end points in cells exposed to 
these NPs and  iii) whether the changes in physicochemical properties could be correlated to 
toxicity of NPs as a function of carbon coating. However, the focus of these studies was not 
to prove that carbon coating offers protection against toxic effects of metal based NPs. 
Specifically, Cu, C-Cu, Ni and C-Ni NPs were tested. The results of these studies suggests 
that carbon coating influenced i) NP physico-chemical properties, and interaction  with 
surrounding media and ii) toxicity, in cell-based assays compared to the non-coated NPs 
especially in the case of Cu and C-Cu NPs. 
Due to high surface energy, agglomeration of NPs was observed upon suspension in 
various media. Higher agglomeration of Ni and C-Ni particles was observed in DMEM 
compared to DI water whereas for Cu NPs agglomeration was lower in DMEM compared to 
DI water and for C-Cu NPs, degree of agglomeration was similar in DMEM and DI water. 
To explain these findings, DLVO [Derjaguin and Landau (Derjaguin and Landau, 1941); 
Verwey and Overbeek (Verwey and Overbeek, 1948)] theory was considered. According to 
DLVO theory, agglomeration and stability of particles depends upon attractive van der waals 
forces and repulsive electrostatic forces. Repulsive electrostatic forces depend upon zeta 
potential and thickness of electrical double layer. Ionization of particle surface, adsorption of 
counter ions and lattice ion dissolution determine surface zeta potential and ionic strength 
determines thickness of electrical double layer. Increase in either zeta potential or thickness 
of electrical double layer increases repulsive electrostatic forces and decreases agglomeration 
(Jiang et al., 2008; Stumm and Morgan, 1996). High ionic strength usually encountered in 
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physiological conditions such as DMEM can result in decrease of the thickness of electrical 
double layer of particles resulting in increased agglomeration which has been reported in 
literature (Jiang et al., 2008) and was the case with Ni and C- Ni particles in our studies. An 
investigation into the effect of low and high ionic strengths on zeta potential was carried out 
by measuring zeta potential in 0.015 mM and 0.15 mM ionic strengths using phosphate 
buffered saline (PBS, pH 7). Zeta potential of Ni and C-Ni particles could not be determined 
in 0.015 M and 0.15 M PBS solutions as rapid settling of large agglomerates were observed. 
For Cu NPs, the average zeta potential was -9 mV in DI water, -28 mV in 0.015 M PBS and -
24.8 in 0.15 M PBS. Surface Cu ionization on Cu NPs and interaction with chloride ions in 
PBS explains higher negative zeta potential and lower agglomerate sizes of Cu NPs in 
DMEM. 
For C-Cu NPs, the average zeta potential was -6 mV in DI water, -31 mV in 0.015 M 
PBS and -24 mV in 0.15 M PBS but the particle size was similar in DI water and DMEM. 
This could be due to formation of aggregates (Jiang et al., 2008)  (made up of tightly bonded  
NPs possibly due to presence of carbon coating) which cannot be dispersed by changing 
ionic strength or surface charge; conditions  which can usually disperse loose NP 
agglomerates which primarily interact by electrostatic forces. 
Compared to DI water, when NPs were suspended in DMEM with 10% FBS, 
considerable decrease in agglomeration of all particles was observed. This observation was 
consistent with literature reports as protein in serum may coat the particle surface (Murdock 
et al., 2008; Xia et al., 2008). Impact of changing media composition on particle size was 
more prominent for non-coated NPs compared to carbon coated NPs. Since major 
applications of Cu NPs are in conducting inks and catalysts, oxidation of Cu NPs can lead to 
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an increase in resistivity and a decrease in conductance. Carbon coating is used as a way to 
protect the NP surface from oxidation without interfering with the functionality of these NPs 
in various applications (Luechinger et al., 2008).  Surface carbon coating can lend a 
hydrophobic surface which may lead to a differential interaction of these particles with 
surrounding media, cells and different toxicity profile as compared to their non-coated 
counterparts. Higher percent atomic concentration of oxygen and lower percent atomic 
concentration of carbon in Cu and Ni NPs compared to C-Cu and C-Ni confirms the presence 
of carbon coating and suggests relative protection of carbon coated NP surface from 
oxidation although some level of surface oxides were also observed in carbon coated NPs as 
indicated by XPS and XRD analysis. X-ray photoelectron spectroscopy is a very surface 
sensitive technique compared to XRD which is not very surface sensitive. 
The release studies in cell free media (Figure 4.6) clearly showed that the carbon 
coating decreased the  release of soluble metal ions from NPs. Compared to Cu NPs in 
DMEM with 10% FBS, four-fold less Cu was released from C-Cu NPs after 2 h incubation. 
Furthermore, the presence of serum enhances the release of Cu from Cu NP surface which is 
in agreement with previous reports (Cronholm et al., 2011).  However, presence of serum in 
cell culture medium did not have any influence on release of Cu from C-Cu NPs suggesting 
stabilization offered by carbon coating. Another interesting difference was almost an order of 
magnitude higher cellular uptake of C-Cu NPs was observed compared to the non-coated Cu 
NPs (Figure 4.5). Cell uptake for C-Cu NPs was almost 10-times greater compared to Cu 
NPs despite their similar size in DMEM+10% FBS because carbon coating provides a 
hydrophobic surface to NPs and thus is more favorable for uptake by cells.  Also, in the 
presence of carbon coating the release of soluble Cu from C-Cu NPs was less compared to 
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Cu NPs and thus quantitatively less Cu NPs compared to C-Cu NPs were available for uptake 
by cells.   
In addition to the differential uptake and interaction of carbon-coated and non-coated 
Cu NPs with cellular environment, differences were also observed in cell-based assays.  
After 24 h incubation with A549 cells, significant differences (P < 0.01) were found between 
the effects of Cu and C-Cu NPs on mitochondrial function but not on lysosomal membrane 
damage at 0.1, 1 and 10 µg/mL doses (Figures 4.3A and 4.3B). Copper ion induced damage 
to lysosomal membrane has previously been reported (Grillo et al., 2009). Recently it was 
reported that Cu NPs with an oxidized copper oxide shell undergoes enhanced dissolution in 
acidic media whereas in the absence of oxidized layer, the reaction to solubilized Cu metal 
from the surface of Cu NPs is less energetically favored (Elzey and Grassian, 2010). 
Interestingly, irrespective of carbon coating, equivalent damage to lysosomal membrane was 
observed from Cu and C-Cu NPs. One hypothesis to explain this effect can be that despite a 
higher release of Cu ions from Cu NPs relative to C-Cu NPs, the total amount of released Cu 
inside acidic compartments such as lysosomes was similar from both NPs due to higher 
cellular uptake of C-Cu NPs relative to Cu NPs. Almost a log-fold higher cellular uptake of 
C-Cu NPs compared to Cu NPs and a slower dissolution inside the cells may lead to 
accumulation of C-Cu NPs in the cells over time. It is possible that with C-Cu NPs, the 
carbon coating may allow only limited but extended release of Cu ions in the cells which 
over time would be available for inducing damage to the mitochondria compared to Cu NPs 
which demonstrate a burst release. This scenario may explain the damage to mitochondria 
due to C-Cu NPs at doses as low as 1 µg/mL. Although it was not the intent of the present 
studies to investigate the mechanisms of toxicity, oxidative stress inducing potential of NPs 
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was evaluated since oxidative stress has been correlated to metal NP toxicity (Nel et al., 
2006).  In fact after 17 h of incubation of Cu and C-Cu NPs with A549 cells, a two and ten-
fold increase in reactive oxygen species (ROS) compared to control at relatively high 
concentrations of 25 and 50 µg/mL, respectively, was observed only with C-Cu NPs and not 
with Cu NPs (data not shown), indicating persistence of C-Cu NPs in the cells. Furthermore, 
when NP effects on plasma membrane integrity was evaluated using ethidium 
homodimer/calcein AM assay after 2 h incubation with the cells, significant differences (P < 
0.001 at 25 µg/mL) were observed between the effects of Cu and C-Cu NPs on plasma 
membrane integrity (Figure 4.7A & 4.7B). Copper NPs damaged the plasma membrane at 
doses of 5 and 10 µg/mL and it was observed that the cells with damaged plasma membrane 
were present in clusters whereas C-Cu NPs had no effect on the plasma membrane integrity. 
A time point of 2 h was chosen to allow sufficient time for most of the NP dose to 
accumulate on the cell surface (Teeguarden et al., 2007).  The release, uptake and cell 
toxicity data suggests that after Cu and C-Cu NPs were added to the wells, Cu NPs 
continuously dissolved in cell culture medium.  As a consequence, the cells were exposed to 
high localized concentrations of soluble Cu which may have lead to plasma membrane 
damage of a group of cells possibly by oxidizing the membrane lipids and proteins (Bremner, 
1998; Cecconi et al., 2002).  Simultaneously, Cu NPs taken up by cells can end up in cell 
compartments such as lysosomes which are similarly exposed to high concentrations of Cu 
ions possibly by a trojan horse type effect (Limbach et al., 2007; Park et al., 2010).  The 
release data suggests that at a given time and dose, C-Cu NPs release only a fraction of 
soluble Cu ions by weight compared to Cu NPs and thus plasma membrane damage is not 
observed with C-Cu NPs. At doses equivalent to Cu NPs, plasma membrane damage was 
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also not observed with aqueous salts like CuCl2. One explanation of why CuCl2 did not show 
any effect on plasma membrane integrity could be the uniform availability of Cu ions in cell 
culture medium and hence are unlikely to reach the cell surface in doses equivalent to soluble 
Cu from Cu NPs in 2 h. Cu NPs are more prone to settling and likely to cause a localized 
response due to their aggregated nature.   
These results corroborate with a recent study on Cu and CuO NPs by Midander et al. 
(2009) where they showed that most of the Cu NPs were dissolved after 4 h in DMEM. They 
also reported 80% non-viable cells (assessed using trypan blue assay which measures 
membrane integrity) after 4 h treatment with Cu NPs as opposed to only a small percentage 
of non-viable cells after treatment with either CuO NPs or Cu and CuO microparticles. 
Additionally, they showed relatively low toxicity to dissolved fraction of Cu and CuO NPs 
(20% non-viable cells) compared to Cu and CuO NPs themselves (90-100% non-viable cells) 
after 18 h incubation with the cells. This further strengthens the proposed hypothesis that Cu 
NPs are more likely to cause membrane damage early on due to their aggregated nature 
helping them to settle on NP surface and making the cells more likely to see the dissolved 
fraction as opposed to a uniform solution of dissolved Cu in form of CuCl2. NPs can change 
size, shape and composition in media and thus their delivered dose to the cell surface can be 
different from their solution counterparts. An extensive review on particokinetics by 
Teeguarden et al. ( 2007)  covered in detail various factors affecting delivered dose of NPs. A 
recent report by Wittmaack (Wittmaack, 2011) also highlights the importance of gravitational 
settling while interpreting nanotoxicity results. In vivo toxicity of Cu NPs is also attributed to 
their conversion to cupric ions. Chen et al. (2006) and Meng et al. (2007) reported grave 
toxicity of copper NPs especially to kidney, liver and spleen after oral gavage administration 
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in mice. Authors reported LD50 of Cu NP and Cu microparticles as 413 mg kg-1 and >5000 
mg kg-1, respectively. Their studies suggest that higher conversion of Cu NP to ionic form 
compared to micro NPs was responsible for higher toxicity observed with Cu NPs.  
Nickel and C-Ni NPs were relatively not toxic to A549 cells compared to Cu and C-Cu 
NPs. Ni NPs were inert in MTT and neutral red membrane integrity assay and some decrease 
in mitochondrial function (40% compared to control) was observed with C-Ni NPs. This is 
consistent with literature reports, Peters et al. (2004) found no toxicity to Ni NPs using MTS 
assay in HDMEC cells. Another study (Lanone et al., 2009) compared the toxicity of Ni NPs 
in THP cells across various labs using MTT assay, either the IC50 was not reached after 24 h 
or was very high (79 µg/mL). Surprisingly, in the studies reported herein, although some 
toxicity was observed with C-Ni NP versus Ni NP in MTT assay, the Ni uptake of cells was 
not  significantly different (P >0.05) between Ni and C-Ni NPs. In fact, with Ni and C-Ni 
NPs, almost the entire administered dose (10 µg/mL) was found to be taken up by cells. 
However, caution should be exercised when interpreting these data since the quantitative 
measure of Ni content associated with the cells includes both un-internalized (NPs sticking 
on cell surface) as well as internalized (NPs inside the cells) components. Therefore, it is 
possible that although no differences were observed between total Ni uptake by cells treated 
with Ni and C-Ni NPs, in reality there might be a difference in internalized versus surface Ni 
fractions. Literature reports (Fletcher et al., 1994; Liu et al., 2007) suggest a “nickel ion 
hypothesis” for explaining toxicity, mutagenicity and carcinogenicity observed with various 
Ni compounds. According to this hypothesis, the toxicity, mutagenicity and carcinogenicity 
observed with various Ni compounds is directly related to the Ni (II) ion concentration in the 
cells and is independent of the form of the parent Ni compound. It has also been shown that 
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accelerated dissolution of Ni compounds can happen in acidic conditions of vacuoles in cells 
(Abbracchio et al., 1982). Therefore, it is possible that the interplay between internalized 
fraction and subsequent dissolution in the cells may be the determining factors that may 
account for differences in toxicity between Ni and C-Ni NPs. However, this is an area of 
future research. 
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Table 4.1 Particle Size and Zeta Potential Analyses of NPs in Various Media. Particle size 
was measured in DI water and DMEM (± 10% FBS) using dynamic light scattering. Zeta 
potential was measured in DI water using a Malvern Zeta Sizer Nano Z. Average particle size 
(intensity analysis) and zeta potential values were calculated from three independent 
measurements. 
 
 
NP Type Manufacturer Particle Size*(nm) 
Surface 
area* (m2/g) 
Particle Size in 
DMEM + 10% 
FBS 
(nm ± SD 
Particle Size 
in DMEM 
(nm ± SD) 
Particle Size 
in H2O 
(nm ± SD) 
 
Zeta 
Potential in 
H2O 
(mV ± SD) 
 
Ni NanoAmor 20 50 560 ± 214 2778 ± 107 1210± 180 3 ± 0.7 
C-Ni NanoAmor 20 50 427 ± 150 954 ± 382 728 ± 281 -16 ± 2 
Cu NanoAmor 25 40 272 ± 93 537 ± 167 1175 ± 369 -9 ± 3 
C-Cu NanoAmor 25 40 253 ± 8 447 ± 121 392± 90 -6 ±0.7 
*Provided by manufacturer. 
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Table 4.2 Comparison of Binding Energies (BE) of Cu and C-Cu NPs with range of BE for 
Standard Reference Compounds (Wagner., 1978). 
 
 
NP Type BE Cu 2p3/2 BE Cu Auger BE Ni 2p3/2 BE O 1s BE C 1s 
Cu NP 932.85 ± 0.04 569.87 ± 0.06 - 
529.92 ± 0.06 
 530.81 ± 0.02* 
531.82 ± 0.03 
284.8* 
285.95 ± 0.09 
288.84 ± 0.06 
C-Cu NP 932.99 ± 0.07 568.03 ± 0.06 - 530.9 ± 0.1  
284.8 
 
Ni NP - - 
852.81 ± 0.03 
854.35 ± 0.08* 
856.20 ± 0.07 
529.79 ± 0.08 
531.46 ± 0.08* 
532.8 ± 0.2 
284.8* 
286.6 ± 0.3 
289.08 ± 0.03 
C-Ni NP - - 852.98 ± 0.02 532.4 ± 0.2 284.8* 286.1 ± 0.2 
Reference Data a 
Cu 932.6 - 933 567.7-568 - - - 
Cu2O 932.2 -932.8 569.7-570 - 530.2-530.7 - 
CuO 933.4 -933.9 568.5-568.8 - 529.5-529.8 - 
Ni - - 852-853 - - 
NiO - - 854-854.7 529.5-529.8 - 
Ni2O3 - - 855.8-856 531.5-531.7 - 
Ni(OH)2 - - 855.6-856 531.2-531.5 - 
 
*Represents the predominant peak 
a A range of BE for standard reference compounds was identified from the X-ray 
Photoelectron Spectroscopy Database, Version 3.5 (National Institute of Standards and 
Technology, Gaithersburg, 2003); http://srdata.nist.gov/xps 
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Figure 4.1 Transmission electron microscopy images of NPs. NPs were suspended at 
concentration of 10 µg/mL in DI water for TEM analysis. The average particle sizes 
measured by TEM correlated with the dynamic light scattering data. 
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Figure 4.2  Representative XPS analysis for C-Cu NPs (top panel) and Cu NPs (lower panel) 
shows the differences in carbon and oxygen content of the surface of these NPs. Percent 
atomic concentration of oxygen and carbon were 13 ± 3% and 54 ± 4% in C-Cu NPs and 38 
± 0.1% and 23 ± 1% in Cu NPs and suggested less surface oxidation of C-Cu NP 
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Figure 4.3 Dose dependent effects of NPs on mitochondrial function and lysosomal 
membrane integrity. (A) MTT assay and (B) lysosomal membrane integrity after 24 h 
treatment with Cu, C-Cu, Ni and C-Ni NPs. Each value is an average ± SE of n= 8 per 
treatment per dose. 
 
 
 
 
 
 
 
 
 
 
(A) 
 
(B) 
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Figure 4.4 Transmission electron microscopy images of NP uptake by A549 cells. A) 
Control A549 cells, B) Cu treated, C) C-Cu treated, D) Ni treated and E) C-Ni treated A549 
cells. Cells were treated with NPs at concentration of 10 µg/mL for 8 h. Arrows indicate 
nucleus and mitochondria. 
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Figure 4.5  Quantitative analyses of Cu and Ni uptake in A549 cells (uptake signifies Cu/Ni 
content in cells from NPs both associated with cell surface and internalized fractions). 
Uptake of Cu from C-Cu NPs was a log-fold higher (* P < 0.05) than from Cu NPs. No 
significant difference was found between uptake of Ni from Ni and C-Ni NPs. Control-Ni 
and control-Cu signifies the amount of Ni and Cu in untreated A549 cells. Quantitative metal 
uptake analyses were performed using ICP-MS. Each value is an average ± SE of three 
independent measurements. 
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Figure 4.6 Release studies for Cu and C-Cu NPs in DMEM media. Percent wt Cu (mg) 
released from NPs (mg) in DMEM ± FBS normalized by particle size (nm).  Cu NP, DMEM 
+ FBS (    ), Cu NP, DMEM (    ), C-Cu NP, DMEM + FBS (    ), C-Cu NP, DMEM (    ). 
After 2 h incubation, four-fold and two-fold greater Cu was released from Cu NPs in DMEM 
+ 10% FBS compared to C-Cu NPs in DMEM ± FBS and Cu NPs in DMEM (no FBS), 
respectively. Therefore, the carbon coating retards release of Cu from C-Cu NPs and the 
presence of FBS enhances release of Cu from Cu NPs but has no effect on C-Cu NPs. Each 
value is an average ± SE of three independent measurements. 
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Figure 4.7 Membrane integrity assay using ethidium homodimer/calcein AM (A) Membrane 
integrity assay using ethidium homodimer/calcein AM revealed that membrane damage can 
be initiated as early as 2 h by Cu NPs. No damage was observed with either C-Cu NPs or 
CuCl2 after 2 h treatment. Red cells are ethidium homodimer positive and damaged because 
ethidium homodimer can enter only plasma membrane damaged cells. Green cells are calcein 
positive and not damaged as calcein AM enters all cells. Note the clustering of red cells in Cu 
treated groups at 5 and 10 µg/mL. (B) Percent ethidium homodimer positive cells compared 
to untreated control (negative control) are plotted. (Average ± SE four fields). Significant 
difference (*** P < 0.001) was found between effects of C-Cu NP, CuCl2   and Cu NP at 25 
µg /mL. 
 
(A) 
(B) 
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Chapter V 
 
Investigation of Cytochrome c (Cyt c) Stability and a Liposome Formulation for 
Its Intracellular Delivery to Induce Apoptosis 
 
5.1    Summary 
Cytochrome c is a mitochondrial protein which upon release to cytosol leads to 
apoptotic cell death. Its mechanism of action reinforces its potential as an anti-cancer 
therapeutic agent if it could be exogenously delivered to cancer cells.  However, Cyt c lacks 
physicochemical characteristics required for successful cell permeation. Nanocarriers have 
been widely used to facilitate intracellular delivery of many protein drugs; however, a major 
limitation of using traditional polymer based nanocarriers for protein drugs is exposure of 
proteins to organic solvents and high shear/stress conditions during formulation. Another 
challenge for successful delivery of intra-cellular acting proteins is to induce their endosomal 
release. The objective of these studies was to investigate stability and intracellular delivery of 
Cyt c using DOTAP and cholesterol (DOTAP-Chol) liposomes prepared using a film 
hydration method. The effect of formulation (pH and ionic strength) and process conditions 
(sonication, freeze thaw cycling and extrusion) on Cyt c stability and entrapment in 
liposomes was evaluated. Modulation of hydration buffer pH from 7 to 8.5 showed an 
increase in the entrapment efficiency of Cyt c in DOTAP-Chol liposomes from 2% to 30%. 
Optimized liposomal Cyt c formulation showed apoptotic activity in MDA-MB-231 cells.
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Cytochrome c released from optimized liposomal formulation was physically and chemically 
stable as no aggregation, secondary and heme crevice structure change and deamidation was 
observed. Additionally, Cyt c released from optimized liposomal formulation retained 
apoptotic activity after storage of formulation for twenty eight days at 4 oC. 
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5.2    Introduction 
Cytochrome c is a 12 KDa, 104 amino acid endogenous heme protein found loosely 
attached to inner mitochondrial membrane in cells (Dickerson, 1971). Cytochrome c has been 
historically known to play a vital role in respiration where it acts as an electron carrier 
between complex III and complex IV in the mitochondria. In recent years, another important 
function of Cyt c, as a central player in inducing apoptosis after its release from mitochondria 
into cytosol has been discovered (Ow et al., 2008). Apoptosis is a tightly regulated form of 
cell death. The intrinsic apoptotic signals such as increased ROS levels in cells triggers 
release of Cyt c into cytoplasm where Cyt c participates and facilitates apoptotic protease 
activating factor 1 (APAF1) and caspase 9 recruitment into a complex known as apoptosome.  
Further downstream signaling involves activation of caspase 9 and other events in apoptosis 
such as translocation of phosphatidyl serine from inner lipid layer to outer lipid layer in 
plasma membrane (Kasibhatla and Tseng, 2003). Cytochrome c microinjected in various 
cancer cells has shown to activate apoptotic cell death (Li et al., 1997; Schafer et al., 2006; 
Zhivotovsky et al., 1998). Zhivotovsky et al., showed induction of apoptosis after 
microinjection of 20 uM Cyt c in normal rat kidney cells (NRK cells) (Zhivotovsky et al., 
1998). Li et al., also observed apoptosis after microinjection of Cyt c in human embryonic 
kidney 293 cells (Li et al., 1997). They also tested other heme containing proteins such as 
myoglobin, hemoglobin in order to check for specificity of Cyt c in inducing apoptotic cell 
death and only Cyt c was shown to induce apoptosis. Interestingly, breast cancer cells show 
unique sensitivity to apoptosis to exogenously administered Cyt c. It has been shown that 
when cytosolic extracts from various cell lines were supplemented with exogenous Cyt c and 
monitored for caspase activity, higher caspase activity was observed in a series of malignant 
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mammary epithelial cell lines compared to cancer cells from other origin such as lung, 
prostate, colon and ovaries (Schafer et al., 2006). Thus, Cyt c is a direct and specific 
apoptogen and a viable anticancer agent especially for the treatment of breast cancer.  
However, due to its hydrophilic, positively charged nature and propensity for 
degradation by plasma proteases, Cyt c lacks the physicochemical characteristics required for 
successful permeation and delivery to cancer cells. Various nanocarriers especially polymeric 
based systems such as poly lactic-co-glycolic acid (PLGA) based systems have been 
proposed for delivery of proteins, however, their formulation often requires the use of 
organic solvents and high shear/temperature conditions which may denature proteins 
(Lassalle and Ferreira, 2007; van de Weert et al., 2000a; van de Weert et al., 2000b; van de 
Weert et al., 2000c). It has been shown that lysozyme entrapped in PLGA microspheres 
prepared using w/o/w solvent evaporation process is present as aggregates (van de Weert et 
al., 2000c). Formulation approaches involving exposure of proteins to organic solvents may 
lead to entrapment of partly or completely denatured therapeutically inactive proteins which 
may ultimately require high and even toxic nanocarrier dose for observing activity. Thus, 
there exists a need to develop processes for formulating proteins in nano-systems which 
involves minimal exposure to denaturing conditions and to evaluate the effect of process and 
formulation conditions on not only activity of proteins but also its structural integrity.  
Recently, polymeric NPs were proposed for intracellular Cyt c delivery to induce 
apoptosis. A solvent evaporation method and exposure to water/dimethylformamide (DMF) 
mixture and acetone was described as steps in prepration (Santra et al., 2010). Exposure to 
DMF is known to induce protein unfolding as it can form hydrogen bonds with the protein 
backbone (Mattos and Ringe, 2001). Although, it was reported that activity of encapsulated 
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Cyt c was equivalent to non-encapsulated Cyt c as measured by peroxidase activity. 
However, it was not stated if peroxidase activity of Cyt c correlates with its apoptosis 
inducing activity. Additionally, an increase in peroxidase activity of Cyt c has been linked 
with partial unfolding of Cyt c (Belikova et al., 2006). Another report describes attachment 
of a hydrophobic peptide to Cyt c with subsequent attachment to the surface of lipid based 
NPs for apoptosis induction (Kim et al., 2012). Apoptosis inducing activity (measured by 
caspase 9 cleavage) of peptide modified Cyt c was two to four fold lower than unmodified 
Cyt c, indicating some denaturation of Cyt c in the process of conjugation. 
Liposomes are bilayered lipid vesicles with an aqueous core suitable for encapsulating 
hydrophilic proteins (Bangham, 1980). Film hydration method can be used to formulate 
proteins in liposomes without using organic solvents, high shear or temperature; however, a 
typical limitation of liposomes is low entrapment efficiencies (EE) (Weiner, 1994). Freeze 
thaw cycling of protein lipid mixture after film hydration has been shown to increase 
entrapment of protein drugs, but freeze thaw cycling can also lead to protein denaturation 
(Mayer et al., 1986; Mayer et al., 1985; Pick, 1981; Weiner, 1994). A recent report on 
acetylcholine transferase entrapment in liposomes suggested increasing the interaction 
(specific or non-specific) between protein drugs and lipids as a means of increasing protein 
entrapment in liposomes (Colletier et al., 2002). 
Another challenge in the intracellular delivery of Cyt c is inducing its endosomal 
release. Failure to escape endosome can result in entrapment of proteins in lysosomes where 
protein denaturation can occur due to low pH and presence of proteases (Du et al., 2012). It 
was recently demonstrated that Cyt c adsorbed onto carbon nanotubes permeated cells but 
could not initiate apoptosis induction until chloroquine (an endosomal disruptor) was co-
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incubated (Kam and Dai, 2005). Therefore, for delivering Cyt c in cytosol, it is imperative to 
include an endosomal releasing agent as a component of delivery system. Dioleoyl-trimethyl-
ammonium-propane lipid has been extensively used in the gene delivery and has been shown 
to induce endosomal release of macromolecular drugs (Fretz et al., 2007). 
The hypothesis for these studies was that the entrapment of Cyt c in DOTAP-Chol 
liposomes prepared using film rehydration method will overcome the challenges for delivery 
of Cyt c while maintaining conditions for optimal Cyt c stability. We further hypothesized 
that modulating the pH of hydration buffer will increase the entrapment of Cyt c in liposomes 
without compromising structural integrity and apoptosis inducing activity of Cyt c. 
  
 114 
 
5.3    Materials and Methods  
Materials 
Cytochrome c (equine heart) and cholesterol were purchased from Sigma Aldrich (St. 
Louis, MO). Dioleoyl-trimethyl-ammonium-propane was purchased from Avanti Polar 
Lipids, Inc. (Alabaster, AL). RPMI media was purchased from Invitrogen (Carlsbad, CA). 
MDA-MB-231 breast cancer cell line, penicillin-streptomycin solution and fetal bovine 
serum (FBS) were purchased from ATCC. Plasmocin was purchased from Invivogen (San 
Diego, CA). Annexin V FITC and propidium iodide (PI) were purchased from BD 
Pharmingen (San Diego, CA). All chemicals were used without any further purification.  
Liposome Preparation 
The film hydration method was used to prepare liposomes. A total of 990 µg lipid 
mixture composed of 1:1 mol ratio of DOTAP and cholesterol in chloroform was added to 7 
mL glass vial and dried under nitrogen stream to form a thin film on the sides and bottom of 
glass vial. This was followed by dessication under vacuum for 4-6 h to ensure complete 
evaporation of chloroform. A series of Cyt c solutions (2 mg/mL) were prepared, each with a 
different ionic strength and pH. During the hydration step, the Cyt c solutions were added to 
separate vials containing the dried lipid film after which the vials were kept at 4 oC 
overnight. Cyt c solutions were buffer exchanged with respective buffers using 3KDa 
Amicon filters before the hydration step. To evaluate the effect of pH and ionic strength on 
entrapment and stability of Cyt c, three pH levels (5, 7 and 8.5) and two ionic strength 
conditions (15 mM and 150 mM) were tested. For sizing the multilamellar vesicles formed 
upon hydration, two methods were used, (1) Sonication + Extrusion (SE) where bath 
sonication (1 min) and extrusion (ten cycles through 100 nm polycarbonate filters) was used 
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and (2) Freeze Thaw + Extrusion (FTE) where four cycles of freezing (in liquid nitrogen) and 
thawing (at 4 oC) were followed by extrusion (ten cycles through 100 nm polycarbonate 
filters). Liposome size and zeta potential was measured using Malvern Nano ZS. 
Unentrapped Cyt c was removed by filtration using 100KDa Amicon filters. Entrapment was 
calculated by measuring the absorbance of entrapped Cyt C at 410 nm. The absorbance at 
410 nm was corrected for any interference from liposome controls (without any Cyt c). 
Percent entrapment and percent protein loading were calculated as follows: 
% Entrapment =  [Protein (mg)in liposomes][Initial protein added (mg)] × 100 
% Protein Loading =  [Protein (mg)in liposomes][Total formulation wt. (mg)] × 100 
 
Dynamic Light Scattering (DLS) 
DLS was used to study the effect of process (FTE or SE) and formulation (pH and 
ionic strength) conditions on aggregation potential of Cyt c (processed-Cyt c) and released 
Cyt c from purified liposomal Cyt c formulation. The effect of pH and ionic strength 
conditions on aggregation of processed-Cyt c was evaluated after Cyt c (2 mg/mL) was 
buffer exchanged with respective buffer and ionic strength conditions and incubated 
overnight at 4 oC.  For assessment of effect of process conditions, Cyt c (2 mg/mL) was 
buffer exchanged with respective buffer and ionic strength conditions, incubated overnight at 
4 oC and additionally samples were processed through SE and FTE cycles. These conditions 
mimicked the conditions that were used to evaluate the entrapment of Cyt c in liposomes 
except that lipids were not included. Samples were centrifuged for 5 min before analysis and 
90 uL supernatant was used for analysis. Similar procedure was followed for determining 
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aggregation of released Cyt c and control Cyt c (Control Cyt c refers to Cyt c that was used 
as a control for process and storage conditions used for releasing Cyt c from liposomal Cyt c 
but without any lipids). DynaPro™ Plate Reader (Wyatt Technology) was used to check for 
presence of any aggregates of Cyt c or change in distribution. 
Circular Dichroism (CD) 
Circular dichroism was used to study the effect of process (FTE or SE) and formulation 
(pH and ionic strength) conditions on secondary and heme crevice structure of processed-Cyt 
c and of released Cyt c from purified liposomal Cyt c formulations.  Processed-Cyt c was 
prepared as described in DLS studies section and diluted before CD analysis so that the 
concentration was close to 0.1mg/mL. The spectra were recorded using Chirascan™ Plus 
Spectropolarimeter (Applied Photophysics) under nitrogen flow using 0.1 cm pathlength at 
25 oC. For determining secondary structure, a range of 190 to 260 nm was scanned and for 
heme crevice structure, a range of 400 to 500 nm was scanned. Spectra were recorded using 
step size of 0.5 nm. Buffer spectra were subtracted from Cyt c spectra and the resultant 
spectra were smoothed using the software supplied with the instrument. The spectra were 
then corrected for concentration of samples using absorbance at 410 nm measured by BioTek 
Synergy™ Microplate Reader.  
Flow Cytometry 
Flow cytometry was carried out to quantitate the early apoptotic and late apoptotic cells 
after treatment of MDA-MB-231 cells with the liposomal formulation and controls. Briefly, 
MDA-MB-231 cells (300,000) were seeded in a six well plate and allowed to attach for 24 h. 
The media was changed after 24 h to serum free media and various treatments (Cyt c, control 
liposomes and purified liposomal Cyt c) were added to cells. Negative control was MDA-
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MB-231 cells without any treatment and positive control was staurosporine (STS) treated 
cells (4 uM overnight treatment). The effect of purified liposomal Cyt c on apoptosis was 
evaluated after 2, 6, 12 and 24 h after incubation while all controls were incubated for 24 h. 
After required incubation, the media supernatants (which contained dead cells) were 
collected; the attached cells were trypsinized, and combined with the supernatants. This was 
followed by centrifugation of cell suspension and resuspension of cell pellet in 1 mL of 
Annexin V FITC binding buffer. Cell suspension (300 uL) was transferred to flow tubes and 
Annexin V FITC (1 uL ) and PI (propidium iodide) solution (4uL) was added to each sample 
tube and allowed to incubate for 15 min in dark. Binding buffer (200 uL) was added and 
fluorescence was quantitated using BD FACS Caliber using FL1 channel for FITC and FL2 
for PI. Analysis was performed using Summit 5.1 software.  
Microinjection 
Microinjection studies were carried out to (1) estimate the amount of Cyt c required to 
induce cell death in MDA-MB-231  cells and (2) to check the apoptotic activity of Cyt c 
upon release from purified liposomal Cyt c after storage for seven and twenty eight days at 4 
oC. Previously published processes in the literature were followed (Kole et al., 2011; Potts et 
al., 2003). Briefly, microinjections were carried out using Narashigi Micromanipulator 
mounted on an Inverted Fluorescence Microscope (Leica). MDA-MB-231 cells (150,000) 
were seeded in 35 mm cell culture petri dishes and allowed to attach overnight. Media was 
changed next day and cells were microinjected using microinjection needles. Several 
concentrations of Cyt c (100, 250, 500 and 1000 µg/mL) in microinjection buffer (100 mM 
potassium chloride and 10 mM potassium phosphate buffer, pH 7.4) were injected. 
Rhodamine dextran dye (4mg/mL) was included in microinjection buffer to mark the injected 
 118 
 
cells. Rhodamine positive viable cells were counted at 0 h and 5 h after microinjection in a 
particular field. Rounded cells and cells that lifted off the plate were counted as dead cells. 
Cell death was expressed in percentage. The concentration of Cyt c solution was converted to 
Cyt c (pg)/cell by assuming a constant microinjection volume of 20 pL per cell. A similar 
procedure was followed for determining apoptotic activity of released Cyt c and control Cyt c 
except Cyt c concentration of 1 mg/mL were used. 
Iso Electric Focusing (IEF)  
The chemical stability of Cyt c released from optimized and purified liposomal Cyt c 
formulation and of control Cyt c against deamidation was assessed using IEF. Formulations 
and control Cyt c were stored for seven days at 4 oC before Cyt c release was induced. A 
IPGphor Isoelectric Focusing System (Amersham Pharmacia Biotech) was used. Released 
Cyt c and control Cyt c was concentrated to 1 mg/mL and mixed with rehydration buffer (8 
M urea, 2% CHAPS, 0.002% bromophenol blue, 2% DTT and 0.5% carrier ampholyte) so 
that 125 uL of diluted sample had 50 ug Cyt c. Immobilized pH 6-11, 7 cm strips were 
hydrated overnight with the rehydration buffer containing Cyt c. The following order of 
voltage increments was used for focusing: 300 V for 1 min followed by gradient up to 3500 
V over 90 min followed by focusing at 3500 V for 5 h.  The PI value was assigned based on 
variation of pH across the length of strip based on data obtained from GE Lifesciences.  
UV Aborbance Studies 
In order to monitor for pH induced unfolding transitions in Cyt c, Cyt c absorbance 
was measured at 393 nm (high spin Fe, unfolded state) and 410 nm (low spin Fe, folded 
state) using BioTek Synergy™ Microplate Reader. Cytochrome c (2mg/mL) solutions of 
varying pH (from 1 to 8.5) were prepared and kept overnight at 4 oC. The solutions were 
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diluted to a concentration of 250 µg/mL using respective pH buffers and absorbance was 
measured at 393 nm and 410 nm.  
Statistical Analysis 
Statistical analysis was performed using either one-way analysis of variances 
(ANOVA) followed by pair-wise comparison using Tukey’s multiple comparison test or two 
way ANOVA followed by bonferroni post tests using GraphPad Prism Software. Data were 
considered statistically significant when p value was less than 0.05. 
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5.4    Results 
Microinjection studies of Cyt c 
Microinjection of Cyt c was carried out to verify the apoptotic inducing activity of Cyt 
c source used in our studies. Furthermore, dose dependent evaluation of apoptotic activity via 
microinjection showed potent Cyt c activity (Figure 5.1A & 5.1B). Within 5 h of 
microinjection, 80% cell death was observed with 5 pg Cyt c/cell which indicated highly 
potent apoptosis inducing activity.  
Effect of process and formulation conditions on stability of processed-Cyt c 
The effect of change in formulation (pH and ionic strength) and process (sonication 
and extrusion) conditions on processed-Cyt c to potentially undergo any aggregation and 
structural integrity change was evaluated using DLS and CD. After overnight incubation of 
Cyt c at 4 oC in buffers (pH 5, 7 and 8.5 and ionic strength 15 mM and 150 mM), no increase 
in aggregation was observed (Figure 5.2A). For evaluation of effect of process conditions 
(SE and FTE) on aggregation and structural change of processed-Cyt c, only pH 7 and pH 8.5 
buffer in low ionic strength conditions (15 mM) were used. These conditions were tested 
because preliminary entrapment results showed aggregation of DOTAP-Chol liposomes in 
high ionic strength (150 mM) and disintegration in pH 5. The purpose of evaluating the effect 
of formulation and process condition on stability of Cyt c was to mimic the effect of 
conditions that would be used for entrapment studies. As seen in Figure 5.2B, no increase 
aggregation of processed-Cyt c was observed in any conditions except in pH 8.5 and FTE 
conditions, where aggregation (5% by mass) was observed. A characteristic CD spectrum for 
alpha helical structure was observed for Cyt c with major bands at 208 and 222 nm and was 
consistent with reported literature (Parthasarthy and Johnson, 1985). No changes in the 
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secondary structure region were observed for pH 7 and pH 8.5, 15 mM conditions and for the 
SE and FTE conditions (Figure 5.3A). A characteristic heme crevice band at 416 nm was 
also observed for Cyt c in pH 7, 15 mM condition (Figure 5.3B). However, the intensity of 
this band was lower in pH 8.5, 15mM condition regardless of the process conditions (SE or 
FTE) tested. In order to investigate whether the change in heme crevice structure due to pH 
8.5 was local or affected global stability of Cyt c, the effect of pH on unfolding of Cyt c was 
determined. Cytochrome c absorbance at 410 nm (characteristic of low spin Fe, folded state) 
and 393 nm (characteristic of high spin Fe, unfolded state) was monitored (Figure 5.4). In 
pH range from 3 to 8.5, higher absorbance at 410 nm compared to 393 nm was observed, but 
below pH 3, a sharp increase in absorbance at 393 nm was observed and absorbance of at 410 
nm was considerably lower.  
Effect of varying ionic strength and pH condition on entrapment of Cyt c 
Cytochrome c entrapment in DOTAP-Chol liposomes was studied at three pH’s (5, 7 
and 8.5) and two ionic strengths (15 mM and 150 mM) using SE and FTE methods. A 
preliminary assessment of hydration of lipid films (DOTAP-CHOL 1:1 mol to mol) in 
buffers (pH 5, 7 and 8.5 and ionic strength 150 mM) resulted in non-uniform dispersion of 
lipid film and presence of lipid aggregates, which were present even upon sonication. 
Furthermore, when pH 5 buffer was added to DOTAP-Chol liposomes, disintegration into 
visible lipid fragments was observed. Therefore, for evaluation of the effect of pH on 
entrapment of Cyt c in DOTAP-Chol liposomes, pH 7 and 8.5 at 15mM ionic strength 
conditions were studied. Highest entrapment (30-35%) was observed under pH 8.5 & 15 mM 
ionic strength conditions (Figure 5.5). Characteristics of formulations at pH 8.5 are 
summarized in Table 5.1. The average size of liposomal Cyt c formed by SE process at pH 
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8.5 (Formulation 1 or “Form 1”) was 160 ± 10 nm while that formed by FTE process at pH 
8.5 (Formulation 2 or “Form 2”) was 170 ± 10 nm. 
Stability and activity of released Cyt c and liposomal Cyt c 
During entrapment studies, it was observed that addition of pH 5 buffer led to 
disintegration of DOTAP-Chol liposomes. This phenomenon of liposome disintegration was 
utilized to induce release of Cyt c from purified liposomal Cyt c (Form 1 and Form 2) after 
storage of formulations at 4 oC. This procedure of inducing Cyt c release also mimics release 
of Cyt c from delivery system in cells as endosomes have an acidic pH and cytosol has 
neutral pH. A schematic describing procedure for induction of Cyt c release from 
formulations is shown in Figure 5.6. Circular dichroism spectra of Cyt c after release from 
purified Form 1 overlapped with that of the CD spectra of Cyt c, pH 7 and processed-Cyt c, 
pH 8.5 (Figure 5.7A).  In contrast, the CD spectra of Cyt c released from purified Form 2 
showed lower band intensity at 208 nm. The heme crevice structure was also monitored after 
release of Cyt c from purified liposomal Cyt c (Figure 5.7B). The CD spectra in the 400- 450 
nm range of Cyt c released from purified Form 1overlapped with Cyt c at pH 7 indicating 
that the lower band intensity induced in processed Cyt c due to exposure to alkaline pH (8.5) 
is reversible upon changing the pH back to pH 7. However, CD spectra of Cyt c released 
from purified Form 2 showed only partial reversibility and lower band intensity compared 
with Cyt c released from purified Form 1 and Cyt c, pH 7. Based on these results it was 
decided to move forward with Form 1 for further stability analysis. Consequently, 
aggregation potential and chemical stability (against deamidation) of Cyt c released from 
purified Form 1 and control Cyt c (after seven days storage of Form 1 and control Cyt c at 4 
oC) was assessed using DLS and IEF. As shown in Figure 5.8A, no aggregation was 
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observed in Cyt c released from purified Form 1. Isoelectric focusing analysis (Figure 5.8B) 
showed that mobility of Cyt c released from purified Form 1 and control Cyt c was same as 
untreated Cyt c. A PI (iso-electric point) value of 9.7 was assigned based on position of Cyt c 
band relative to the length of immobilized strip. No other band was observed in Cyt c 
released from purified Form 1 and control Cyt c indicating absence of any deamidated 
species. The activity of  Form 1 was assessed using annexin V FITC which detects the 
presence of phosphatidyl serine on outer leaflet of plasma membrane (which is a hallmark of 
early apoptosis) and PI which enters cells with compromised plasma membrane ( a sign of 
late apoptosis). After 24 h incubation with no treatment (negative control), Cyt c only, STS 
and Form 1; annexin V FITC and PI positive cells were quantified using flow cytometer 
(Figure 5.9A). Each panel in Figure 5.9A has four quadrants: Q1 (PI only positive cells or 
necrotic cells), Q2 (PI and FITC positive or late apoptotic cells), Q3 (FITC only positive or 
early apoptotic cells) and Q4 (PI and FITC negative or viable cells). For quantifying 
apoptosis, percent cells in Q2 and Q3 were added together. In untreated and Cyt c only 
treated cells, 6.3 ± 0.7% and 6.6 ± 1.7% of the cell population were apoptotic whereas Form 
1 after 24 h showed 27.0 ± 5 % apoptotic cells. A kinetic analysis of apoptosis induction in 
MDA-MB-231 cells upon treatment with Form 1 (Figure 5.9B) showed basal level of 
apoptotic cell population after 2 h and 6 h treatment and after 12 h, 18 ± 0.3% apoptotic cell 
population was present. Released Cyt c from purified Form 1and control Cyt c (after seven 
and twenty eight days storage of formulation at 4 oC) was also checked for apoptotic activity 
using microinjection (Figure 5.10). No significant difference (P > 0.05) was found between 
percent cell death after microinjection of fresh Cyt c (0 days), Cyt c released from Form 1 
and control Cyt c.  
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5.5    Discussion 
Many barriers exist for successful intracellular delivery of cytosolic proteins such as 
Cyt c. Nanocarriers can be used to improve cell permeability of hydrophilic and charged 
proteins, however, one of the major drawbacks of protein delivery using traditional 
nanocarriers like PLGA based systems is exposure of protein drugs to organic solvents, high 
temperatures and high shear conditions.  In the last five years, many reports have been 
published on the intracellular delivery of proteins. Most of these reports focus on improving 
the intracellular delivery of model proteins using various approaches like bacterial inclusions 
bodies (Villaverde et al., 2012), stapled peptides (Verdine and Hilinski, 2012), cell 
penetrating peptides (Chugh et al., 2010), silk NPs (Kundu et al., 2009), charge conversional 
polyionic complexes (Lee et al., 2009), and layer by layer cross linked carriers (Shu et al., 
2010). Although it is important to develop approaches for enhanced intracellular delivery of 
proteins, it is also imperative to evaluate the effect of process and formulation conditions 
used in these new technologies on structural integrity and specific activity of the protein of 
interest. Only a few studies (De Rosa et al., 2011; Son et al., 2009) have focused on the 
protein stability aspect of protein delivery. In this investigation, studies were designed to 
evaluate the effect of formulation and process conditions on structural integrity, liposomal 
entrapment and apoptosis inducing activity of Cyt c. Initial studies were focused on 
characterizing the apoptosis inducing activity of Cyt c using microinjection. After the release 
of Cyt c from mitochondria to cytosol, specific residues in Cyt c interact with β propeller 
structures in APAF 1 to induce a conformational change in APAF 1 from closed to open 
confirmation, which initiates the formation of apoptosome and further downstream signaling 
for apoptosis (Yuan et al., 2010). Many residues in Cyt c including 7, 62, 65, 25, 39 and 72 
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have been implicated in mediating binding of Cyt c to APAF 1 and mutation in residue 72 
(lysine) is known to abolish Cyt c binding to APAF 1 (Yu et al., 2001). Assessment of 
apoptotic activity of Cyt c using microinjection technique mimics most closely the cellular 
environment (in the presence of other required proteins) to determine apoptotic activity of 
Cyt c (Kole et al., 2011). Microinjection studies showed that Cyt c possesses very potent 
apoptotic activity, only 5 pg Cyt c/cell led to 80% cell death at 5 h after microinjection. The 
microinjection studies also provided an estimate (5 pg/cell) of the threshold Cyt c required to 
induce apoptosis when introduced exogenously in cells. This threshold estimate was very 
helpful from a protein delivery standpoint. Consequently, the film hydration method was 
used to entrap Cyt c in DOTAP-Chol liposomes. The film hydration method does not involve 
exposure of protein to any organic solvents and minimizes the potential of protein 
denaturation; however, the limitation of this method is low protein entrapment. Freeze –thaw 
cycling of lipid protein mixtures has been proposed in literature as a method of increasing 
protein entrapment in liposomes (Mayer et al., 1986; Pick, 1981). However, repeated freeze 
thaw cycling may also lead to protein denaturation (Weiner, 1994).  In these studies, the 
effect of modulating the pH of Cyt c hydration buffer (and essentially Cyt c net charge) and 
freeze thaw cycling on Cyt c stability and entrapment in liposomes was studied. Prior to 
entrapment studies, the effect of various formulation and process related stresses like varying 
pH conditions, bath sonication, extrusion (increased air water interface) and freeze thaw 
cycling on aggregation potential and structural integrity of processed-Cyt c was determined. 
Aggregation was not observed after exposure of processed-Cyt c to changes in pH and ionic 
strength conditions. Usually, at a pH close to PI of the protein, aggregation is common in 
high concentration protein solutions (Chi et al., 2003; Shire et al., 2004). However, in our 
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studies, the utilized protein concentration was 2 mg/mL. This concentration was used 
because Cyt c entrapment in DOTAP-Chol liposomes was also studied at 2 mg/mL. However 
after exposure to pH 8.5 and FTE conditions, aggregation (5% by mass) was observed. This 
could be due to a combination of the pH being closer to PI (9.7-10) of Cyt c where protein 
has lower net charge and additionally exposure of processed- Cyt c to repeated freeze thaw 
cycles. Proteins are very sensitive to changes in their environment and in case of repeated 
freeze thaw cycling, higher stresses due to increased ice/water interface, phase separation and 
change in pH have been reported to lead to protein aggregation (Wang, 2000). No structural 
change in the secondary structure of Cyt c (monitored by intensity of CD bands at 222 and 
208 nm) was observed after the process and formulation runs. Intensity of CD band at 416 
nm (signifying the heme crevice structure) of processed-Cyt c was lower after processed-Cyt 
c exposure to pH 8.5, pH 8.5 SE and pH 8.5 FTE compared to pH 7 (Figure 5.3B). However, 
when Cyt c was released from purified Form 1, its intensity was similar to processed-Cyt c at 
pH 7 and suggested that the change in heme crevice structure of Cyt c was reversible in Form 
1(Figure 5.7B). After Cyt c was released from purified Form 2, its intensity at 416 nm was 
lower than processed-Cyt c at pH 7 and suggested that the change in heme crevice structure 
of Cyt c released from Form 2 was not reversible. The CD band at 416 nm signifies the heme 
crevice structure of Cyt c, specifically the coordination bond between Fe in heme and Met80 
but does not signify global unfolding. Absorbances at 393 nm and 410 nm were measured to 
determine any unfolding. No unfolding was observed at pH 8.5 as no change was observed 
between absorbance (410 nm and 393 nm) at pH 7 compared to pH 8.5.  Furthermore, it has 
been reported that a transient change between Met 80 and Fe in Cyt c can occur around pH 
8.8 but does not signify breakage of Met80 and Fe coordination or lysine misligation since 
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that requires higher pH of around 9.2 (Weinkam et al., 2008). Additionally, it has been 
reported that Cyt c loses its tertiary structure only under extreme alkaline conditions (pH 12). 
The entrapment results clearly showed a significant difference (p < 0.05) between the 
entrapment of Cyt c in DOTAP-Chol liposomes at different pH’s. The entrapment was 30% 
at pH 8.5 compared to 2% at pH 7. One possible explanation of higher entrapment of Cyt c in 
DOTAP-Chol liposomes can be lower net positive charge of Cyt c at pH 8.5 compared to pH 
7 (Cyt c PI is 9.7-10). Lower net positive charge at pH 8.5 could result in lower electrostatic 
repulsion between positively charged Cyt c and positively charged DOTAP-Chol film during 
hydration step and this could lead to lower separation distances between lipid and Cyt c 
molecules. As per the DLVO [Derjaguin and Landau (Derjaguin and Landau, 1941); Verwey 
and Overbeek (Verwey and Overbeek, 1948)] theory, at smaller interparticle separation 
distance the attractive forces start dominating the repulsive forces. Moreover, Cyt c has 
patches of negatively charged (aspartic acid and glutamic acid) and positively charged 
(lysine) residues on its surface (Dickerson, 1971). Therefore, it is possible that due to low net 
charge and decreased electrostatic repulsion between DOTAP and Cyt c, the negatively 
charged face of Cyt c interacts with DOTAP and leads to higher entrapment. It was also 
noted that addition of pH 5 buffer to liposomal Cyt c lead to disintegration of blank 
liposomes and liposomal Cyt c. This phenomenon was then used to induce Cyt c release from 
liposomal Cyt c and to study aggregation, structural integrity and apoptotic activity of 
released Cyt c after buffer exchanging the released Cyt c to pH 7. These conditions of 
inducing Cyt c release from liposomes at pH 5 and changing pH to 7 also mimics the change 
in pH occurring in cells as the protein/delivery system traverses through endosomes (acidic 
pH) to cytosol (neutral pH). Released Cyt c from purified Form 2 showed changes in 
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secondary and heme crevice structure whereas released Cyt c from purified Form 1 showed 
CD spectra (for secondary structure and heme crevice structure) similar to processed-Cyt c at 
pH 7. Therefore, Cyt c released from Form1 was studied further for aggregation, deamidation 
and apoptotic activity.  As seen in Figure 5.8A & 5.8B, Cyt c released from purified Form 1 
showed no aggregation or deamidation. Moreover the apoptotic activity of Cyt c after its 
release from Form 1 (after Form 1was stored at 4 oC for seven and twenty eight days) was 
similar (P > 0.05) to fresh Cyt c apoptotic activity at day 0. The apoptotic activity of Form 1 
after incubation with MDA-MB-231 cells was checked with Annexin V FITC assay and 27% 
cells were found apoptotic after 24 h which was significantly higher than negative controls 
and liposome only blanks. Thus, by systematically evaluating the effect of various process 
and formulation conditions on structural integrity, aggregation potential and apoptosis 
inducing activity of Cyt c, a liposomal Cyt c system was developed with sufficient 
entrapment and without exposing the protein to organic solvent or high shear conditions. 
DOTAP was included in the formulation to induce endosomal release; however, the 
positively charged DOTAP-Chol liposomes are known to aggregate in presence of serum. 
Therefore, pegylation of DOTAP-Chol liposomes is necessary to confer serum stability. 
Thus, future research studies will be focused on characterizing DOTAP-Chol liposomes 
interaction with Cyt c in the presence of PEG lipids and the evaluation of pegylated system 
for Cyt c delivery both in vitro and in vivo. 
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Table 5.1 Characteristics of Formulation 1 and Formulation 2 
 
 
Formulations  Description  Size (nm) 
Formulation 1 (Form 1) Liposomal Cyt c; pH 8.5 SE 160 ± 10 
Formulation 2 (Form 2) Liposomal Cyt c; pH 8.5 FTE 170 ± 10 
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Figure 5.1 Microinjection studies of Cyt c. (A) Image showing MDA-MB-231 cells 
microinjected with Cyt c (20 pg) and rhodamine dextran (red) mixture. 20 pL volume was 
injected per injection. Flat and attached cells were counted as viable cells whereas rounded 
and floating cells were counted as dead cells. 5 h after microinjection, cells round up and 
number of flat cells could not be found at 20 pg/cell dose (B) Dose dependent cell death 
induced by Cyt c microinjecton in MDA-MB-231 cells, percent cell death was calculated 5 h 
after microinjection. For each dose at least 100 -150 cells were counted in total in three 
separate injections. 
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Figure 5.2 Effect of formulation and process conditions on aggregation of processed-Cyt c. 
Aggregation was measured using dynamic light scattering. (A) Processed-Cyt c did not show 
any aggregation under the tested conditions. The effect of three pH’s (5, 7 and 8.5) and two 
ionic strengths (15 mM and 150 mM) conditions were tested. (B) Processed-Cyt c showed 
aggregation (5% by mass) when it was subjected to pH 8.5 and 15 mM conditions and 
processed using freeze thaw extrusion (FTE) entrapment procedure. 
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Figure 5.3 Effect of formulation and process conditions on structural integrity of processed-
Cyt c. The x-axis is wavelength in nm. (A) α-helical secondary structure (222 nm and 208 
nm) of processed-Cyt c was intact after it was subjected to pH 7 and pH 8.5 and processed 
using sonication extrusion (SE) and freeze thaw extrusion (FTE) entrapment procedure (B) 
The heme crevice structure of Cyt c showed changes (lower intensity at 416 nm) when 
subjected to pH 8.5, pH 8.5 SE and pH 8.5 FTE conditions compared to pH 7.  
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Figure 5.4 Effect of pH on unfolding of Cyt c. Changes in UV absorbance of Fe occurs when 
Cyt c is unfolded (higher absorbance at 393 vs. 410 nm). Cytochrome c is present in folded 
confirmation between pH 3 and pH 8.5 and unfolding occurs below pH 3. 
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Figure 5.5 Effect of pH modulation of hydration buffer on entrapment of Cyt c in DOTAP-
Chol liposomes. A significant (p < 0.05) difference in entrapment of Cyt c in DOTAP-Chol 
liposomes was observed with a change in pH from 7 to pH 8.5 (15 mM). At pH 7 only 2% 
entrapment was observed, whereas at pH 8.5, the entrapment was 30%. At pH 5, entrapment 
studies could not be conducted due to disintegration of DOTAP-Chol liposomes. The average 
and SD of at least three separate experiments are plotted. 
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Figure 5.6 Schematic showing the process of inducing Cyt c release from purified liposomal 
Cyt c. The addition of pH 5 buffer lead to disintegration of liposomes into lipid fragments. 
Cyt c released in this way was collected in filtrate after passing through 100 KDa 
centrifugation filters. Released Cyt c pH was changed to pH 7 by buffer exchanging using 
3KDa centrifugation filters. Released and buffer exchanged Cyt c was tested for the presence 
of any aggregates, structural changes and apoptotic activity. 
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Figure 5.7 Secondary and heme crevice structure of released Cyt c (from purified Form 1and 
Form 2 were stored at 4 oC before release studies were conducted). (A) Released Cyt c from 
Form 1 showed secondary structure similar to Cyt c; pH 7, whereas released Cyt c from 
Form 2 showed lower intensity at 208 nm. (B) Released Cyt c from Form 1 showed heme 
crevice structure similar to Cyt c; pH 7 indicating that the change in heme crevice structure 
that occurred due to exposure to alkaline pH (8.5) was transient and reversible. However, in 
released Cyt c from Form 2, lower intensity at 416 nm was still observed indicating that the 
change in heme crevice structure induced due to exposure to pH 8.5 was not completely 
reversed. 
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Figure 5.8 Assessment of aggregation potential (A) and deamidation (B) of released Cyt c 
and control Cyt c. Purified Form 1 and control Cyt c were stored at 4 oC for seven days 
before these studies were conducted. (A) No aggregation of released Cyt c was observed. 
However, aggregates greater than one micron ( 0.1 % by mass) were observed for control Cyt 
c. (B) No change in mobility was observed for either released Cyt c or control Cyt c as 
measured by IEF. PI value of Cyt c was estimated to be 9.7.  
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Figure 5.9 Apoptosis induction by Formulation 1 in MDA-MB-231 cells. (A) Dual labeling 
(Annexin V FITC and PI) was used to determine apoptosis induction in MDA-MB-231 cells 
compared to controls. Percent cells in Q1 (PI only positive cells or necrotic cells), Q2 (PI and 
FITC positive or late apoptotic cells), Q3 (FITC only positive or early apoptotic cells) and 
Q4 (PI and FITC negative or viable cells) were quantified using flow cytometer. Significant 
increase in percent apoptotic cells was present after 24 h treatment with Form 1 and STS. (B) 
Kinetic study evaluating time dependent apoptosis induction. Percent apoptotic cells were 
calculated by adding the percentages together in Q2 and Q3. All controls were incubated for 
24 h and Form 1 was incubated for different time intervals. Control liposomes denote blank 
DOTAP-Chol liposomes. 
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Figure 5.10 Microinjection studies of released Cyt c. Retention of apoptotic activity of 
released Cyt c and control Cyt c was assessed using microinjection into MDA MB 231 cells. 
Activity was assessed after Cyt c was released after purified Form1 and control Cyt c were 
stored for seven and twenty eight days at 4 oC. No significant difference (p >0.05) was found 
between activity of released Cyt c, control Cyt c and fresh Cyt c (0 day) indicating that 
formulation and process conditions did not induce any changes that may interfere with Cyt 
c’s apoptotic activity. 
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Chapter VI 
 
Summary and Future Studies 
 
6.1    Part 1: Toxicity Evaluation of Cu, C-Cu, Ni and C-Ni NPs 
The hypothesis in these studies was that compared to non-coated Cu and Ni NPs, 
carbon coated Cu and Ni NPs will have different physico-chemical properties including their 
interactions with the surrounding media and cells which will influence the resultant toxicity 
in cell-based assays. By utilizing a battery of inter-disciplinary techniques for evaluation of 
the physico-chemical characteristics and cell based toxicity, it was shown that a correlation 
between physico-chemical characteristics and toxicity of NPs could be established especially 
for C-Cu and Cu NPs. Due to the presence of carbon coating, C-Cu NPs had less surface 
oxide and released lower Cu in cell culture media compared to Cu NPs. Furthermore, the 
cellular association of C-Cu NP in A549 cells was almost ten-fold higher compared to Cu 
NPs. These changes in interaction with cell culture media and cellular association for C-Cu 
NPs compared to Cu NPs also translated to results observed in cell based toxicity assays. C-
Cu NPs showed higher mitochondrial damage (45% damage by C-Cu NP versus 18% 
damage by Cu NP at 24 h) and lower plasma membrane damage (1-3% damage by C-Cu NPs 
versus 40% by Cu NPs at 25 µg/mL at 2 h) compared to Cu NPs. The higher mitochondrial 
damage by C-Cu NPs compared to Cu NPs was attributed to higher cellular association and 
presumably extended release of Cu ions after association with cells. Higher plasma
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 membrane damage by Cu NPs compared to C-Cu NPs was attributed to greater release of Cu 
ions by Cu NPs than C-Cu NPs in cell culture media. Thus, it was concluded that by studying 
the effect of a unique characteristic such as surface carbon coating, correlations could be 
drawn between toxicity and physico-chemical properties of NPs. In case of Ni and C-Ni NPs, 
no toxicity was observed in lysosomal membrane integrity test. C-Ni NPs showed only slight 
toxicity (mitochondrial damage) after 24 h incubation with A549 cells whereas no 
mitochondrial damage was observed with Ni NPs. These observations contrasted with almost 
equal cellular association of Ni and C-Ni NPs. Cellular association of metals after treatment 
of cells with metal NPs was determined using ICP-MS. After the cells were treated with NPs, 
they were washed twice to remove any surface bound NPs. However, even after washing, it 
is highly likely that some cell surface bound NP fraction will be present (especially if NPs 
are very hydrophobic) and that both cell associated as well as internalized fractions were 
analyzed. Thus, future studies should include quantitative assessment of internalized versus 
cell surface associated NPs. This will help correlate cellular toxicity results of Ni and C-Ni 
NPs with cellular uptake rather than cell association. Nickel toxicity has been reported to be 
dependent upon intracellular Ni ion concentration regardless of the initial dose. Therefore, it 
will be important to determine cellular uptake of Ni and C-Ni NPs (internalized) and 
correlate the cell uptake results with the toxicity results. In the studies reported herein, the 
major goal was to correlate physico-chemical properties with cytotoxicity. Therefore, the 
MTT assay (to assess mitochondrial damage) and neutral red assay (to assess lysosomal 
membrane damage) were used. Another important measure of toxicity that should be 
evaluated for all four NPs is the potential to induce inflammatory responses as this is an 
important factor for predicting safety in-vivo. For this purpose macrophage cell lines could be 
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used and inflammation may be assessed by measuring interleukin secretion. Moreover, an 
important goal of nanotoxicology studies in-vitro is to predict toxicity in-vivo. Therefore, the 
exposure conditions and cell culture systems that most closely mimic in-vivo conditions 
should be employed in future. Inhalation is the most common exposure route under 
occupational settings and therefore lung cell culture system with intact mucosal and ciliated 
barrier should be used in future studies to assess the toxicity of Cu, C-Cu, Ni and C-Ni NPs 
in-vitro. Additionally, it will be important to correlate the results of in-vitro toxicity and 
physico-chemical characterization to in-vivo inhalational toxicology studies so that critical 
parameters that define the correlation between physico-chemical properties and important in-
vivo end points could be determined. The knowledge derived from correlating physico-
chemical properties with toxicological findings will help guide prediction of NP toxicity and 
will contribute to achieve the ultimate goal of manufacturing safe and useful NPs.  
6.2    Part II: Intracellular Delivery of Cyt c to Induce Apoptosis in Breast Cancer Cells 
The hypothesis for these studies was that the entrapment of Cyt c in DOTAP-Chol 
liposomes prepared using film rehydration method will overcome the challenges for delivery 
of Cyt c while maintaining conditions for optimal Cyt c stability. Further, it was 
hypothesized that modulating the pH of hydration buffer will increase the entrapment of Cyt 
c in liposomes without compromising structural integrity and apoptosis inducing activity of 
Cyt c. 
Various formulation and process related stresses are encountered during protein 
entrapment using traditional nano-carrier approach of using PLGA particles. Therefore, to 
avoid any exposure to organic solvents and high shear/stress conditions, liposomal approach 
using film hydration method was used. Dioleoyl-trimethyl-ammonium-propane was used as 
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one the lipids to induce endosomal release of Cyt c/delivery system from endosomes to 
cytosol as entrapment in endosome can reduce efficacy. Liposomal formulation of proteins 
using film hydration method results in only limited protein entrapment. It was showed that by 
modulating the pH of hydration buffer during entrapment of Cyt c in DOTAP-Chol 
liposomes, entrapment was increased from 2% at pH 7 to 30% at pH 8.5. Cytochrome c has a 
PI value close to 10. The overall net charge on Cyt c is positive during conditions employed 
for entrapment (at pH 7 and 8.5). However, the net charge on a protein decreases at pH 
values approach closer to protein’s PI. Therefore decreased repulsion between the positively 
charged DOTAP-Chol film and Cyt c, and increased interaction between negatively charged 
patch on Cyt c (due to aspartic acid and glutamic acid) and positively charged DOTAP-Chol 
film at pH 8.5 could possibly explain higher entrapment at pH 8.5 compared to pH 7. 
Furthermore, since Cyt c entrapment in liposomes required pH adjustment closer to protein 
PI, extrusion and sonication, the effect of these conditions on Cyt c stability (aggregation, 
structural and chemical integrity) and apoptosis inducing activity was studied. It was shown 
that Cyt c structural integrity and activity was intact after it was released from optimized 
formulation stored at 4 ºC for seven and 28 days. Additionally, the apoptotic activity of 
optimized formulation was shown in MDA-MB -231cells in-vitro. The major focus in these 
studies was on formulation and developing a process to preserve Cyt c activity, which was 
accomplished as described above. However, inclusion of DOTAP in the formulation resulted 
in a highly positively-charged liposomal formulation which can result in aggregation of 
liposomes in the presence of serum proteins. Thus, future studies should examine ways to 
overcome this limitation. One way this could be accomplished is by inclusion of PEG lipids 
in liposomes. Interactions between Cyt c and DOTAP can change in presence of PEG. 
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Therefore, entrapment studies should be carried out in the presence of PEG. Usually, higher 
temperatures are required for PEG incorporation, therefore optimizing the right temperature 
for inclusion of PEG, so that Cyt c stability is not affected will also be important. The 
optimized pegylated formulation containing Cyt c should be tested for in-vivo efficacy in 
animal models and also long term stability of formulations should be investigated. In-vivo 
study design is very elaborate and contains various variables so only some of the important 
considerations for in-vivo studies are presented below.  
Various tumor models can be developed to test the anticancer efficacy of formulations. 
Xenograft, orthotopic and genetically engineered mouse models have been reported in the 
literature. Each model has its limitations and advantages. Therefore, selection of tumor 
model will depend on the goal of the study and available resources. In-vivo studies requires 
higher doses than in-vitro studies  and thus a more concentrated formulation due to limitation 
in injection volumes via IV (intra-venous) and SC (subcutaneous) routes are required. 
Therefore, scale up experiments should be performed to test the feasibility of developing 
concentrated formulations without compromising formulation characteristics and Cyt c 
stability. Proper control groups along with the formulation group should be included in in-
vivo studies in order to identify efficacy of formulated drug (Cyt c) over Cyt c alone and 
pegylated carrier. Another aspect of in-vivo studies should examine safety of formulations. 
Since some aggregated proteins are known to elicit immunogenic reactions, it will be 
important to test for any immunogenic reactions in addition to standard toxicity indices such 
as blood chemistry and body weight, etc. If the formulation shows promising anticancer 
activity in preliminary in-vivo studies, it will be important to examine the dosing regimen and 
pharmacokinetics of optimized formulation. Since repeated dosing is often required to sustain 
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the anticancer activity, long-term stability of Cyt c in formulation should also be 
investigated. A formulation should be stable for sufficient period of time at an appropriate 
storage condition so that repeated dosing could be performed. Thus, detailed characterization 
of preservation of Cyt c structural and chemical integrity, and retention of apoptosis inducing 
activity after long term storage should be assessed.   
The studies mentioned above will ultimately contribute to the overall goal of 
developing a viable formulation for intracellular delivery of Cyt c for the treatment of breast 
cancer. 
  
Appendix A 
 
Characterization and Toxicity Analysis of CeO2 Nanoparticles 
 
A.1    Summary 
The work on evaluation and characterization of CeO2 NPs described here was part of 
the report contributed to the round robin effort of studying CeO2 NPs across different 
universities funded by SRC (Semiconductor Research Corporation) SEMATECH 
Engineering Research Center for Environmentally Benign Semiconductor Manufacturing. 
Following studies were conducted  
• Cerium oxide nanoparticle characterization: particle size, zeta potential and surface 
composition analysis using X-ray Photoelectron Spectroscopy (XPS). 
• Cerium oxide nanoparticle in-vitro toxicity studies: assessment of mitochondrial 
function and membrane integrity. 
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A.2    Materials and Methods 
Materials 
Cerium oxide NPs (10% wt/wt suspension, pH 4.5 in water) were provided by Dr. 
Yongsheng Chen from Georgia Institute of Technology. A549 lung cancer cells were 
purchased from ATCC and maintained in DMEM (Dulbecco’s Modified Eagle’s Medium) 
with 10% FBS (Fetal Bovine Serum), 5 µg/mL plasmocin (Invivogen), 100 U/mL penicillin 
and 100 µg/mL streptomycin (ATCC). MTT and Neutral Red reagents were purchased from 
Sigma Aldrich. Dispex A40 was provided as a gift by BASF. Beckman Coulter N5 
submicron particle size analyzer was used for particle size analysis. This instrument relies 
upon dynamic light scattering to measure particle size between 3 nm to 3000 nm. A 90º 
scattering angle was used for all measurements. For zeta potential analysis, Malvern Zeta 
Sizer NanoZ was used. Viscosity and refractive index and dielectric constant of water at 25º 
C were used for calculating the potential using Smoluchowski model. Zen 1002-zeta dip cell 
was used for all measurements. For XPS analysis, Kratos AXIS ultra DLD photoelectron 
spectrometer. Energy Source was Al Kα rays. Area analyzed for XPS was 300u x 700 µm2. 
Surface Composition Analysis using XPS 
The CeO2 nanoparticle stock (10% wt/wt) was slightly vortexed and sonicated for three 
minutes using a bath sonicator and diluted to 2 mg/mL concentration in DI water. X-ray 
photoelectron spectroscopic analysis was carried out on gold sputtered silicon wafers on 
which a droplet of nanoparticle suspension was placed and allowed to air dry. Full spectrum 
for CeO2 NPs as well as high resolution spectrum was obtained for cerium, carbon and 
oxygen. 
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Particle Size Analysis  
The stock of CeO2 NPs (10% wt/wt) was slightly vortexed and sonicated for three 
minutes using a bath sonicator.  A diluted suspension of 10mg/mL concentration in DI (De-
Ionized) water (pH 6) was prepared from the sonicated stock.  A further dilution to 20 µg/mL 
was made in DI water (pH 6), DI water with 0.5% v/v Dispex A40 , DI water (pH 7), DI 
water (pH 4.5), DMEM media and DMEM media supplemented with 10% FBS. The diluted 
samples were further sonicated for three minutes using a bath sonicator. One ml of above 
mentioned samples were analyzed at 0 h (immediately after preparation) and at 24 h (storage 
at room temperature) using Beckman Coulter N5 submicron particle size analyzer.  Three 
independent runs were performed for each sample.  
Zeta Potential Analysis 
The stock of CeO2 NPs (10% wt/wt) was slightly vortexed and sonicated for three 
minutes using a bath sonicator.  A diluted suspension of 10 mg/mL concentration in DI (De-
Ionized) water (pH 6) was prepared from the sonicated stock.  A further dilution to 200 
µg/mL was made in DI water (pH 6), DI water (pH 7) and DI water (pH 4.5). The diluted 
samples were further sonicated for three minutes using a bath sonicator. 700 µl of above 
mentioned samples were analyzed using the Zen 1002-zeta dip cell in the Malvern Zeta Sizer 
NanoZ. Each measurement cycle comprised of fifteen runs with three sub-runs.  
Membrane Integrity Assay 
For assessment of membrane integrity, neutral red dye was used. Neutral red is 
permeable to all cells but is retained only in cells with intact lysosomal membrane as its 
binds to the anionic sites in the lysosomes. Any insult to cell resulting in lysosomal 
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membrane damage results in decreased uptake of neutral red; which is also the principle of 
this assay. A549 cells (15,000 cells/well in a 96 well plate) were allowed to attach overnight. 
For 24 h, cells were treated with 25, 50, 100, 250, 500 and 1000 µg/mL doses of CeO2 NPs. 
All dilutions for different doses were made 10X in DI water and the desired concentration in 
well was achieved after a tenfold dilution of 20 µL of nanoparticle stocks when added to 180 
µL of DMEM media with FBS. After 24 h treatment, cells were washed twice with PBS 
(Phosphate Buffered Saline) to remove excess NPs and neutral red dye in media was allowed 
to incubate with the cells for 4 h. Appropriate controls such as NPs alone with neutral red dye 
and cells with NPs without neutral red dye were incubated to account for any interference. 
A549 cells without any treatment were the negative control for this experiment. After 
washing the cells once with PBS, the incorporated neutral red dye was extracted using a 
mixture of water, ethanol and glacial acetic acid. The absorbance was measured at 540 nm 
and results were reported as percent membrane integrity compared to negative control. A 
similar study was also carried out to evaluate the effect of 25, 50, 100, 250, 500 and 1000 
µg/mL doses of CeO2 NPs in the presence of 0.05% v/v Dispex A40. An extra control in this 
set of experiment was to incubate the cells with 0.05% v/v Dispex A40. 
Mitochondrial Function Assay 
In cells with functional mitochondria, MTT (yellow colored) is reduced to a formazan 
derivative (blue color) which is quantified after solubilization of the formazan derivative in 
DMSO. Dimethyl-thiazolyl-diphenyl-tetrazolium bromide (MTT)  was used to evaluate the 
mitochondrial function of A549 cells (15,000 cells/well in a 96 well plate) after 24 h 
treatment with  25, 50, 100, 250, 500 and 1000 µg/mL doses of CeO2 NPs. Similar to the 
neutral red study, all dilutions for different doses were made 10X in DI water and the desired 
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concentration in well was achieved after a tenfold dilution of 20 µL of NPs stock when added 
to 180 µL of DMEM media with FBS. After 24 hr treatment, cells were washed twice with 
PBS (Phosphate Buffered Saline) to remove excess NPs and MTT reagent in media was 
allowed to incubate with the cells for 4 h.  Appropriate controls such as NPs alone with MTT 
reagent and cells with NPs without MTT dye were incubated to account for any interference. 
A549 cells without any treatment were the negative control for this experiment. After 
washing the cells once with PBS, the reduced formazan derivative was solubilized using 
DMSO.  The absorbance was measured at 570 nm and results were reported as percent 
mitochondrial function compared to negative control. 
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A.3    Results and Discussion 
XPS Analysis 
In the full spectrum of CeO2 NPs (Figure A.1), characteristic peaks from Ce, O and C 
were observed. The characteristic peaks from Ce were at 122 eV and 124 eV (Ce 4d); 221 eV 
and 222 eV (Ce 4p); 883 eV, 899 eV and 917 eV (Ce 3d). Cerium auger peaks were observed 
at 730 eV and 833 eV. The O1s characteristic peak was observed at 530eV. A small C1s 
peak was also observed at 285 eV and 289 eV. The presence of carbon in the CeO2 
nanoparticle samples is due to atmospheric contamination and some degree of surface carbon 
contamination is observed on all samples in XPS analysis.  A Na peak was also observed at 
513 eV. The relative percent atomic concentrations of various elements was 26.8% (Ce), 
52.6% (O), 18.3% (C ) and 2.2% (Na). 
Particle Size Analysis 
A summary of particle size average and SD calculated from three independent runs 
from each sample at 0 h and 24 h respectively is shown in Table A.1 and Table A.2. Clearly 
a pH, time and media dependent effect on CeO2 nanoparticle size was observed.  At 0 h, 
average particle size at pH 7 was a log fold higher than that at pH 4.5 or pH 6. The addition 
of 0.5% v/v Dispex A40 helped maintain the NPs in dispersion and the particle size was 
comparable to suspensions at pH 4.5 or pH 6. Particle size in the presence of 10% FBS in 
DMEM media was close to three-fold lower as compared to particle size in DMEM without 
10% FBS. This may be a result of stabilization of particles due to coating of proteins present 
in the serum.  
After 24 h storage at room temperature, for NPs in H2O at pH 4.5, pH 6, 0.5% v/v 
Dispex A40 and in DMEM media with 10% FBS, no significant change in the average 
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particle size was observed. Whereas for NPs in H2O at pH 7 and in DMEM without FBS, 
most of the particles measured were at the upper limit of the instrument e.g, near 3000 nm. 
The representative particle size distributions of CeO2 NPs are also shown in Figure A.2. 
Zeta Potential 
The zeta potential was measured using 200 µg/mL concentrations of CeO2 NPs. The 
average zeta potential (mV) is reported in Table A.3.  It is important to note that like particle 
size, zeta potential results obtained from the instrument are an average value for each 
measurement but there also exists a considerable range for that reported average. This is 
reported as “SD within one measurement” in Table A.3. Considering SD within one 
measurement, similar value of zeta potentials were obtained at pH 4.5 and pH 6. However, at 
pH 7, it was difficult to achieve reproducible measurements since the SD within one 
measurement exceeded the average value. 
Mitochondrial Function Assay  
No significant alteration in mitochondrial function after treatment with CeO2 NPs was 
observed up to 1000 µg/mL (Figure A.3). Both controls, NPs alone with MTT dye and cells 
with NPs without MTT dye did not show any interference with the assay. 
Membrane Integrity Assay 
No significant alteration in membrane integrity as assessed by uptake of neutral red dye 
was observed after treatment with CeO2 NPs up to 1000 µg/ml (Figure A.4). Even in the 
presence of 0.05% v/v Dispex A40, toxicity was not observed with any dose level (Figure 
A.5). Cells with NPs without neutral red dye did not show any interference with the assay, 
although the data was corrected for interference from NPs with neutral red dye. 
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A.4    Conclusions 
X-ray photoelectron spectroscopy analysis confirmed presence of CeO2 as the major 
species on the top 5 nm of the NPs. Except Na, no other contaminating metal was found. 
Particle Size of CeO2 NPs was found to be dependent on pH and presence of FBS.  Lower 
pH and presence of proteins seems to stabilize NPs. No significant toxicity of CeO2 NPs was 
observed after 24 h treatment of A549 cells in-vitro in either mitochondrial function or 
membrane integrity assay. Addition of Dispex A40 (0.05% v/v) does not alter the toxicity 
profile of CeO2 NPs when tested using the membrane integrity assay. 
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Table A.1 Average particle size and SD of CeO2 NPs in various medium at 0 h 
 
 
 
 
 
 
 
 
 
 
Sample (CeO2, 20µg/ml) pH Average (nm) SD 
H2O  4.5 124 16 
  6 122 15 
  7 1151 450 
  
H2O  with 0.5% v/v Dispex A40  8 140 14 
        
DMEM, No FBS 7.4 1547 155 
 DMEM + 10% FBS 7.4 455 22 
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Table A.2 Average particle size and SD of CeO2 NPs in various medium at 24 h 
 
 
 
 
 
 
 
 
 
 
Sample (CeO2, 20 µg/ml) pH Average (nm) SD 
H2O  4.5 144 12 
  6 114 3 
  7 3000 0 
  
H2O  with 0.5% v/v Dispex A40 8 150 26 
  
DMEM, No FBS 7.4 2964 6 
  
DMEM + 10% FBS 7.4 475 66 
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Table A.3 Average zeta potential and SD 
 
Sample (CeO2, 200 
µg/mL) 
pH 
Average of three 
Measurements (mV) 
SD within one 
measurement 
SD between three 
measurements 
H2O 
4.5 30 11 0 
6 43 17 3 
7 Could not obtain reproducible measurements 
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Figure A.1 Full XPS Spectrum of CeO2 NPs 
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Figure A.2  Particle size distributions of CeO2 NPs in (A) H2O, 0 h (B) H2O, 24 h (C) 
Media, 0 h (D) Media, 24 h (E) H2O with Dispex A40, 0 h (F) H2O with Dispex A40, 24 h 
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Figure A.3 Mitochondrial function assay. A549 cells were treated with CeO2 NPs for 24 h 
(n=3). 
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Figure A.4 Neutral red membrane integrity assay. A549 cells were treated with CeO2 NPs 
for 24 h (n=3). 
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Figure A.5 Neutral red membrane integrity assay with Dispex. A549 cells were treated with 
CeO2 NPs with 0.05% v/v Dispex A40 for 24 h (n=3). 
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Appendix B 
 
Cardiolipin Cytochrome c Complexes for Intracellular Delivery of Cyt c 
 
B.1    Introduction 
Cardiolipin (CL) is a diphosphatidyl glycerol lipid with four alkyl chains bound to the 
glycerol backbone. Cardiolipin is majorly found in inner mitochondrial membranes 
(Rytomaa et al., 1992). In humans, heart Linoleic acid (C18:2) is the most common 
component, whereas in lymphoblast cells, oleic acid is the major fatty acid component 
(C18:1). In mitochondria, Cyt c is present both in free and membrane bound fractions. The 
bound form of Cyt c is present in association with CL. Cytochrome c (15%) is bound tightly 
(through both electrostatic and hydrophobic interactions) with CL whereas rest of it is bound 
loosely (electrostatic interaction) (Kagan et al., 2004). Extensive research has been focused 
on delineating the mechanism of Cyt c–CL interactions. The current understanding is that 
Cyt c in a loosely bound form serves as a mobile electron carrier between complex III and IV 
in the respiratory pathway and in tightly bound form it acts as a peroxidase (Kagan et al., 
2005). It has been postulated that Cyt c can bind to CL simultaneously by (a) electrostatic 
interaction, through interaction between deprotonated phosphate group in CL and Lys 72 and 
73 in Cyt c (which is also known as the “A site”) and (b) via the hydrogen binding at the “C 
site” i.e. Asn 52 in Cyt c and protonated phosphate group in CL. Based on different
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conditions such as pH and H2O2 concentration, the binding between Cyt c and CL is sensitive 
to change (Kagan et al., 2004; Rytomaa and Kinnunen, 1995; Rytomaa et al.1992). The 
loosely bound form of Cyt c–CL can be reversed by increasing ionic strength and does not 
involve pronounced conformational change and all six coordination sites of heme iron are 
occupied, whereas at the C site, partial unfolding of protein occurs with the disruption of S-
Fe coordination bond between Met-80 and heme iron is possible (Belikova et al., 2006). 
Binding through C site can also affect secondary structure of Cyt c and a decrease in α-
helical content has been reported. It was hypothesized that the electrostatic interaction 
between Cyt c and CL could be utilized to formulate a negatively charged complex which 
could then be coated with DOTAP-Chol liposomes so that the resulting positively charged 
complex could be used for intracellular delivery of Cyt c in MDA-MB-231 breast cancer 
cells to induce apoptosis. 
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B.2    Materials and Methods 
Materials 
Cytochrome c (equine heart) and cholesterol were purchased from Sigma Aldrich (St. 
Louis, MO).  DOTAP and CL (bovine heart) were purchased from Avanti Polar Lipids, Inc. 
(Alabaster, AL). RPMI media was purchased from Invitrogen (Carlsbad, CA). MDA-MB-
231 breast cancer cell line, penicillin-streptomycin solution and fetal bovine serum (FBS) 
were purchased from ATCC. Plasmocin was purchased from Invivogen (San Diego, CA). 
Caspase Glo® reagent was purchased from Promega. All chemicals were used without any 
further purification. 
Formulation of CL-Cyt c complexes 
For formulation of CL-Cyt c complexes, CL liposomes were first prepared by film 
hydration method. A series of CL liposomes containing increasing concentration of CL (83, 
166, 332, 664, 1328 and 2656 nano mol lipid) were prepared. To a series of glass vials, 
different volumes of 10 mg/mL CL solution in chloroform were added and chloroform was 
evaporated under a stream of nitrogen. The glass vials were then kept in vacuum for 3-4 h to 
allow complete evaporation of chloroform after which, 1 mL DI water was added to each of 
the glass vials containing dried CL lipid film and the vials were kept at RT for 3-4 h to allow 
hydration of lipid films. After hydration, the lipid suspension in DI water was vortexed for 1 
min and extruded 20 times through polycarbonate filters (50 nm size). To the series of glass 
vials containing 900 µL of CL liposomes (each with different concentration of CL), 100 µL 
Cyt c solution (10 mg/mL) was added drop wise while vortexing the vial for 1 min. The 
resulting complex particle size and zeta potential were measured using Beckman Coulter N5 
Submicron Particle Size Analyzer and Malvern Zeta Sizer Nano Z. 
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Formulation of DOTAP-Chol (DOTAP-Chol) coated CL-Cyt c complex 
To prepare DOTAP-Chol coated CL-Cyt c complex, a concentrated suspension 
containing DOTAP-Chol (1:1 mol to mol) liposomes were prepared using film hydration 
method. Briefly, lipids (8µmol DOTAP and 8 µmol Chol) dissolved in chloroform were 
added to a 7 mL glass vial and chloroform was evaporated under a stream of nitrogen. The 
glass vial was then kept in vacuum for 3-4 h to allow complete evaporation of chloroform 
after which, 1 mL DI water was added to the vial containing dried lipid film. The lipid 
suspension in the vial was vortexed for 1 min. This was followed by bath sonication for 1 
min, after which the vial was kept at 4 ºC for overnight hydration. The following day the 
hydrated lipid suspension was serially extruded through 400 nm (12 extrusion cycles), 200 
nm (12 extrusion cycles), 100 nm (15 extrusion cycles) and 50 nm (15 extrusion cycles) 
polycarbonate filters. To coat CL-Cyt c complex, the complex with 8:1 CL: Cyt c (mol to 
mol) composition was selected.  Several dilutions from the concentrated DOTAP-Chol 
liposomes were prepared by dilution with DI water in eppendorf tubes. To each eppendorf 
containing 160 µL diluted DOTAP-Chol liposomes, 40 uL of CL-Cyt ccomplex (8:1 
mol:mol) was added and the mixture was pipetted up and down twenty times to allow charge 
interaction between negatively charged CL-Cyt c complex and positively charged DOTAP-
Chol liposomes. The dilutions for DOTAP-Chol liposomes was carried out so that after 
mixing CL-Cyt c complex, different  mol to mol ratio of DOTAP:CL could be achieved 
(1.5:1, 3:1, 6:1, 12:1,18:1, 24:1, 36:1 and 42:1). The particle size and zeta potential of all 
complexes were measured using Beckman Coulter N5 Submicron Particle Size Analyzer and 
Malvern Zeta Sizer Nano Z. 
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TEM analysis of liposomes and complexes 
Transmission electron microscopy images of CL liposomes, CL-Cyt c complexes and 
DOTAP-Chol coated CL-Cyt c complexes were acquired using FEI-Philips Tecnai 12 
transmission electron microscope. The samples (liposomes/complexes) were allowed to 
deposit on carbon coated copper TEM grids for 1 min after which the excess sample was 
removed using a blotting paper. Negative staining was accomplished by using 1% uranyl 
acetate solution which was allowed to deposit on the sample for 30 sec to 1 min after which 
excess was removed using a blotting paper. The sample was air dried for a few minutes and 
then imaged. 
Caspase Assay to study induction of apoptosis in MDA-MB-231 Cells 
Caspase 3 and 7 are known as effector caspases which are responsible for breaking 
down the cell cytoskeleton during apoptosis. To test the apoptosis inducing activity of 
DOTAP-Chol coated CL-Cyt c complex to induce apoptosis in-vitro in MDA-MB-231 cells, 
caspase assay was used. MDA-MB-231 cells (6,000) were seeded in 96 well plate and 
allowed to attach for 24 h at 37 ºC. The following day, media was changed to serum free 
RPMI media and various treatments were added and allowed to incubate for 4 h. Various 
treatments included Cyt c alone, CL-Cyt c complex, CL liposomes, DOTAP-Chol liposomes, 
DOTAP-CL complex and DOTAP-CL-Cyt c complex. Negative control was MDA-MB-231 
cells without any treatment and positive control was Sturosporine (STS) treated cells (4 µM 
overnight treatment). Caspase Glo kit® from Promega was used to quantify caspase activity 
and manufacturer’s instructions were followed. Luminescence was quantified using Biotek 
Synergy Plate Reader. 
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B.3    Results and Discussion 
Formulation of CL-Cyt c complexes 
Naturally occurring electrostatic interaction between Cyt c and CL was utilized to form 
a CL-Cyt c complex which could then be utilized as a core for the DOTAP-Chol coating. The 
goal was to identify the mol ratio at which a negatively charged CL-Cyt c core could be 
formed within in a nano size range and then be coated with positively charged DOTAP-Chol 
liposomes. Complexes with various mol ratios of CL and Cyt c were formulated and 
monitored for particle size and zeta potential. The particle size of the complexes decreased 
and zeta potential increased (negative) as the CL amount in the complex was increased 
(Table B.1). Starting with 4:1mol ratio, CL:Cyt c nanosize complex were formed. The large 
SD values of particle size can be attributed to two sized populations formed upon 
complexation of Cyt c with CL. Rod shaped structures were formed in addition to spherical 
complexes (Figure B.3). Inverted hexagonal phases (rod shaped structures) are lipid 
polymorphs where the hydrophobic lipid chains extend out into aqueous medium and the 
hydrophilic head is towards the core. Lipids with a bulky lipid tail have an increased 
tendency to form inverted hexagonal phases. Formation of inverted hexagonal phases by CL 
after association with Cyt c has previously been reported (De Kruijff et al., 1982).  It was 
decided to use CL-Cyt c complex with 8:1 mol ratio for further coating by DOTAP-Chol 
liposomes because of sub 100 nm size and lower SD values. 
Formulation of DOTAP-Chol (DOTAP-Chol) coated CL-Cyt c complex 
Dioleoyl-trimethyl-ammonium-propane and cholestrol liposomes were positively 
charged (50 mV, Figure B.4) and about 100 nm in size. For coating the CL-Cyt c complex 
with DOTAP-Chol liposomes, the mol ratio of DOTAP to CL was varied from 1.5:1 to 42:1. 
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Between mol ratio of 1:5 and 1:12, very high SD values were observed although the zeta 
potential values remained in 30-40 mV range. This could be due to insufficient DOTAP 
coating on the CL-Cyt c core. At 18:1 DOTAP:CL ratio, particle size of 160 nm and zeta 
potential of 40 mV was observed. The particle size and zeta potential did not change even at 
higher DOTAP:CL mol ratios, therefore DOTAP:CL 18:1 mol ratio was selected for further 
cell based assays. 
Caspase Assay to study induction of apoptosis in MDA-MB-231 Cells 
The caspase assay results (Figure B.4) showed that CL-Cyt c complex or DOTAP-
Chol coated CL complex did not induce caspase activation above baseline levels as response 
was similar to the negative control. However, CL liposomes and DOTAP-Chol–CL complex 
treatment induced caspase activation.  Interestingly, the DOTAP-Chol-CL induced activation 
of caspase was higher than CL liposomes alone and indicated that DOTAP-Chol liposomes 
facilitated CL induced caspase activation. Baseline level of caspase activation was observed 
with DOTAP-Chol liposomes alone indicating that the higher caspase response observed 
after treatment with DOTAP-Chol-CLcomplex may be attributed to higher cell uptake of this 
complex (due to DOTAP) compared with CL liposomes alone. Although not shown in the 
figure, it was confirmed that the increased response (caspase activation) observed with CL 
liposomes and DOTAP-Chol–CL complex was specifically a caspase signal, because after 
incubating a caspase inhibitor (a selective binding agent for activated caspase that prevents it 
from cleaving the substrate in the reagent kit and inducing a luminescence response), the 
baseline luminescence response was observed. Although the incubation time was only 4 h 
and it can be argued that at longer incubation times, may be some level of caspase activity 
would have been observed with DOTAP-Chol coated CL-Cyt c complex, but because higher 
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caspase activation was observed with CL and DOTAP-Chol-CL complexes, it was decided 
not to move forward with this strategy for encapsulating Cyt c.  
B.4    Conclusion 
It was shown that a negatively CL-Cyt c complex was formulated with a particle size 
of about 100 nm. It was also showed that this negatively charged complex was coated with 
DOTAP-Chol liposomes so that a positively charged complex was formed with a particle 
size of 160 nm. When the DOTAP-Chol-CL-Cyt c complex was tested for caspase induction 
activity in-vitro, it did not induce caspase induction above baseline levels. However, higher 
caspase induction was observed after treatment with CL liposomes and DOTAP-Chol-CL 
complex controls which indicated that CL was toxic and therefore this strategy of using CL 
to deliver Cyt c was not pursued further. 
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Table B.1 Particle Size and Zeta Potential Analysis of CL-Cyt c Complex 
 
Mol Ratio (CL_Cyt c) PS (nm) SD ZP (mV) SD 
1_1 2466 668 0.8 5 
2_1 544 414 -2 4 
4_1 119 67 -27 10 
8_1 99 49 -32 10 
16_1 120 52 -38 12 
32_1 121 48 -37 12 
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Figure B.1 Schematic illustrating formulation of complexes 
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Figure B.2 Particle size and zeta potential analysis of DOTAP-Chol-CL-Cyt complex. 
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Figure B.3 TEM images of liposomes and complexes. DCCC means DOTAPChol-CL-Cyt c. 
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Figure B.4 Evaluation of Caspase activity of various complexes 
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